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Faust. Habe nun, ach! Philosophie, 
Juristerei und Medizin, 
Und leider auch Theologie! 
Durchaus studiert, mit heißem Bemühn. 
Da steh’ ich nun, ich armer Tor, 
Und bin so klug als wie zuvor! 
Heiße Magister, heiße Doktor gar, 
Und ziehe schon an die zehen Jahr, 
Herauf, herab und quer und krumm, 
Meine Schüler an der Nase herum – 
Und sehe, daß wir nichts wissen können! 
Das will mir schier das Herz verbrennen. 
Zwar bin ich gescheiter als alle die Laffen, 
Doktoren, Magister, Schreiber und Pfaffen; 
Mich plagen keine Skrupel noch Zweifel, 
Fürchte mich weder vor Hölle noch Teufel – 
Dafür ist mir auch alle Freud’ entrissen, 
Bilde mir nicht einm was Rechts zu wissen, 
Bilde mir nicht ein, ich könnte was lehren, 
Die Menschen zu bessern und zu bekehren. 
Auch hab’ ich weder Gut noch Geld, 
Noch Ehr’ und Herrlichkeit der Welt; 
Es möchte kein Hund so länger leben! 
Drum hab’ ich mich der Magie ergeben, 
Ob mir durch Geistes Kraft und Mund 
Nicht manch Geheimnis würde kund; 
Daß ich nicht mehr mit sauerm Schweiß, 
Zu sagen brauche, was ich nicht weiß; 
Daß ich erkenne, was die Welt 
Im Innersten zusammenhält, 
Schau’ alle Wirkenskraft und Samen, 
Und tu’ nicht mehr in Worten kramen. 
      Johann Wolfgang von Goethe 
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Summary 
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Neuronal circuits form the basis of a functional nervous system to process and integrate 
information and to react to environmental cues. The formation of functional synaptic 
connections between neurons is essential for the establishment of these circuits. During 
development and in response to activity information processing within neuronal circuits is 
adjusted by the selective addition or elimination of individual synapses. Impairment of 
synapse stability can lead to the disruption of neuronal circuits and results in severe 
neurodegenerative diseases. Thus, it is important to understand the molecular mechanisms 
controlling synaptic maintenance and plasticity. 
Trans-synaptic interactions mediated by cell adhesion molecules (CAMs) have the potential 
to provide a stable connection between two neighboring neurons. Many cell adhesion 
molecules have been identified controlling the initial steps of neuronal circuit formation such 
as axon guidance, target recognition and synaptogenesis. However detailed knowledge about 
the identity and regulation of cell adhesion molecules during synapse stabilization is missing 
to date. 
In this study I used the Drosophila melanogaster larval neuromuscular junction (NMJ) as a 
model system to identify novel cell adhesion molecules controlling synaptic maintenance in 
vivo. I performed an unbiased RNAi-based screen targeting entire classes of cell adhesion 
molecules with potential functions during nervous system development. I identified a number 
of novel candidates that have the potential to control synapse stabilization and performed a 
detailed characterization of two genes: neuroglian (nrg) encoding the L1-type CAM and 
CG31708 (uhu) coding for an Immunoglobulin (Ig) domain protein 
The L1-type CAM Neuroglian has the capability to interact with the adaptor protein 
Ankyrin2 (Ank2), which is part of a molecular network underneath the cell membrane that 
can control synapse stability by directly coupling CAMs to the presynaptic actin and 
microtubule cytoskeleton. In addition to Ank2, this network consists of the scaffolding 
proteins α- and β-Spectrin and the actin capping molecule Hts/Adducin. By combining 
biochemical, biophysical and genetic assays I demonstrated that the impairment of Ankyrin 
binding causes an increase in Nrg mobility that correlates with increased synaptic growth but 
decreased stability. In summary my results provide evidence of a novel regulatory module 
controlling synapse stability and growth through the regulated interaction between L1-type 
CAMs and Ankyrins.  
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1. Introduction 
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The nervous system is composed of billions of neurons and glial cells that form a complex 
interconnected structure to process information which is transferred via electrical signals 
(action potentials, AP) that are propagated from one cell to the other through direct 
connections between neurons. The synaptic contacts are asymmetric to ensure directionality 
of information transfer (Bucher and Goaillard, 2011). A functional unit in the nervous system 
is a neuronal circuit which can consist of many different neuronal cell types that can be 
located in very distant locations within the brain or body. To form a functional circuit the 
axons of the neurons have to perform the difficult task to navigate through the body and find 
the right target area and cell (Maness and Schachner, 2007; Schwarting and Henion, 2011). 
After the first contact various changes within the pre- and postsynaptic cell have to occur to 
ensure the functionality of the synapse (Lu et al., 2009; Owald and Sigrist, 2009). During 
nervous system development in many cases exuberant synaptic contacts form that are not 
needed for the mature circuit (Low and Cheng, 2005). In a process called pruning these 
additional contacts are removed in a controlled fashion to ensure the stability of the circuit 
(Faulkner et al., 2007; Low and Cheng, 2005). In response to activity changes, neuronal 
circuits can change their wiring pattern to adapt and allow for learning and memory 
(Bednarek and Caroni, 2011; Ruediger et al., 2011). In contrast, most synaptic contacts 
remain stable during lifetime to ensure proper nervous system function (Bednarek and 
Caroni, 2011). Failures in synaptic maintenance can result in severe neurodegenerative 
disease including amyotrophic lateral sclerosis (ALS) or spinal muscular atrophy (Boillee et 
al., 2006; Dion et al., 2009). A brief summary of the processes important for neuronal circuit 
assembly is shown in Figure 1.  
 
Figure 1 - Steps of synapse development 
Neuronal circuits are the basis of a functional nervous system. They consist of multiple neurons that 
form specialized connections with each other called synapses. Synapses are important to process and 
transfer action potentials thus information about external or internal cues. Synapse formation can be 
divided into three distinct steps. (a) Axon guidance and target recognition: A dynamic growth cone 
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extends towards the target area and finds its right target cell and sub cellular department.  
(b) Synaptogenesis: Once the right target cell is reached an initial synaptic contact is made and pre- 
and postsynaptic specializations are formed. The immature synapse differentiates into a functional 
mature synapse. (c) Synapse elimination and maintenance: During and after development synaptic 
contacts need to be stable but at the same time allow dynamic changes of the wiring pattern due to 
pruning of excessive synapse formation during normal development or activity changes during 
learning and memory. 
Trans-synaptic interactions mediated by CAMs have the potential to control formation, 
function and stability of neuronal circuits (Dalva et al., 2007; Shapiro et al., 2007). In my 
RNAi screen I targeted entire classes of CAMs to identify important players for synapse 
stabilization. Here, I would like to briefly describe key characteristics of the different classes 
of CAMs included in my screen and then highlight some examples during the three steps of 
neuronal circuit development shown in Figure 1. 
1.1. Cell adhesion molecules in the nervous system 
The classes of CAMs included in the screen were the Cadherins, Integrins, Ig-domain 
proteins, Semaphorins and leucine-rich repeat (LRR) proteins (Shapiro et al., 2007). 
Cadherins are homophilic cell adhesion molecules that can provide adhesion between 
neighboring cells and can be regulated in a Ca2+-dependent manner (Arikkath and Reichardt, 
2008; Shapiro and Weis, 2009; Tanaka et al., 2000). Integrins are single pass transmembrane 
proteins, which consist of a large extracellular domain and a small intracellular domain. The 
functional unit of an Integrin is a heterodimer of α- and β-subunits (Arnaout et al., 2005; 
Humphries et al., 2003). Integrins have been implicated in many functions in the nervous 
system such as learning and memory (Grotewiel et al., 1998; McGeachie et al., 2011). 
Members of the class of Ig-domain proteins usually harbor multiple Ig-domains in their 
extracellular domain that promote homo- and heterophilic interactions (Blaess et al., 1998; 
Castellani et al., 2002; Hillenbrand et al., 1999; Volkmer et al., 1996). Examples for Ig-
domain proteins are the NCAM family, the SynCAM family and the L1CAM family (Kriebel 
et al., 2012; Maness and Schachner, 2007; Schmid and Maness, 2008). The cytoplasmic 
domain of Ig-domain proteins is important for downstream signaling and connections to the 
cytoskeleton (Forni et al., 2004; Garver et al., 1997; Gil et al., 2003; Islam et al., 2004; 
Pollerberg et al., 1987; Tuvia et al., 1997). Semaphorins are a heterogeneous class of secreted 
and transmembrane proteins characterized by special Sema domains (Kolodkin et al., 1993). 
They interact with their receptors called Plexins and Neuropilins (Raper, 2000) but also can 
interact with Ig-domain proteins (Castellani et al., 2002; Godenschwege and Murphey, 2009). 
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The last class of CAMs I would like to describe here are the leucine-rich repeat (LRR) 
proteins (de Wit et al., 2011; Linhoff et al., 2009). LRR domains are generally known as 
protein-protein interaction domains and proteins with this domain can be either secreted or 
harboring a transmembrane domain (Chen et al., 2001; Linhoff et al., 2009; Owuor et al., 
2009). Many LRR proteins are essential for nervous system development and function (Chen 
et al., 2001; Ko et al., 2009; Linhoff et al., 2009) 
1.2. Axon guidance 
The axonal growth cone of a newborn neuron navigates through the brain by using a variety 
of navigation cues. These include interaction with proteins presented on cells at intermediate 
targets or diffusible morphogens that create gradients along which the axon can grow (Vitriol 
and Zheng, 2012). Neurons are highly compartmentalized and the axons need to make the 
right decision which part of the target neuron to contact. (Figure 1 a) 
Cell adhesion molecules play an important role during axon guidance and target recognition 
as they can mediate direct contacts between cells (Schwarting and Henion, 2011). The 
interaction can be either homophilic or heterophilic and can either induce repulsion or 
attraction from this cell (Hummel et al., 2003; Luo and Flanagan, 2007; Marquardt et al., 
2005; Vitriol and Zheng, 2012). The DSCAM/Dscam family of Ig-domain CAMs mediates 
homophilic interactions that induce self avoidance of cells expressing the same isoform of 
Dscam (Hattori et al., 2008). In Drosophila many thousands of isoforms can be expressed 
from a single locus through differential splicing (Schmucker et al., 2000), which contribute to 
the establishment of a variety of neuronal circuits like the olfactory and the visual system 
(Hummel et al., 2003; Millard et al., 2007). Examples of a heterophilic interaction required 
for axon guidance that can be either attractive or repulsive are the family of GPI anchored 
Ephrins and their receptors. These are receptor tyrosine kinases and activate downstream 
signaling cascade upon Ephrin binding (Boulin et al., 2006; Helmbacher et al., 2000; Luo and 
Flanagan, 2007; Marquardt et al., 2005).  
In addition, a large number of CAMs have been described that mediate axon guidance and 
target recognition via homo- and heterophilic interactions such as the Semaphorins, L1CAMs 
and Cadherins (Godenschwege and Murphey, 2009; Hall and Bieber, 1997; Hummel and 
Zipursky, 2004). 
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1.3. Synapse formation and differentiation 
Once the axon growth cone comes in contact with the appropriate postsynaptic target cell it 
needs to differentiate into a presynaptic terminal. At the same time the target cell also 
specializes to serve as the postsynaptic site of the synapse. Pre- and postsynaptic cells 
accumulate components needed for neurotransmission. During later steps of development 
these initial contacts further differentiate to build the mature contact. 
Trans-synaptic connections mediated by cell adhesion molecules are important for the 
appropriate formation and regulation of these processes (Chen and Cheng, 2009; Siddiqui and 
Craig, 2011). Cell culture studies revealed important CAMs involved in synapse formation 
(Linhoff et al., 2009; Scheiffele et al., 2000). The expression of Neuroligins in non-neuronal 
cells induced the assembly of a functional presynapse within contacting neurons (Scheiffele 
et al., 2000). Neuroligins interact with presynaptic expressed Neurexins (Craig and Kang, 
2007) and can induce the formation of excitatory and inhibitory synapses. Neurexins, in 
addition, can interact with the class of LRR transmembrane (LRRTM) proteins and 
cooperates with N-Cadherin during vesicle accumulation (de Wit et al., 2009; Ko et al., 2009; 
Stan et al., 2010). 
The integrin family has been described to be essential for the change from an immature 
synapse to a mature synapse. This is accompanied by the change in neurotransmitter subunit 
composition and activity. Chavis and colleagues blocked integrin β3 in an in vitro assay and 
observed proper initial formation of synaptic contacts but failures during the differentiation 
into a mature synapse (Chavis and Westbrook, 2001). 
1.4. Synapse maintenance and elimination 
Another unique feature of the nervous system is its ability to modulate its wiring pattern in 
response to external stimuli. Synapse stabilization and elimination need to be highly 
regulated to ensure the functionality of the system (Faulkner et al., 2007; Kantor and 
Kolodkin, 2003; Low and Cheng, 2005). Failures in these processes can lead to the 
progressive loss of neurons and subsequent neurodegenerative diseases like ALS or 
Huntington`s disease (Boillee et al., 2006; Luo and O'Leary, 2005). 
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Cell adhesion molecules have the potential to control both maintenance and elimination since 
they can mediate strong adhesion, which can be regulated in a number of ways (Crossin and 
Krushel, 2000). However, little is known regarding the identity and regulation of cell 
adhesion molecules during synapse stabilization. A class of cell adhesion molecules involved 
in the maintenance of synaptic contacts are the Cadherins (Benson and Huntley, 2012; 
Lefebvre et al., 2008; Wang et al., 2002). In vivo studies showed that gamma-Protocadherins 
are essential for the survival of neurons in the spinal cord, the cerebral cortex as well as in the 
retina. Knock down of gamma-Protocadherins in vitro results in apoptosis of differentiated 
mature synapses (Lefebvre et al., 2008; Wang et al., 2002). In humans the autosomal 
recessive retinal dystrophy has been associated with mutations in the protocadherin21 gene. 
The onset of this disease is in late teenage years with night vision loss and progresses during 
adult live due to severe cone and rod degenerations (Henderson et al., 2010). 
The identification of molecules that promote the stabilization of synaptic contacts is 
important for the understanding of the mechanisms leading to neurodegenerative diseases. All 
classes of cell adhesion molecules, described above, have the potential to provide a direct 
mechanic link between two cells via extracellular interactions and thus CAMs are likely 
candidates to control synapse stability. However, the complexity of the vertebrate nervous 
system and genome makes it more difficult to investigate the function of CAMs (Hortsch, 
2000). I used the model system fruit fly Drosophila melanogaster to circumvent these 
problems. 
In the following chapter I will describe and highlight the advantages of the Drosophila model 
system, especially the larval neuromuscular junction (NMJ) in comparison to more complex 
systems in vertebrates. 
1.5. Drosophila melanogaster as a model system 
The fruit fly Drosophila melanogaster was first described in 1830 by Johann Wilhem Meigen 
and has been first maintained and studied in the lab by Charles W. Woodworth. Since then, it 
was used to answer a wide range of biological questions. There are many advantages for 
using Drosophila as a model system in the lab in comparison to vertebrates. These include 
the short generation time, the easy handling, the little space need and the great variety of 
genetic and molecular tools developed in the last 100 years. Many genes from Drosophila are 
conserved during evolution thus studies in the fly can give answers to processes and 
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mechanisms in the vertebrate system (Hortsch, 2000; Zhao and Hortsch, 1998). In Figure 2 
the life cycle of Drosophila melanogaster is shown. From a fertilized egg to the hatching of a 
fly it takes about 8 days at 25 °C.  
 
Figure 2 - Drosophila life cycle and stages of development 
The life-cycle of Drosophila melanogaster from egg-hatching to the adult fly lasts about 8 days. After 
embryogenesis the larvae hatch and pass through three larval stages (1st instar larvae, 2nd instar larvae, 
3rd
1.5.1. The Drosophila neuromuscular junction to study synapse development 
 instar larvae) and two larval molts. These larval stages can be identified based on the structure of 
the mouth apparatus and the appearance and structure of the anterior and posterior spiracles. 4 days 
after egg-hatching the puparium formation occurs and the imago emerges after another 4 days. 8 h 
post-hatching the adult flies become perceptive and start mating. 
The Drosophila NMJ was first used as a model system in neurobiology in the 1970s by Jan 
and Jan describing the basic physiological and pharmacological properties of the system (Jan 
and Jan, 1976a; Jan and Jan, 1976b). Since then the NMJ became an important model system 
to study neurodevelopmental problems such as axon guidance, target selection, synaptic 
function and synapse maintenance (Fouquet et al., 2009; Hall and Bieber, 1997; McCabe et 
al., 2004; Owald et al., 2012; Ramser et al., 2010; Schuster et al., 1996a; Schuster et al., 
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1996b; Wan et al., 2000). What makes this system so attractive for scientists? The advantages 
of this model system are various. First, we can analyze proteins at the level of individual 
synapses in high resolution using different advanced imaging techniques. Second, it is 
possible to manipulate single motoneurons using genetic tools like the Gal4/UAS system or 
the MARCM technique (Brand and Perrimon, 1993; Lee and Luo, 2001). Third, each 
motoneuron can be identified based on the projection pattern and muscle innervation and the 
dendritic tree in the ventral nerve cord (VNC) of the brain (Landgraf et al., 2003). Fourth, the 
Drosophila NMJ is a glutamatergic synapse and therefore shares key features with central 
synapses in vertebrates (Jan and Jan, 1976a; Thomas and Sigrist, 2012).  
 
Figure 3 - Overview of the larval motoneurons and muscles 
(a) Schematic view onto a larval preparation. The brain is shown in grey with the ventral nerve cord 
(VNC), where the motoneuron cell bodies are located. Simplified examples of two motoneurons 
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innervating muscle 4 and muscle 6/7 of abdominal segment A5 are shown here in the zoom-in 
(highlighted through the red boxes). These extend their axons towards their target muscle and form 
NMJ terminals. Muscle 4 is innervated by the intersegmental nerve (ISN) and muscle 6/7 by the 
segmental nerve b (SNb).Using our larval preparation we can analyze the abdominal segments A2-
A6. The larvae are opened along the dorsal midline and each segment is separated into two equal 
hemisegments by the ventral midline. (b) Schematic scheme of the larval muscles within a 
hemisegment, the muscle are colored based on the nerves that innervate the muscles. The green 
muscles are innervated by the ISN (1, 2, 3, 4, 9, 10, 11, 18, 19, 20), the orange muscles are innervated 
by the SNa (5, 8, 21-24), the yellow muscles by the SNb (6, 7, 12, 13, 30, 14, 28) and the red muscles 
by the SNc/d (15-17, 25-27, 29). 
 
1.5.2. Organization and structure of the neuromuscular circuitry 
Motoneurons are characterized by their axonal trajectorys, the innervation of specific muscles 
and the dendritic tree in the central nervous system (CNS) (Landgraf et al., 2003). The 
motoneuron cellbodies are located in the outer layer of the CNS in the VNC (Figure 3). The 
motoneuron axons exit the VNC and extend their axons towards the target muscle. Most 
muscles are innervated by multiple motoneuron types described below, but there are 
exceptions such as muscle 4 which is only innervated by Type I motoneurons. The 30 
muscles per hemisegment are innervated by three nerves, the transversal nerve (TN), the 
intersegmental nerve (ISN) and the segmental nerve (SN) (Figure 3 b). There are three types 
of motoneurons in Drosophila larvae. Type I motoneurons (1b and 1s) are glutamatergic 
motoneurons (Jan and Jan, 1976a; Jan and Jan, 1976b). At the NMJ each Type I synaptic 
terminal consists of multiple varicosities called boutons and within each bouton there are 
multiple synapses opposed by glutamate receptors in the muscle. Ultrastructurally most 
synapses of Type I motoneurons are characterized by an electron dense structure called T-bar. 
Vesicles seem to be physically attached to the T-bars, which facilitates vesicle release (Owald 
et al., 2012; Reiff et al., 2002; Thomas and Sigrist, 2012). T-bars are associated with Ca2+ 
channels, to induce locally high Ca2+-domains (Kittel et al., 2006; Owald et al., 2012). Type I 
motoneurons submerge deep into the muscle and are surrounded by the sub synaptic 
reticulum (SSR) which are foldings of the muscle membrane (Figure 4). Type II and III 
motoneurons use octopamine or peptides as neurotransmitter. They differ ultrastructually 
from the Type I motoneurons and remain on the muscle surface (Figure 4) 
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Figure 4 - Three types of motoneurons and their characteristics 
Type I motoneurons are glutamatergic neurons. They submerge deep into the muscle and are 
surrounded by the sub synaptic reticulum (SSR). Ultrastructurally Type I synapses are characterized 
by an electron dense structure called T-bars which facilitate vesicle release. T-bars are associated with 
synaptic vesicles and Ca2+-channels to induce local high Ca2+
1.5.3. Synaptic maintenance at the Drosophila larval NMJ 
-domains required for vesicle release 
thus for the propagation of action potentials. In the postsynaptic muscle, glutamate receptors cluster 
are opposite of T-bars. In contrast, Type II and III motoneurons are peptidergic or octopaminergic 
neurons that stay on top of the muscles and are not surrounded by the SSR. Both contain synaptic 
vesicles and mitochondria but no glutamate receptors cluster in the muscle and only in Type III 
motoneuron terminal T-bars can be found. 
So far a small number of proteins has been identified to be essential for synapse stability. The 
functions of these protein range from signaling molecules to cytoskeleton proteins. 
Previously an assay has been established that can be used to visualize synaptic retractions 
(Eaton et al., 2002; Pielage et al., 2011; Pielage et al., 2008). The pre- and postsynaptic 
structures are stained with specific antibodies. At stable synapses these markers are opposing 
each other (Figure 5 a). The elimination of the presynapse is faster than the disassembly of 
the postsynaptic specialization, thus unopposed postsynaptic markers indicate the presence of 
an instable synapse (Figure 5 b, c). The establishment of a genome wide RNAi library (Dietzl 
et al., 2007) allows now to screen directly any genes of interest. 
 
Figure 5 - Process of synapse destabilization at the Drosophila NMJ 
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(a) A stable Drosophila larval NMJ is characterized presynaptic markers (green) opposed by 
postsynaptic glutamate markers (red) and a continuously formed presynaptic membrane (grey). (b) 
Failures during synapse stabilization caused by RNAi mediated knock down or mutations of stability 
promoting genes the presynaptic terminal retracts. (c) A synaptic “footprint” is marked by the loss of 
presynaptic markers, a clustering of glutamate receptors and the fragmentation of the membrane. 
In the RNAi-based screen of cell adhesion molecules I identified the L1-type CAM homolog 
Neuroglian as an important CAM for synapse maintenance. The main part of this thesis was 
the detailed characterization of Nrg and its function and regulation at the larval NMJ. 
Therefore, I will describe and discuss here the family of L1CAMs in vertebrates and 
Drosophila in more detail. 
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1.6. L1CAM and the Drosophila homolog Neuroglian 
1.6.1. The L1CAM family 
In vertebrates the L1CAM family consists of four members, which are Neurofascin, L1CAM, 
CHL1 (close homolog of L1) and NrCAM (Neuronal cell adhesion molecule). L1CAM 
proteins are highly conserved during evolution (Figure 7) (Zhao and Hortsch, 1998). In 
contrast to the vertebrate family, Drosophila melanogaster and the nematode Caenorhabditis 
elegans (C. elegans) have only one L1CAM homolog whereas in the zebrafish Danio rerio 
two homologous genes have been identified (Becker et al., 2004; Pocock et al., 2008; 
Sasakura et al., 2005). A series of gene duplications could be responsible for this difference 
in the number of genes from arthropods to mammalians (Amores et al., 1998; Pebusque et al., 
1998). 
Most L1CAMs family members have six Ig-domains and five Fibronectin (Fn) type III 
domains in the extracellular domain. Exceptions exist for Neurofascin and C. elegans Sax-7 
due to alternative splicing (Hassel et al., 1997; Sasakura et al., 2005). Both homo- and 
heterophilic interactions within the L1CAM family as well as with other CAMs have been 
demonstrated for the extracellular domain. A summary is shown in Table 1. Homophilic 
binding has been reported for all L1CAM family members except CHL1 (Hillenbrand et al., 
1999). Heterophilic interactions have been demonstrated e.g. for Neurofascin and NgCAM 
which interact in trans as well as for Neurofascin and NrCAM (Hillenbrand et al., 1999; 
Volkmer et al., 1996). The cytoplasmic domains of L1CAMs are between 85 and 148 amino 
acids long. A summary of interaction partners of the intracellular domains is shown in  
Table 1.  
The neuronal isoforms of vertebrate L1CAMs can have an RSLE motif in their cytoplasmic 
domain which is important for the sorting of L1 proteins to growth cones of neurons and the 
induction of AP-2 mediated endocytosis via clathrin coated pits (Kamiguchi et al., 1998). 
This motif is spliced into the neuronal isoforms of most L1CAMs (Reid and Hemperly, 
1992). Further conserved domains between vertebrates and invertebrates are the FERM 
binding domain, the FIGQY motif and a PDZ protein binding domain. The binding of FERM 
domain proteins is involved in neurite outgrowth and regeneration of injured hippocampal 
neurons (Cheng et al., 2005a; Haas et al., 2004). The FIGQY motif is an important regulatory 
region controlling the interactions with Ankyrins and Doublecortin (Hortsch et al., 2009; 
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Kizhatil et al., 2002). Taken together L1CAMs have the potential to integrate and regulated 
many different processes through their great variety of interaction partners. 
Table 1 - Table of L1CAM interaction partners 
Domain Interaction partner Cellular context 
Immunoglobulin 
domain 1-610 
Axonin-TAG115, Neurocan17, 
Neuropilin2, Contactin10, L1CAM4, 
20, 26, 27, Integrin1, 6, 16, 20, 
Neurofascin21 
neurite outgrowth, synapse 
stability28, axon guidance 
Fibronectin 
domains type III 
1-510 
Axonin-TAG115, Integrin1, 6, 20 
L1CAM3, Contactin10 
neurite outgrowth 
FERM10 ERM proteins5 neurit outgrowth and branching  
RSLE10 AP212,5 L1CAM endocytosis12 
FIGQY10 Ankyrin7, 19, Doublecortin13 synapse function8, synapse 
growth and stability28, neurite 
outgrowth 
PDZ10 Syntenin-114, MAGUK  SAP10210, 
SAP9010, PSD9510  
neurite outgrowth, axon 
bundling9 
C-terminus10 CKII18, 23, ERK2, p90rsk24, RanBP3, 
Shootin118 
neurite outgrowth 
A summary of intra- and extracellular interaction partners of the L1CAM family grouped by the 
specific domains. The cellular context if identified is noted in the last column. Direct and indirect 
interactions in cis and trans are included in the list. The numbers indicate the reference listed here: 
((1) Blaess et al., 1998; (2) Castellani et al., 2002; (3) Cheng et al., 2005b; (4) De Angelis et al., 2002; 
(5) Dickson et al., 2002; (6) Felding-Habermann et al., 1997; (7) Garver et al., 1997; (8) 
Godenschwege et al., 2006; (9) Goossens et al., 2011; (10) Haspel and Grumet, 2003; (11) Herron et 
al., 2009; (12) Kamiguchi et al., 1998; (13) Kizhatil et al., 2002; (14) Koroll et al., 2001; (15) Kunz et 
al., 1998; (16) Montgomery et al., 1996; (17) Oleszewski et al., 1999; (18) Ramser et al., 2010; (19) 
Shimada et al., 2008; (20) Silletti et al., 2000; (21) Tuvia et al., 1997; (22) Volkmer et al., 1996; (23) 
Wong et al., 1996a; (24) Wong et al., 1996b; (25) Yip et al., 1998; (26) Zhao and Siu, 1995; (27) 
Zhao et al., 1998; (28) Enneking et al., this study). 
Many different functions of L1CAMs have been described so far in the nervous system in 
vertebrates and other model systems. These include neurite outgrowth and cell body adhesion 
(Appel et al., 1993), axon fasciculation (Ohyama et al., 2004; Wiencken-Barger et al., 2004), 
myelination (Barbin et al., 2004), axonal positioning (Pocock et al., 2008; Sasakura et al., 
2005) axon guidance (Ango et al., 2004; Godenschwege and Murphey, 2009; Hall and 
Bieber, 1997) and synapse formation (Triana-Baltzer et al., 2006). However, L1CAMs have 
not been implicated in the control of synapse stabilization so far. 
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Mouse knockout studies describe a variety of phenotypes including hydrocephalus, a smaller 
hippocampus and cerebellum, hyperfasciculation, corpus callosum hypoplasia and memory 
dysfunctions (Dahme et al., 1997; Demyanenko et al., 1999; Fransen et al., 1997; Wiencken-
Barger et al., 2004). Only a weak impairment of some motor functions has been described 
(Pratte et al., 2003). Most of these functions are regulated via extracellular interactions since 
knock-in mutations of C-terminal deletions showed only weaker defects (Nakamura et al., 
2010). In contrast hippocampal neurons in vitro displayed a decrease in branching number 
(Nakamura et al., 2010). 
L1CAMs have been implicated to contribute and be influenced by many signaling pathways 
during cell survival and neurite outgrowth in vivo and vitro (Forni et al., 2004; Islam et al., 
2003; Nishimune et al., 2005; Whittard et al., 2006). In cultured motoneurons L1 and CHL1 
can act as survival factors. This function was completely blocked by MEK and PI3K 
inhibitors, which indicates a role of mitogen-activated protein (MAP) kinase and PI3 kinase 
signaling pathways in promoting survival of motoneurons via L1 (Nishimune et al., 2005). L1 
mediated neurite outgrowth requires the phosphorylation of the FIGQY Ankyrin binding 
motif via MAPK signaling since inhibitors of this pathway inhibit L1 mediated neurite 
outgrowth (Whittard et al., 2006). In vitro studies in cultured Drosophila neurons showed that 
a reduction of the fibroblast growth factor receptor (FGFR) signaling pathway reduced Nrg-
stimulated neurite outgrowth (Forni et al., 2004). Islam and colleagues (2004) showed in vivo 
that Neuroglian overexpression altered nerve growth and pathfinding in the wing, which can 
be reduced through the decrease of epidermal growth factor receptor (EGFR) signaling (Islam 
et al., 2004).  
1.6.2. L1CAM in human disease 
Human mutations in the L1CAM family have been first described in 1992 to be associated 
with a neurological disorder (X-linked hydrocephalus) (Rosenthal et al., 1992). Mutations in 
L1CAMs are responsible for a least four neurological diseases: X-linked hydrocephalus 
(HSAS), MASA-syndrome (Mental retardation, Aphasia, Shuffling gait, Adducted thumbs), 
complicated spastic paraplegia (SP-1) and X-linked agenesis of the corpus callosum. In 1995 
Fransen and colleagues defined the name CRASH (Corpus callosum hypoplasia, Retardation, 
Adducted thumbs, Spastic paraplegia and Hydrocephalus) syndrome for this variety of 
neurological syndromes caused by mutations in L1CAMs (Fransen et al., 1995). Since then, 
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over 100 different L1 mutations have been reported (Fransen et al., 1997; Piccione et al., 
2010; Silan et al., 2005). 
Most mutations identified are private and exist only in single families. Mutations can be 
grouped based on the type of mutation and the domains affected. The first group affects the 
cytoplasmic domain, the second group affects the extracellular domain including point- and 
missense-mutations and the third group consists of nonsense and frame shift mutations in the 
extracellular domain. Mutations of the third group correlate with the most severe forms of the 
CRASH syndrome, whereas the first group displays mostly milder phenotypes (Yamasaki et 
al., 1997). 
The CRASH syndrome is an X-linked disease and the clinical phenotypes can vary 
significant between families, but only rarely within affected families. However, the syndrome 
of adducted thumbs is commonly associated with patients with this syndrome. Patients with 
mutations in the cytoplasmic domain display this phenotype implicating the loss of either 
intracellular interactions with the cytoskeleton or downstream signaling activation are the 
cause of this specific phenotype. In more severe forms of the CRASH syndrome the presence 
of a severe hydrocephalus correlates often with severe mental retardation and a poor survival 
rate (Yamasaki et al., 1997).  
Some mutations identified in patients have been studied in cell culture assays to investigate 
the molecular mechanism underlying the disease cause. Two missense mutations in the 
extracellular domain (group 2) have been shown to reduce the adhesion dependent activation 
of EGFR (epidermal growth factor receptor) (Islam et al., 2004). However, both mutations 
show normal homophilic adhesion in cell aggregation assays (Nagaraj et al., 2009). Other 
group 2 mutations affect homo- and heterophilic binding properties or surface expression in 
CHO cells (De Angelis et al., 1999; De Angelis et al., 2002). Each missense mutation can 
affect different aspects of protein function and could thus explain the high variability of 
phenotypes (De Angelis et al., 1999). In Drosophila a hypomorphic mutation exists that 
mimics a human mutation in L1. This nrg849 mutation reduces homophilic binding of 
Neuroglian and leads to synapse formation defects in the giant fiber (GF) synapse in the adult 
fly (Godenschwege et al., 2006). 
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1.6.3. Drosophila L1CAM 
The Drosophila L1CAM homolog is named based on its expression in the nervous system in 
neurons and glial cells. Nrg was identified in the late 1980th by Bieber and colleagues (Bieber 
et al., 1989). In contrast to vertebrates the Drosophila genome encodes one L1CAM gene 
from which two isoforms of Neuroglian are expressed that differ only in their cytoplasmic 
domain but are expressed in different tissues (Figure 6 b). Nrg167 (167 kDa) is ubiquitously 
expressed while Nrg180 (180 kDa) is exclusively expressed in the nervous system (Hall and 
Bieber, 1997; Hortsch et al., 1990). The first expression of Nrg180 can be detected 6 h after 
egg laying (AEL) on the surface of specific CNS and PNS neurons. In contrast, Nrg167 
expression in glial cells and other tissues like trachea, salivary gland and muscles can be 
detected only 11 h AEL. 
 
Figure 6 - Domain structure of Drosophila L1CAM Neuroglian 
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(a) Genomic locus of neuroglian. The intron and exon structure of the neuroglian locus is shown. The 
start codon is marked by the ATG. The two isoforms (Nrg167 and Nrg180) are generated via 
alternative splicing. Importantly the FIGQY Ankyrin binding motifs of the two isoform is encoded by 
two different exons (depicted in green for Nrg167 and blue for Nrg180). The region around the 
FIGQY motif is highlighted for both isoforms. The Nrg180 isoform harbors a unique C-terminus 
absent from the Nrg167 isoform (b) The Drosophila L1CAM homolog Neuroglian exists in two 
isoforms, a neuronal isoform of 180 kDa (Nrg180) and a ubiquitously expressed isoform of 167 kDa 
(Nrg167). Both have the same extracellular domain structure consisting of six Immunoglobulin (Ig) 
domains and five Fibronectin (Fn) type III domains. After the transmembrane domain a common 
FERM protein binding domain allows the binding of FERM domain proteins. Both isoform harbor an 
Ankyrin binding motif in their cytoplasmic domain. The neuronal isoform Nrg180 contains in 
addition an uncharacterized cytoplasmic domain of 66 amino acids, which includes a PDZ-protein 
binding domain in the last three amino acids. (c) Various mutations are available that alter the level or 
functions of both Nrg isoforms. Nrg17 is a strong hypomorphic allele and characterized by a 
transformation of amino acid 80 into a STOP codon. Nrg849 is a viable hypomorphic mutation 
(S213L). This mutation impairs homophilic binding properties of Nrg. Nrg14 is an nrg null mutations 
caused by an uncharacterized inversion in the nrg gene. Nrg305
The domain structure of the Neuroglian isoforms is shown in Figure 6 b. Both have identical 
extracellular domains with six Ig-domains and five Fn type III domains like vertebrate 
L1CAMs. A single transmembrane domain spans the cell membrane followed by a FERM 
protein binding domain. The FIGQY motif is also common in both isoforms however it is 
encoded by two different exons (Figure 6 a). The Nrg167 isoform ends directly after the 
FIGQY motif (Figure 6 a, b, Figure 7). In contrast, the Nrg180 isoform has a longer unique 
C-terminus of 66 amino acids, which includes a PDZ protein binding domain (TYV) and a so 
far uncharacterized region between the FIGQY and the PDZ binding domain (Figure 6 b, 
Figure 7). 
 is a viable hypomorphic mutation. A 
GFP enhancer trap is inserted into the intron before the exon encoding the Nrg167 FIGQY Ankyrin 
binding motif, decreasing the levels of both Nrg180 and Nrg167. 
Many studies investigated the function of Neuroglian in the nervous system and other tissues 
of Drosophila (Garcia-Alonso et al., 2000; Godenschwege et al., 2006; Goossens et al., 2011; 
Hall and Bieber, 1997; Wei et al., 2004; Williams, 2009). In the following section I would 
like to describe the available mutations (summary in Figure 6 c). There are two embryonic 
lethal mutations. Nrg14 is a mutation generated using X-ray and this induced an inversion in 
the nrg gene (Hall and Bieber, 1997; Lefevre, 1981), which is considered as a real protein 
null mutation. Nrg17 is generated using ethyl methanesulfonate (EMS) and described as a 
mutation that leads to a premature stop (W80STOP) (Lefevre, 1981; Yamamoto et al., 2006). 
The mutation is considered as a strong hypomorphic mutation, as we and other demonstrated 
the presence of protein in mutant embryo and larvae (data not shown, Hall and Bieber, 1997). 
Two other viable hypomorphic mutations have been described, nrg849 and nrg305. The nrg849 
mutation is a point mutation within the 2nd Ig-domain of the extracellular domain (S213L). 
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Importantly, this mutation is similar to a mutation found in humans in families with CRASH 
syndrome (De Angelis et al., 2002). Nrg305 is caused by a GFP enhancer trap insertion in the 
intron before the exon that encodes the Nrg167 FIGQY motif (Figure 6 c). This leads to the 
reduction of Nrg levels and the tagging of both isoforms with GFP (Yamamoto et al., 2006, 
Figure 6 c, Figure 22). Nrg3 is a temperature sensitive mutation that is lethal at 29 °C but 
viable at 18 °C (King et al., 1986). The shift to 29°C leads to a misslocalization of the protein 
to the cell bodies (Hall and Bieber, 1997). Using this mutation the critical phase of Nrg for 
viability has been defined between embryonic mid stage 15 and late stage 16 (Hall and 
Bieber, 1997). 
First descriptions of nrg null mutations observed an overall normal nervous system based on 
FasciclinII (FasII) staining (Hall and Bieber, 1997). But sensory neurons cell bodies were 
disorganized and motoneurons in embryonic stage 15-17 displayed abnormal projections and 
contacts (Hall and Bieber, 1997). In sensory neurons like the ocellar pioneer (OP) and the 
bristle mechanosensory (BM) neurons the nrg3 mutations caused axon guidance defects. The 
defects observed could not be rescued by the expression of Nrg167, but by Nrg180. In 
addition expression of FasII was able to rescue the OP but not BM phenotypes (Kristiansen et 
al., 2005), which indicates a partial redundancy of CAMs within the nervous system. Also 
functions of Nrg in glial cells have been described. Simultaneous knock down of nrg and 
ank1 in glial cells that wrap around dorsal dendritic arborization neurons E (ddaE) and the 
ddaE neuron led to an increase in ectopic dendritic branches of the ddaE neuron (Yamamoto 
et al., 2006). Godenschwege et al. (2006, 2010) described a function of Nrg in synapse 
formation and function within the GF system of the adult fly (Boerner and Godenschwege, 
2010; Godenschwege et al., 2006). Recently a function of Nrg in the mushroom body (MB) 
of adult flies has been described. Mutant MB display axon bundling and stalling phenotypes 
(Goossens et al., 2011). 
1.6.4. L1 and Ankyrin interaction 
Ankyrins are a family of adaptor molecules that link integral membrane proteins to the 
submembranous Spectrin-based cytoskeleton (Jenkins and Bennett, 2001). The Ankyrin 
binding motif FIGQY in the cytoplasmic domain of L1CAMs binds to the N-terminus of 
Ankyrins (Davis and Bennett, 1994; Garver et al., 1997; Tuvia et al., 1997). This FIGQY 
motif is highly conserved between species from C. elegans to vertebrates (Figure 7). Binding 
of L1 and Ankyrins is highly regulated by the phosphorylation of the tyrosine residue within 
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the FIGQY motif (Figure 8, Garver et al., 1997). Studies showed that phosphorylation of the 
tyrosine within the FIGQY motif inhibits Ankyrin binding and leads to increased neurite 
outgrowth (Garver et al., 1997; Tuvia et al., 1997). Mutations within the FIGQY (Y1229H) 
motif have been identified in families with CRASH syndrome and shown to impair Ankyrin 
recruitment to the membrane in HEK cells. In contrast, mutation within other cytoplasmic 
domains did not cause any phenotype. Another interesting aspect of the regulation of protein 
binding to the FIGQY motif is that Ankyrins are not the only interaction partner of L1CAMs. 
The phosphorylation of the FIGQY motif inhibits Ankyrin binding but allows the binding of 
Doublecortin. A study in 2002 showed that the cytoplasmic molecule Doublecortin, which is 
linked to the neuronal migration disorder X-linked lissencephaly, is able bind to the 
phosphorylated FIGQY motif of Neurofascin (Kizhatil et al., 2002). 
 
Figure 7 - Sequence alignment of the Ankyrin binding motif of L1CAM family proteins 
The Ankyrin binding motif FIGQY is highly conserved between species. Here the protein sequences 
from the human L1CAM to the C. elegans homolog Sax-7 around the FIGQY Ankyrin binding motif 
are shown. The STOP codon is indicate by the *. In contrast to the Drosophila Nrg167 isoform, which 
ends directly after the FIGQY motif, other L1-type CAMs have an extended C-terminus with a length 
between 85 and 148 amino acids (indicated by the //). 
In the vertebrate genome there are three ankyrin (ank1-3) genes which encode multiple 
different isoforms generated through complex alternative splicing (Cunha et al., 2008; Cunha 
and Mohler, 2009; Hopitzan et al., 2005; van Oort et al., 2008). The splicing products are 
classified as Ankyrin R, B and G (Ank1-3 respectively).  In Drosophila two Ankyrin genes 
exist, Dank1 (ank1) and Dank2 (ank2). Ank2 is only expressed in neurons whereas Ank1 is 
more ubiquitously expressed. In contrast in C. elegans only one Ankyrin homolog, unc-44, 
has been identified. 
In general ,Ankyrins consist of four Ankyrin domains (formed by multiple ankyrin repeats) 
followed by a Spectrin binding domain and a death domain (Davis and Bennett, 1984; 
Michaely and Bennett, 1993). The giant isoforms of Ankyrin have individual C-termini of 
different length. Together with the death domain these domains are important for the 
regulation of Ankyrin functions. The different C-termini of the Ankyrin isoforms are 
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generated through alternative splicing (Zhang and Bennett, 1998; Zhou et al., 1997). In 
addition to L1CAMs, Ankyrins are known to bind to ion channels, anion exchangers and 
inositol(1, 4, 5)-triphosphate (IP3) receptors through their Ankyrin domains (Cunha et al., 2007; 
Mohler et al., 2005; Mohler et al., 2004; Nelson and Veshnock, 1987). Whereas the exact 
binding sites within the Ankyrin domains for the voltage gated sodium channel (Lowe et al., 
2008) or the IP3 receptor (Mohler et al., 2005) have been identified, it is not known which 
Ankyrin domains are important for L1CAM interactions. However, Neurofascin and the 
anion exchanger AE1 bind to different Ankyrin domains in red blood cells (Bennett and 
Stenbuck, 1980), indicating that Ankyrins have the potential to bind multiple CAMs at the 
same time to form protein complexes that are linked to the Actin/Spectrin cytoskeleton 
(Michaely and Bennett, 1995a; Michaely and Bennett, 1995b). 
Ankyrin B deficient mice exhibit neurological phenotypes such as hypoplasia of the corpus 
callosum and pyramidal tracts, dilated ventricles and severe postnatal degeneration of the 
optic nerve. These effects are caused by abnormal neurite outgrowth, axon guidance and axon 
fasciculation (Scotland et al., 1998).  
Ankyrin binding to L1CAM molecules enhances their homophilic adhesive properties and 
reduces their mobility within the plasma membrane (Garver et al., 1997). Homophilic 
interaction of L1CAMs can activate EGF receptor tyrosine kinase activity (Islam et al., 
2004), which is important for growth cone axon guidance in sensory neurons (Garcia-Alonso 
et al., 2000). Whittard et al. (2006) used an in vitro assay to monitor the FIGQY 
phosphorylation status. They showed that EGFR, mitogen-activated protein kinase (MAPK) 
and neuronal growth factor receptor (NGFR) activation induced phosphorylation of the 
tyrosine and this prevents the recruitment of AnkyrinG to the cell membrane (Whittard et al., 
2006).  
Figure 8 - Regulation of L1-Ank interaction 
Binding of L1-type CAMs (red) to Ankyrins (grey) 
is mediated by the FIGQY motif in the cytoplasmic 
domain of L1CAMs and the N-terminal Ankyrin 
domains of Ankyrins. Phosphorylation (indicated 
here with a blue dot) of the tyrosine via an unknown 
kinase  within the FIGQY motif prevents Ankyrin 
recruitment to L1CAM proteins. The 
phosphorylation of the FIGQY motif allows the 
binding of another protein called Doublecortin. 
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The Drosophila Ank2 protein is part of a previously identified molecular network essential 
for synapse stability at the Drosophila NMJ (Koch et al., 2008; Pielage et al., 2011; Pielage et 
al., 2008; Pielage et al., 2005; Pielage et al., 2006). This network consists of the adaptor 
molecule Ank2, α- and β-Spectrin and the actin-capping molecule Hts/Adducin and has the 
potential to link cell adhesion molecules to the underlying actin/microtubule cytoskeleton 
(Figure 9). In the screen I identified Nrg as essential for synapse stability and thus could be 
the cell adhesion molecule upstream of this network controlling synapse stability. 
 
Figure 9 - Network underlying the cell membrane important for synapse stability 
Ankyrin2 is part of a molecular network underlying the cell membrane, which has the potential to 
provide a link from the cell membrane to the microtubule and actin cytoskeleton, thus controlling 
synaptic stability. All members of this network including the anchoring molecule Ank2 (grey), the 
scaffolding molecules α- and β-Spectrin (blue) and the actin capping molecule Hts/Adducin have been 
identified to be important for synapse stability (Koch et al., 2008; Pielage et al., 2011; Pielage et al., 
2008; Pielage et al., 2005; Pielage et al., 2006). Neuroglian can interact with Ank2 in a regulated 
fashion having the potential to be upstream of this network controlling synapse stability. 
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1.4. Aim of the Work 
In the nervous system synaptic contacts between neurons are highly specialized structures 
essential to transfer information. During the formation of the nervous system neurons have to 
connect with each other and form functional circuits. Importantly these neuronal circuits need 
to be stable and plastic at the same time allowing changes in connectivity both during 
development and in response to activity e.g. during learning and memory. The inappropriate 
loss of synaptic contacts can lead to severe neurodegenerative diseases. Trans-synaptic 
interactions mediated by cell adhesion molecules have the potential to directly link two 
neighboring cells and provide a regulatory module controlling stability and plasticity of this 
contact. Many cell adhesion molecules have been described as crucial during early steps of 
neuronal circuit development such as axon guidance and synapse formation. In contrast, little 
is known about the cell adhesion molecules controlling synapse maintenance and plasticity. 
In this study, I aimed to identify cell adhesion molecules and the underlying regulatory 
mechanisms controlling synapse maintenance. As a model system I used the Drosophila 
neuromuscular junction, which allows the analysis of synapse development at the resolution 
of single synapses in vivo. I performed an unbiased RNAi screen to identify potential 
stabilizing cell adhesion molecules and performed a detailed analysis of two genes using 
advanced genetic, biochemical, biophysical and imaging techniques. 
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2. Results 
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3.1. RNAi Screen 
To identify new cell adhesion molecules important for NMJ development and stability, I 
performed an unbiased RNAi-based screen using a high-resolution assay that combines 
immunohistochemistry with high resolution confocal microscopy. This assay has been used 
in a number of studies to identify stability and formation defects at the Drosophila NMJ 
(Eaton and Davis, 2005; Eaton et al., 2002; Pielage et al., 2011; Pielage et al., 2008; Pielage 
et al., 2005; Wan et al., 2000). I screened entire classes of cell adhesion molecules that were 
selected based on previous described functions in the nervous system (listed in Table 2). In 
addition, I screened a selection of potential CAM interacting proteins and included positive 
controls of genes with previously described functions at the NMJ. To identify important pre- 
as well as postsynaptic cell adhesion molecules, I used a Gal4 driver line combination that 
allowed the knock down of proteins in the motoneuron and the muscle simultaneously 
(elavC155-Gal4; UAS-dcr2; BG57-Gal4).  
Table 2 - List of the transmembrane protein classes screened in this study 
Class of transmembrane protein # candidates 
Ig-domain proteins 126 
LRR-domain proteins 70 
Cadherins 19 
Laminins 9 
Integrins 8 
Semaphorins 10 
Von willebrand factor 5 
CAM interacting proteins 40 
Positive controls 26 
Total 313 
The numbers indicate the number of VDRC lines screened for each class. A total of 313 candidates 
have been screened, a list of all VDRC lines and CG numbers can be found in the appendix Table 17-
24. Abbreviations used in the table: Ig = immunoglobulin, LRR = leucine-rich repeat, CAM = cell 
adhesion molecule 
The assay used in the RNAi screen is based on the observation that the presence of a 
presynaptic motoneuron induces the formation of postsynaptic specializations. Thus, 
whenever postsynaptic markers are observed without opposing presynaptic markers we can 
conclude that the NMJ has been retracted. In wild type pre- and postsynaptic markers are 
always opposing each other and only in 1-2% of all NMJs unopposed postsynaptic markers 
can be observed. However, these are only small retractions of maximal 1-3 boutons per NMJ. 
In addition, the presynaptic membrane is stained using Hrp, which allows analyzing the 
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membrane integrity. RNAi mediated knock down or mutations of genes involved in synapse 
stability results in an increase in the frequency of NMJs showing unopposed postsynaptic 
markers and a fragmentation of the presynaptic membrane. 
In the screen, I analyzed in a first step all NMJs of the abdominal segments A2-A6 in three 
animals to identify potential candidates affecting synapse stability. Additionally, muscle and 
morphology phenotypes like protrusions were noted. Using RNAi lines of genes with 
previously identified phenotypes at the NMJ, I ensured that the RNAi conditions enabled a 
significant knock down of target genes. Importantly, I was able to identify 80% of all positive 
controls. In the next chapter, I would like to describe some of these positive controls since 
this validates the RNAi method to screen for candidates important for NMJ development and 
stability 
3.1.1. Validation of the screening conditions 
Among the positive controls, RNAi lines were included that target the pre- and postsynaptic 
markers used for our screening assay: Brp and the glutamate receptor subunit GluRIIE. In 
Drosophila glutamate receptor are heteromultimeric receptors with four distinct subunits: 
GluRIII, GluRIIE, GluRIID and either GluRIIA or B. In Figure 10, I show exemplary images 
of muscle 4 NMJs after knock down of Brp and GluRIIE. Both markers are significantly 
decreased. Brp is knocked down completely, thus only postsynaptic markers are visible. The 
analysis of the presynaptic membrane demonstrates that these NMJs are still stable in 
accordance with previous studies using brp mutations (Fouquet et al., 2009; Kittel et al., 
2006; Wagh et al., 2006).  
 
Figure 10 - RNAi mediated knock down of Brp and GluRIIE reduced protein level 
without affecting synaptic stability 
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(a-c) Muscle 4 NMJ stained for presynaptic active zone marker Brp (green), postsynaptic glutamate 
receptors DGluRIII (red) and the presynaptic membrane (Hrp, blue, grey). (a) A wild type NMJ with 
opposing pre- and postsynaptic markers and an intact presynaptic membrane. Terminal boutons are 
highlighted in the inset. (b) A muscle 4 NMJ after simultaneous pre- and postsynaptic knock down of 
DGluRIIE. In Drosophila glutamate receptor are heteromultimeric receptors with four distinct 
subunits: GluRIII, GluRIIE, GluRIID and either GluRIIA or B. Thus, the loss of GluRIIE leads to a 
decrease in DGluRIII staining in the muscle. However, the NMJ remains stable based on the 
membrane staining. Terminal boutons are highlighted in the inset. (c) A muscle 4 NMJ after pre- and 
postsynaptic knock down of Brp. This leads to the loss of Brp in the NMJ terminal. The NMJ is still 
stable, based on the integrity of the membrane and the normally clustered glutamate receptors. 
Terminal boutons are highlighted in the inset. Scalebar in (a) corresponds to (a-c), 10 µm, insets  
5 µm. 
In addition, the SMADs medea (med) and mother against decapentaplegic (mad) were used 
as positive controls. Both genes have been previously identified as important for NMJ 
development. Mutants display severe growth defects and synaptic instability at the NMJ 
(Eaton and Davis, 2005). I was able to identify the RNAi lines targeting med and mad based 
on their synaptic retraction phenotypes. Presynaptic knock down of Med led to 10-20% of 
retractions on muscle 4 and muscle 6/7. An exemplary image of a muscle 6/7 retraction after 
RNAi mediated knock down of Med is shown in Figure 11. Figure 12 shows images of NMJs 
after presynaptic mad RNAi and quantifications of synaptic retraction frequencies are shown 
for muscle 6/7 and muscle 4. Loss of Mad in the presynaptic motoneuron led to about 40% of 
retractions at both NMJs (Figure 12 e, f). This phenotype has been confirmed using two 
different presynaptic Gal4 driver lines. Interestingly, the frequency of retractions was higher 
than in the mad mutants (Eaton and Davis, 2005). This is most likely due to the tissue 
specificity of our RNAi approach. Mad mutant animals have severe developmental problems 
indicating a requirement outside the nervous system. 
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Figure 11 - Presynaptic knock down of the SMAD Medea leads to synaptic retractions 
(a-b) Muscle 6/7 NMJs stained for the presynaptic active zone marker Brp (green), postsynaptic 
glutamate receptors (red) and the presynaptic membrane (Hrp, white). (a) A wild type muscle 6/7 
NMJ with opposing pre- and postsynaptic markers and an intact membrane is shown. (b) A muscle 
6/7 NMJ after presynaptic med RNAi. No presynaptic markers are present in the areas highlighted by 
the asterisk and the membrane is fragmented. (c) Quantification of the retraction frequency after 
presynaptic knock down of Med. At muscle 6/7 23% of all NMJs are affected (P ≤ 0.0001, n = 5 -12 
animals analyzed). (d) Quantification of retraction frequency on muscle 4. 11% of all NMJ show 
retractions after presynaptic med RNAi (P = 0.0014, n = 7-12 animals analyzed). Scale bar in (a) 
corresponds to (a-b), 10 µm. Error bars represent SEM. 
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Figure 12 - Presynaptic knock down of the SMAD Mother against dpp leads severe 
retractions 
(a-d) Larval NMJs stained for presynaptic active zone marker Brp (green) and postsynaptic glutamate 
receptors (red). In addition, the presynaptic membrane is stained with Hrp (blue, white). (a) A wild 
type muscle 6/7 NMJ is shown. Pre- and postsynaptic markers are opposing each other and the 
membrane is intact. (b) A muscle 6/7 NMJ after presynaptic knock down of Mad is shown. The NMJ 
partially lost the presynaptic marker Brp and shows a strong fragmentation of the membrane in the 
region indicated by the asterisk. (c) A wild type muscle 4 NMJ with opposing pre- and postsynaptic 
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markers and an intact membrane. The asterisk indicates the boutons highlighted in the insets. (d) A 
muscle 4 NMJ after presynaptic mad RNAi. The presynaptic membrane is highly fragmented and the 
presynaptic marker Brp is lost from the entire NMJ terminal. Remnants of Brp cluster are visible in 
the axon of the NMJ. The area indicated by the asterisk is highlighted in the insets. (e) Quantification 
of retraction frequency on muscle 6/7 using two different Gal4 driver line combinations. 40% of 
muscle 6/7 NMJs show a significant increase in synaptic instability independent from the Gal4 driver 
line combination used (P ≤ 0.0001  for both Gal4 lines, n = 5-12 animals analyzed) (f) Quantification 
of retraction frequency on muscle 4 using two different Gal4 driver line combinations. 40% of all 
muscle 4 NMJs show a significant increase in synaptic instability independent from the Gal4 driver 
line combination used for knock down of Mad (P ≤ 0.0001for both Gal4 lines, n = 5 -12 animals 
analyzed). Gal4 driver line legend: pre1= elavC155-Gal4; UAS-dcr2 and pre2= elavC155-
Importantly, not only retraction phenotypes can be identified using this assay. In addition, it 
also allows the identification of other phenotypes like morphology and growth related 
phenotypes. As a positive control for these phenotypes the RNAi line targeting highwire 
(hiw, VDRC28163) was included in the screen. Hiw has been shown to be essential for the 
restriction of NMJ growth (McCabe et al., 2004; Wan et al., 2000). As expected, I observed a 
significant NMJ overgrowth after presynaptic RNAi of Hiw. 
Gal4;  
UAS-dcr2-sca-Gal4. Scale bars in (a, c) corresponds to (a-d), 10 µm, insets 5 µm. Error bars 
represent SEM. 
 
Figure 13 - Presynaptic knock down of Highwire leads to a massive growth defects 
(a-b) Muscle 4 NMJs stained for presynaptic active zone marker Brp (green), postsynaptic glutamate 
receptors DGluRIII (red) and the presynaptic membrane (Hrp, blue, white). (a) A wild type muscle 4 
NMJ with a normal size and morphology. (b) A muscle 4 NMJ after presynaptic knock down of 
Highwire. The size of the NMJ is massively increased through the formation of side branches and 
membrane protrusions. Scale bar in (a) corresponds to (a, b), 10 µm. 
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Taken together, the identification of 80% of all positive controls demonstrated that the RNAi 
screen should allow the identification of novel genes important for synapse stability and 
morphology. The great advantage of the RNAi technique in comparison to the mutant 
analysis is the spatial and temporal control of the knock down. Thus, the overall health of an 
animal is in not affected by the RNAi mediated knock down and even stronger phenotypes 
can be observed at the NMJ in cases like mad.  
3.1.2. Identification of genes important for synapse stability 
In my RNAi screen, I identified 10 novel genes essential for synapse stability. The two top 
hits were Ig-domain proteins that are important for synapse stability in the presynaptic 
motoneuron: the L1CAM Neuroglian and CG31708. Neuroglian was of special interest since 
it has been shown to be a direct interaction partner of Ankyrins (Garver et al., 1997; Tuvia et 
al., 1997) and thus could be the cell adhesion molecule upstream of the molecular network 
controlling synapse stability at the NMJ (Koch et al., 2008; Pielage et al., 2011; Pielage et al., 
2008; Pielage et al., 2005; Pielage et al., 2006, Figure 9). The main part of my thesis focused 
on the characterization of Neuroglian function and the interaction with Ank2 at the larval 
NMJ (submitted manuscript and chapter 3.3). CG31708 is essential presynaptically for 
synapse stability and showed a novel retraction phenotype different from all stability genes 
identified so far. A phenotypic description and first characterization of this gene is described 
in chapter 3.4. Here, I would like to briefly describe the phenotypes of three additional hits 
identified in the screen. A summary of the five top hits is shown in Table 14 and a list of 
additional weaker hits is found in the Appendix Table 25.  
Table 3 - List of Top 10 Hits from RNAi Screen  
VDRC line Name Score Class of proteins 
6688/107991 nrg +++ Ig 
38261 CG31708 +++ Ig 
18225 inc ++ CAM interaction 
31044 CG5195 ++ LRR 
9788/9788 cora + CAM interaction 
The five top hits from the RNAi screen based on the retraction frequency: +++ indicates a severe 
retraction phenotype, ++ a strong retraction phenotype, + mild retraction phenotype. The VDRC stock 
number, the gene name (CG number if uncharacterized) and the respective class of proteins are listed. 
Abbreviations used in this table: nrg = neuroglian, inc = insomniac, cora = coracle, Ig = 
immunoglobulin, CAM = cell adhesion molecule, LRR = leucine-rich repeat. 
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The first gene I would like to describe is insomniac (inc) which was identified using the 
VDRC line 18225. Presynaptic knock down of inc led to an increase in retraction frequency 
to 18% at muscle 6/7 and 16% at muscle 4 (Figure 14 d, e). Two NMJs that demonstrate the 
phenotype are shown in Figure 14. Importantly, I observed retractions and formation defects 
(Figure 14 b, c). Insomniac has been identified in 2011 as an important gene in the nervous 
system for the duration and consolidation of sleep (Stavropoulos and Young, 2011). The 
protein belongs to the BTB/POZ superfamily and is very small (24 kDa, 211 amino acids). 
Only one isoform has been identified so far. It will be interesting to relate the synaptic defect 
to its function in sleep control. 
 
Figure 14 - Presynaptic knock down of Insomniac leads to synaptic retractions 
(a-c) Larval muscle 4 NMJ stained for presynaptic active zone marker Brp (green) and postsynaptic 
glutamate receptors (red). In addition the presynaptic membrane is stained with Hrp (white, blue). (a) 
A wild type muscle 4 NMJ. Pre- and postsynaptic markers are opposing each other and the membrane 
is intact. The asterisk indicates the region highlighted in the inset below. (b) A muscle 4 NMJ with 
severe synaptic retractions. Large parts of this NMJ lost the presynaptic marker Brp, the glutamate 
 41 
receptors cluster together and the membrane is highly fragmented. The region shown and highlighted 
in the inset below is marked by the asterisk. (c) A muscle 4 NMJ with formation and instability 
defects. The area highlighted in the inset below shows a single bouton without Brp and a fragmented 
membrane. The rest of the NMJ is abnormally formed based on membrane and pre- and postsynaptic 
staining. (d) Quantification of retraction frequency at muscle 6/7 after inc RNAi. 18% of all muscle 
6/7 NMJs show synaptic retractions (P = 0.0022, n = 8-12) (e) Quantification of retraction frequency 
at muscle 4 (P = 0.0008, n = 8-12). 16% of all muscle 4 NMJ show synaptic retractions. Scale bar in 
(a) corresponds to (a-c), 10 µm, insets 5 µm. Error bars in (d) and (e) represent SEM. 
The second hit was the 4.1 protein Coracle (Cora). Figure 15 shows that knock down of Cora 
led to a small but significant increase in synaptic retractions. Importantly this is caused by the 
presynaptic loss of Cora since the simultaneous pre- and postsynaptic knock down of Cora 
resulted in the identical frequency of retractions (Figure 15 c, d). Cora encodes a FERM-
domain (F = 4.1 protein, E = ezrin, R = radixin, M = moesin) protein that has been identified 
as important for the selective clustering of glutamate receptors at the larval NMJ (Chen et al., 
2005). Interestingly, Neuroglian has a FERM protein binding domain in the cytoplasmic 
domain and could therefore be a potential interaction partner of Cora. 
The last hit I would like to highlight is the so far uncharacterized gene CG5195 which 
belongs to the family of LRR proteins. The phenotype of the RNAi knock down of CG5194 
was unique in some aspects. Firstly, in contrast to all other identified candidates CG5195 was 
important postsynaptically to promote synapse stability (Figure 16 e, f). Secondly, 
postsynaptic knock down also led to severe muscle defects and corresponding changes in 
NMJ morphology (Figure 16 d). Presynaptic knock down resulted in synapse formation 
defects including the presence of satellite boutons (Figure 16 c). CG5195 is an LRR protein 
without a transmembrane domain but a signal peptide (Figure 16 g), thus CG5195 is likely a 
secreted protein controlling the coordination of pre- and postsynaptic development. 
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Figure 15 - Presynaptic knock down of the 4.1.protein Cora reduces synaptic stability 
(a-b) Muscle 4 NMJ stained for presynaptic active zone marker Brp (green), postsynaptic glutamate 
receptors (red) and the presynaptic membrane (Hrp, white). (a) A wild type muscle 4 NMJ is shown 
with opposing pre- and postsynaptic markers and an intact presynaptic membrane. (b) A NMJ after 
RNAi mediated presynaptic knock down of Cora. Whereas the Type Ib NMJ is still stable, the  
Type 1s NMJ lost one branch where only little remnants of the membrane and the glutamate receptors 
are still present. Note the formation defect in the still stable Type Ib NMJ. (c) Quantification of the 
retraction frequency on muscle 6/7 after simultaneous pre- and postsynaptic cora RNAi. A significant 
increase of synaptic retractions can be observed (P = 0.0067, n = 6-12). (d) Quantification of the 
retraction frequency after presynaptic knock down of Cora. A similar number of synaptic retractions 
to (c) can be observed (P = 0.0069, n = 6-12). Scale bar in (a) corresponds to (a, b), 10 µm. Error bars 
represent SEM. 
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Figure 16 - Postsynaptic knock down of CG5195 results in synaptic retractions 
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(a-d) Larval NMJ stained for presynaptic active zone marker Brp (green) and postsynaptic glutamate 
receptors (red). In addition the presynaptic membrane is stained with Hrp (white). (a) A wild type 
muscle 6/7 NMJ. Pre- and postsynaptic markers are opposing each other and the membrane is intact. 
(b) A muscle 6/7 NMJ after postsynaptic knock down of CG5195. This NMJ partially lost Brp 
(asterisk), the glutamate receptor cluster and the presynaptic membrane is fragmented. Note the severe 
muscle defects caused by postsynaptic knock down of CG5195. (c) A muscle 4 NMJ after presynaptic 
knock down of CG5195 is shown. No synaptic retractions can be observed. However satellite boutons 
(asterisk) can be observed which are never seen in wild type. (d) A muscle 4 NMJ after postsynaptic 
knock down of CG5195. The NMJ is not retracted but lost the bouton structure of wild type NMJs.  
(e) Quantification of synaptic retraction frequency after pre- or postsynaptic knock down of CG5195 
for muscle 6/7 (P ≤ 0.0001 for postsynaptic knock down, n = 9 -11). (f) Quantification of retraction 
frequency after pre- or postsynaptic knock down of CG5195 for muscle 4 (P = 0.032 for postsynaptic 
knock down, n = 9-11). (g) The domain structure of CG5195 is shown based on SMART. In the N-
terminus a signal peptide was identified and the protein harbors a total of 29 LRR or LRR-type 
domains. However no transmembrane domain has been identified. Scale bar in (a) corresponds to  
(a-d), 10 µm. Error bars in (e) and (f) represent SEM. 
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3.2. Submitted manuscript 
The following manuscript has been submitted to Nature Neuroscience and is still under 
revision:  
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Abstract 
Cell adhesion molecules mediate axon guidance and synapse formation but the mechanisms 
controlling synapse maintenance or plasticity in vivo remain largely uncharacterized. We 
identify the Drosophila L1-type CAM Neuroglian (Nrg) as a central coordinator of synapse 
growth, function and stability with distinct requirements in the peripheral and central nervous 
system. At the larval neuromuscular junction synapse stability depends on the extracellular 
Ig-domains and the intracellular Ankyrin interaction motif. Alterations in binding affinities to 
Ankyrin2 directly correlate with mobility of Nrg in vivo and control the balance of synapse 
growth and stability. At the central Giant fiber synapse Nrg coordinates pre- and postsynaptic 
development via a trans-synaptic signaling mechanism that depends on the dynamic 
regulation of the intracellular Ankyrin-binding motif. Together, our results identify the L1-
type CAM Ankyrin interaction as a novel regulatory module enabling local control of 
synaptic connectivity and function while maintaining neuronal circuit architecture. 
Introduction 
Trans-synaptic interactions mediated by cell adhesion molecules (CAMs) control the 
formation, function and stability of synaptic connections within neuronal circuits. While a 
large number of synaptogenic CAMs controlling the initial steps of synapse formation have 
been identified 1, 2, relatively little is known regarding the identity or regulation of CAMs 
selectively controlling synapse maintenance or plasticity. Information processing within 
neuronal circuits is adjusted by the selective addition or elimination of individual synapses 
both during development and in response to activity 3, 4. These changes in connectivity can 
occur in very close proximity to stable synapses 5, 6 indicating the existence of mechanisms 
capable of local alterations of trans-synaptic adhesion. Potential mechanisms include the 
direct alteration of extracellular binding affinities of CAMs through binding of ligands 
including metal ions (e.g. Ca2+) to extracellular domains 7. In addition, trans-synaptic 
adhesion can be modulated indirectly through the selective association of CAMs with the 
intracellular cytoskeleton via adaptor proteins. Regulation of these interactions via 
posttranslational modifications can alter mobility, clustering and adhesive force of CAMs 8. 
These controlled changes in biophysical properties can then induce changes in synapse 
morphology, strength or stability and modulate trans-synaptic signaling 9, 10
We have previously identified a presynaptic molecular network at the Drosophila 
neuromuscular junction (NMJ) that has the potential to control synapse stability by directly 
.  
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coupling CAMs to the presynaptic actin and microtubule cytoskeleton. This network consists 
of the adaptor molecule Ankyrin2 (Ank2), the scaffolding proteins α- and β-Spectrin and the 
actin-capping molecule Hts/Adducin 11-14. Ank2 can directly interact with transmembrane 
proteins including ion channels, receptors and cell adhesion molecules via its N-terminal 
Ankyrin-repeat domain and bind to β-Spectrin or presynaptic microtubules via distinct C-
terminal domains 15. Spectrin can interact directly or via the actin-capping molecule Adducin 
with presynaptic actin filaments 12, 15. Loss-of-function mutations in all of these genes 
severely impair synapse stability in Drosophila 11-14 and result in learning and memory 
defects as well as progressive neurodegeneration in vertebrates 16-18
To identify cell adhesion molecules that control synapse maintenance and plasticity 
upstream of the Ank2/Spectrin/Adducin network, we performed an unbiased RNAi-based 
screen of 313 transmembrane proteins that are predicted to function as synaptic CAMs based 
on their domain structure 
.  
19
Nrg encodes the Drosophila ortholog of the vertebrate L1-type protein family that is 
composed of four closely related members: L1, CHL1 (close homolog of L1), NrCAM 
(neuronal CAM) and Neurofascin 
. These included Ig-domain containing proteins, LRRs, Cadherins, 
Integrins and Semaphorins. In this screen we identified the Drosophila L1-type CAM Nrg as 
an essential protein for synapse stability.  
20, 21. L1-type IgCAMs usually consist of 6 Ig-domains, 3-5 
fibronectin type III domains, a single transmembrane domain and an intracellular tail. The 
extracellular domain of L1 family proteins can mediate cell-cell adhesion via homophilic 
interactions and engage in a variety of heterophilic interactions with other Ig-domain proteins 
(e.g. NCAM, TAG-1, Contactin and others), extracellular matrix proteins and integrins 20-22. 
The intracellular tail contains distinct protein-protein interaction domains controlling the 
localization and function of L1 proteins 23. Most prominent is a central Ankyrin interacting 
motif that is highly conserved among all vertebrate L1 family proteins and Drosophila 
Neuroglian 23. Phosphorylation of a single tyrosine within this FIGQY motif abolishes 
binding to Ankyrins 24-27. The Ankyrin-binding domain is essential for mediating neuronal 
adhesion in vivo in C. elegans, however it is dispensable for L1 mediated homophilic 
adhesion in transfected cells in culture 28, 29
Studies in a variety of animal models implicated all L1 family members in nervous system 
development 
. 
20, 21. Human mutations in L1CAM cause a broad spectrum of neurological 
disorders grouped under the name L1 or CRASH syndrome. These disorders include MASA 
syndrome (mental retardation, aphasia, shuffling gait, adducted thumbs), agenesis of the 
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corpus callosum and spastic paraplegia, and additionally weak mutations in L1CAM and 
NrCAM have been linked to psychiatric diseases 21, 22, 30. At the cellular level L1-type 
proteins are involved in neurite outgrowth, axon pathfinding and fasciculation and synapse 
development 21, 23. The subcellular localization of L1-type proteins contributes to the 
establishment and maintenance of specialized neuronal membrane compartments including 
the axon initial segment (AIS) and nodes of Ranvier 31-33. At the AIS an Ankyrin-based 
gradient of Neurofascin regulates the subcellular targeting of inhibitory pinceau synapses to 
the AIS of Purkinje cells 31, 34. Similarly, disruption of the L1CAM - Ankyrin interaction in 
mice impairs inhibitory synapse function 35. While these studies highlight essential functions 
of L1 family proteins, potential redundant or antagonistic functions between different L1-type 
proteins may mask the full extent of their importance for nervous system development. 
Indeed, evidence for redundant functions between L1-type proteins was provided by a double 
mutant analysis of L1CAM and NrCAM 36
Nrg encodes the sole homolog of L1-type proteins in Drosophila with equal homology to 
all four vertebrate proteins. This provides a unique opportunity to unravel the contributions of 
L1-type proteins in synapse development and maintenance. Here, we address the specific 
contributions of extra- and intracellular domains of Nrg to synapse stability. We also 
demonstrate that binding of Nrg to Ank2 is critical for the control of mobility of Nrg in vivo. 
We use two complementary model systems, the larval neuromuscular junction and the central 
Giant Fiber synapse to assess the importance of this interaction for synapse development. We 
demonstrate that the Nrg-Ank2 interaction is essential to control the balance between synapse 
growth and stability. In addition, we provide evidence that regulation of the Ankyrin-binding 
domain of Nrg is essential to coordinate pre- and postsynaptic development via trans-synaptic 
signaling mechanisms. 
. Together with the requirement of L1-type 
proteins for early nervous system development this confounds our current mechanistic 
understanding of L1-type protein function and regulation in synapse development and 
plasticity. 
 
Results 
RNAi screen identifies the Drosophila L1-type CAM Neuroglian as essential for synapse 
stability 
To identify cell adhesion molecules necessary for the maintenance of synaptic connections 
we performed a transgenic RNAi-based screen of 313 transmembrane proteins encoding 
potential cell adhesion molecules based on their domain structure and previously described 
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functions in axon guidance or synapse development. We knocked down candidate genes 
simultaneously in presynaptic neurons and postsynaptic muscles and analyzed third instar 
larvae for defects in synapse stability using selective pre- and postsynaptic markers (Fig. 1 a-
f). In wild type animals the presynaptic active zone marker Brp is found in close opposition 
to postsynaptic glutamate receptor cluster at all individual synapses within the presynaptic 
nerve terminal demarcated by the membrane marker Hrp. In contrast, NMJs displaying 
postsynaptic glutamate receptor clusters without opposing presynaptic active zone markers 
and a fragmentation of the presynaptic membrane indicate synapse retractions 12, 13
To monitor the efficiency of our RNAi mediated knock down we analyzed Nrg levels at 
larval NMJs and in brain extracts. The neuronal specific isoform Nrg180 was present 
throughout motoneuron axons and within the presynaptic nerve terminal (Supplementary Fig. 
2 a). In contrast, Nrg167 was detected in muscles and glial cells (Supplementary Fig. 2 e). 
Western blots of larval brain extracts and analysis at the NMJ demonstrated that all 
combinations of presynaptic nrg RNAi efficiently knocked down Nrg180 (Figure 1 h; 
Supplementary Fig. 2 b). Similarly, muscle specific nrg RNAi knocked down Nrg167 in 
muscles (Supplementary Fig. 2 f). While postsynaptic nrg RNAi did not alter Nrg180 levels 
in brain extracts (Fig. 1 h), the loss of postsynaptic Nrg resulted in a significant change in 
presynaptic Nrg180 levels and distribution at the NMJ (Supplementary Fig. 2 f; reduced to 
62.9 ± 3.7% of wild type protein within the presynaptic terminal, P < 0.001) indicating a 
requirement of postsynaptic Nrg for presynaptic Nrg localization. However, this reduction in 
presynaptic Nrg180 was not sufficient to impair synapse stability (Supplementary Fig. 2 c, f; 
Fig. 1 c, f) implicating the existence of alternative postsynaptic Nrg interaction partners 
essential for NMJ maintenance. To validate the specificity of our RNAi mediated knock 
. We 
identified Drosophila Nrg as the top hit resulting in synaptic retractions at more than 50% of 
all NMJs on muscle 4. We first tested whether specific knock down of Nrg either in the 
motoneuron or the muscle also impairs synapse stability. Presynaptic knock down of Nrg was 
sufficient to cause synaptic retractions equivalent to the simultaneous pre- and postsynaptic 
knock down (Fig. 1 b, e, g). In contrast, muscle specific nrg RNAi did not lead to a 
significant increase in synaptic retractions (Fig. 1 c, f, g). We obtained similar results when 
we expressed an independent nrg RNAi line and were able to enhance the phenotype by 
combining different motoneuron Gal4 drivers or by co-expressing UAS-dcr2 to enhance 
RNAi efficacy (Fig. 1 g). We observed similar rates and severities of synapse retractions 
when using independent pre- and postsynaptic markers and when analyzing different subsets 
of muscles (Fig. 1 d-e; Supplementary Fig. 1; Supplementary table 1).  
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down we aimed to rescue the synaptic phenotypes by co-expressing wild type Nrg180. 
Simultaneous expression of UAS-nrg180 but not of UAS-mCD8-GFP or of the homophilic 
cell adhesion molecule Fasciclin II (Fas II) significantly restored synapse stability and 
restored Nrg180 levels both in larval brains and at the NMJ (Fig. 1 g, h; Supplementary Fig. 2 
d). Thus the specific loss of pre- but not postsynaptic Nrg resulted in a loss of synapse 
stability.  
To gain insights into the molecular processes inducing synaptic retractions in animals 
lacking presynaptic Nrg we analyzed the distribution of two presynaptic components, Ank2 
and Futsch, at early stages of synaptic retractions. The presynaptic adaptor protein Ank2 has 
previously been identified as an essential molecule for synapse stability and Ankyrins can 
directly bind to Nrg 11, 13, 15. In addition, loss of microtubules represents an early step in 
synaptic retractions at the Drosophila NMJ that can be monitored by staining for the 
microtubule-associated protein Futsch 13, 14, 37
 
. We co-stained these NMJs either with the 
presynaptic active zone marker Brp or the synaptic vesicle marker DvGlut to monitor the 
molecular sequence of events underlying the disassembly of the presynaptic compartment. At 
wild type NMJs Ank2 and Futsch were present in all terminal boutons together with Brp and 
DvGlut. In contrast, after presynaptic knock down of Nrg we observed NMJs where Ank2 or 
Futsch were absent from terminal boutons that still contained presynaptic Brp or DvGlut and 
where the presynaptic membrane was still intact (Fig. 1 i-k). Thus loss of Ank2 and the 
associated microtubule cytoskeleton may represent an early step during synapse retractions 
caused by the loss of Nrg.  
Distinct contributions of the extra- and intracellular domain of Nrg for synapse stability 
Two domains of Nrg that may be essential for synapse maintenance are the extracellular Ig 
domains mediating association with postsynaptic CAMs and the intracellular Ankyrin 
binding domain that provides an interaction with the presynaptic cytoskeleton. To directly 
test for a potential role of these domains in synapse stability we generated genomic rescue 
constructs that allow expression of wild type and mutated nrg at endogenous levels using a 
site-directed Pacman based approach 38. A transgenic construct encompassing the entire nrg 
locus including 25 kb upstream and 10 kb downstream regulatory sequences (P[nrg_wt]; Fig. 
2a) rescued the embryonic lethal nrg null mutation nrg14 (and nrg17). We then used galK-
mediated recombineering 39 to generate a deletion of the extracellular Ig domains 3 and 4 
(P[nrgΔIg3-4]), that completely disrupts hetero- and homophilic binding capacities of Nrg 40. In 
addition, we generated a specific deletion of the Ankyrin-binding domain of Nrg180 
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(P[nrg180ΔFIGQY]), which is possible because the domain is encoded by separate exons for the 
two Nrg isoforms (Fig. 2a). All constructs were inserted into the same genomic insertion site 
to ensure identical expression. While P[nrg180ΔFIGQY] rescued the embryonic lethality of 
nrg14 mutants similar to the wild type construct, P[nrgΔIg3-4] failed to rescue the embryonic 
lethality.  In order to analyze the larval NMJ in these embryonic lethal nrg14; P[nrgΔIg3-4] 
flies, we combined the Pacman rescue approach with the MARCM technique 41. First we 
analyzed motoneurons completely lacking nrg using the nrg14 null mutation and observed 
two striking phenotypes. We found synapse retractions indicated by NMJs displaying 
remnants of the presynaptic MARCM membrane marker opposite postsynaptic glutamate 
receptors but lacking the presynaptic marker Brp (Fig. 2 c, d). While synapse retractions were 
only observed at low frequency the most common phenotype was motoneuron axons ending 
in “bulb-like” structures within nerve bundles, which were not connected to a postsynaptic 
muscle (50% of all labeled axons, Fig. 2 g-i). While the wild type nrg Pacman construct fully 
rescued these axonal and NMJ phenotypes (Fig. 2 b, f, i; Supplementary Fig. 3 a), P[nrgΔIg3-4] 
did not rescue these defects and the presence of P[nrg180ΔFIGQY
Prior studies showed a delay of axonal outgrowth in nrg mutant embryos 
] resulted only in a partial 
rescue. In both genotypes we observed synaptic retractions as well as axons ending in bulbs 
distant from a potential target muscle (Figure 2 d, e, h, i; Supplementary Fig. 3 b; 
Supplementary Table 1).  
42-44. Our axonal 
phenotypes would be consistent with such stalling of axons but, because we also observe 
synapse retractions in these animals, could equally be caused by a retraction of axons after 
initial innervation of a target muscle. Indeed, we were able to demonstrate that synaptic 
retractions resulted in axonal retractions. For example, Figure 2 e shows an elimination of an 
NMJ indicated by the complete loss of presynaptic vesicles, while fragments of the mCD8-
GFP marked motoneuron membrane were still present opposite postsynaptic Dlg (Fig. 2 e1). 
We were able to follow the tract of fragmented membrane remnants over a distance of more 
than 150 µm to the retraction bulb-like structure (Fig. 2 e, e2). Additionally, we observed 
large axonal swellings in the same axon further proximal towards the cell body of the 
motoneuron (Figure 2 e, e3). Other examples were identified as retraction bulbs because they 
were in close proximity to NMJs that lacked all presynaptic vesicles and the MARCM 
membrane marker and showed clearly reduced postsynaptic membranes when compared to a 
stable NMJ in close proximity (Supplemental Figure 3 b, asterisk). Rates of retraction bulbs 
and axonal swellings were identical in MARCM clones of nrg14 and nrg14; P[nrg180ΔIg3-4] 
animals (Fig. 2 i). Finally, when we analyzed the innervation pattern of motoneuron axons 
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that still formed stable NMJs at this larval stage we could demonstrate that the lack of Nrg 
did not result in general axon guidance defects. We observed similar rates of innervations for 
all 4 major classes of motoneurons and detailed scoring revealed uniform innervation of all 
muscles with no obvious differences between wild type and mutant motoneurons (Fig. 2 j, 
Supplementary Fig. 2 c). In summary, while we cannot exclude a role for Nrg in axonal 
outgrowth for some cases, we provide clear evidence that Nrg is required for the maintenance 
of the NMJ and that this function requires both the extracellular domain and the intracellular 
Ankyrin-binding domain of Nrg. 
 
Mutations in the Nrg FIGQY motif differentially affect Ankyrin2-binding 
Based on these results we aimed to understand in detail how synaptic function of Nrg is 
controlled by its interaction with the Ankyrin associated cytoskeleton. Prior studies in 
vertebrates demonstrated that phosphorylation of the conserved tyrosine residue within the 
FIGQY motif has the potential to abolish the interaction of L1 type proteins with Ankyrins 24-
27. Similarly, Yeast-2-Hybrid assays showed that Nrg directly binds to Drosophila Ankyrin1 
and Ankyrin2 and that replacing the tyrosine with a phenylalanine (Y-F) alters binding 
capacities 45
 
. We used protein immunoprecipitation (IP) assays to further characterize the 
interaction between Nrg and Ank2. We generated tagged Nrg180 and Ank2 UAS constructs 
(Ank2-S: short isoform of Ank2 containing all potential Nrg interacting domains) and co-
expressed the constructs in Drosophila S2 cells. We were able to efficiently pull down Nrg 
using Ank2-S and vice versa demonstrating a biochemical interaction between the two 
proteins (Fig. 3 a; and data not shown). Next, we generated a series of mutations that are 
likely to differentially impair the binding capacities between Nrg and Ank2 by mutating the 
tyrosine to a phenylalanine (Y-F), aspartate (Y-D) or alanine (Y-A) or by deleting the entire 
FIGQY motif (∆FIGQY). The IP assays demonstrated quantitative differences in Ank2 
binding capacities for all Nrg mutations (Fig. 3 a). Compared to wild type the quantifications 
demonstrated a 30% decrease in binding capacities for Y-F, a 70% decrease for Y-D and a 
90% reduction for the Y-A mutation. The deletion of the FIGQY motif essentially abolished 
the Nrg-Ank2 interaction completely (Fig. 3 b). Thus, we have identified a series of 
mutations that result in defined reduction of Nrg-Ank2 binding that can be used to assess the 
importance of the regulation of this interaction in vivo. 
Loss of Ankyrin2 binding results in increased lateral mobility of Nrg 
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Studies of CAMs in vertebrates and Drosophila demonstrated that impairing the 
association with the cytoskeleton leads to an increase in lateral mobility and a simultaneous 
reduction of adhesive properties 24, 46, 47. To analyze if Nrg is regulated in a similar manner 
we tested how the selective impairment of the Ank2 association changes the biophysical 
behavior of Nrg in vivo. We generated GFP-tagged UAS-transgenes of all described nrg 
FIGQY mutations using site-specific integration to ensure equal expression levels between 
constructs (Fig. 3 d, h). In order to test whether these mutations affect the mobility of Nrg180 
within motoneurons, we used fluorescence recovery after photobleaching (FRAP) 
experiments in vivo. At the presynaptic nerve terminal only 10% of Nrg180 wild type protein 
was recovered indicating a very limited lateral mobility within the 200 sec time frame (Fig. 3 
c, e, f). The complete deletion of the Ank2 binding site (Nrg180ΔFIGQY) led to a small but not 
significant increase in the mobile fraction of Nrg180 within this time frame (Fig. 3 e, f; P = 
0.11). These results indicate that at the presynaptic nerve terminal interactions with 
postsynaptic CAMs may prevent significant mobility of Nrg. This is supported by our 
observation of a significantly larger recovery rate for wild type Nrg180 (mobile fraction of 
about 40%) when we tested the mobility within axonal compartments distally of muscle 4, 
where extracellular interactions are likely to be less significant (Fig. 3 d, g, i, j). Importantly, 
the deletion of the Ank2 binding domain further increased the mobile fraction by a factor of 
two to about 80% of total protein. When testing the different tyrosine specific point 
mutations, we observed a significant increase in the mobile fraction for all alterations 
compared to wild type, but to a lesser extent than Nrg180ΔFIGQY
 
 (Fig. 3 j). Thus, impairing the 
interaction between Nrg and Ank2 significantly changes the mobility of Nrg in motoneuron 
axons in vivo. 
Association of Nrg180 with Ankyrin2 balances NMJ growth and stability 
To further address the function of the Nrg180-Ank2 interaction in vivo we introduced all 
FIGQY specific mutations into the wild type nrg Pacman construct using galk-mediated 
recombineering. In addition, we generated a deletion of the entire C-terminus of Nrg180, a 
complete deletion of the FIGQY motif of Nrg167 as well as a specific deletion of the last 3 
amino acids of Nrg180 as this potential PDZ-protein interacting domain has been implicated 
in axon outgrowth of mushroom body neurons 48 (Fig. 2 a; Supplementary table 1). All 
constructs were inserted into the same genomic landing site and crossed into the background 
of the nrg14 null mutation to create a series of “knock-in” like mutations that express mutant 
Neuroglian protein under endogenous control. Interestingly, all modifications of the 
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intracellular cytoplasmic domains of Nrg167 and Nrg180 rescued the embryonic lethality 
associated with nrg null mutations (nrg14 and nrg17). To confirm the specificity, expression 
levels and localization of our mutations we analyzed these larvae with specific antibodies 
recognizing either both isoforms (Nrg3c1) or only Nrg180 (Nrg180BP104). Because 
Nrg180BP104 recognizes only wild type non-phosphorylated Nrg180 but none of our FIGQY 
mutations (Supplementary Fig. 4 a, b; Fig. 3 h and data not shown) we used two newly 
generated antibodies: Nrg180cyto recognizes the cytoplasmic tail of Nrg180 C-terminal of the 
FIGQY motif and NrgFIGQY
The series of “knock-in”-like Pacman mutations allowed us to systematically determine 
the requirement of the different domains for normal synapse development in third instar 
larvae. Our analysis of synapse stability revealed a significant increase in synaptic retractions 
in mutants with severely disrupted Nrg180-Ank2 interactions (nrg180
 recognizes the FIGQY motif of both isoforms. With these 
antibodies we were able to unambiguously identify all mutated proteins and demonstrate that 
all constructs are expressed at equal levels within larval brains (Supplemental Fig. 4 b, d). In 
addition, wild type and all mutant nrg constructs restored Nrg180 expression within the 
presynaptic nerve terminal as well as Nrg167 expression within glial cells and muscles 
(Supplementary Fig. 4 a, c). This data demonstrates that the FIGQY domain is not essential 
for presynaptic localization of Nrg180.  
Y-D, nrg180Y-A, 
nrg180ΔFIGQY) but not in animals lacking the Nrg167 FIGQY motif, deletion of the PDZ 
binding motif nor in mutations only slightly impairing binding capacities (nrg180Y-F) (Fig. 4 
a-d; Supplementary Table 1). In addition, we observed a significant increase in the severity of 
retractions including complete eliminations (Fig. 4 c, e) consistent with our observations of 
the nrg14; P[nrg180ΔFIGQY] MARCM clones (Fig. 2 i; Supplementary table 1). We next asked 
whether the Nrg FIGQY motif is directly required for the synaptic localization of Ank2 to 
mediate NMJ stability. Interestingly, we did not observe obvious alterations of presynaptic 
Ank2-L localization or protein levels in P[nrg_wt, Y-F or ∆FIGQY] at stable synapses when 
compared to w1118
In addition to the synapse stability defects we observed a second striking defect in our nrg 
mutations when we analyzed NMJ growth and organization. With an increasing loss of Ank2 
 (Supplementary Fig. 5 a; P > 0.05 for comparison of protein levels, data 
not shown). Thus, this suggests that while Nrg and Ank2 do not depend on each other for 
initial synaptic localization they display a high sensitivity towards normal levels of their 
interaction partner because Nrg and Ank2 are among the first proteins to be lost at nrg and 
ank2 mutant semi-stable NMJs respectively (Fig. 1 i, j; Supplementary Fig. 5 b-d).  
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binding capacities of Nrg180 we found an increase in both the span of the presynaptic nerve 
terminal and the number of synaptic boutons. At the same time we observed a corresponding 
decrease in synaptic bouton area (Fig. 5 a-f). Interestingly, only very subtle alterations were 
observed for the Y-F mutation that still binds Ank2 efficiently (Fig. 5 b, e, f) highlighting a 
role for Ank2 in determining NMJ size. The finding that the phenotypes for the deletion of 
the Nrg180 FIGQY motif and the larger C-terminal deletion were almost identical indicates 
that control of NMJ growth critically depends on this motif (Fig. 5 e, f). We did not observe 
any growth related phenotypes in nrg14; P[nrg167ΔFIGQY] or nrg14; P[nrg180ΔPDZ
 
] mutant 
animals (Fig. 5 e, f). Together, these data demonstrate that the loss of Ank2 binding 
capacities of Nrg180 correlates with a loss of NMJ growth control and an impairment of 
synapse stability and suggest that these two parameters are tightly coupled. 
Nrg180 FIGQY motif is essential for giant fiber synapse development 
To address synaptic functions of the Nrg180-Ank2 interaction in the central nervous 
system (CNS), we extended our analysis to the adult Giant Fiber (GF) circuitry. We used the 
GF to TTMn (Tergo-trochanteral motoneuron) connection as a model neuro-neuronal synapse 
as it provides precise genetic control of pre- and postsynaptic neurons 49. Previous analysis of 
nrg mutations affecting either homophilic cell adhesion properties (nrg849) or protein levels 
(nrg305) identified both axon guidance and synaptic defects at the GF terminal 50, 51
We analyzed the function of the GF to TTM (Tergo-Trochanteral Muscle) pathway in all 
viable nrg
. Our 
“knock-in” like mutations enabled us to directly determine a requirement for the different 
intracellular Nrg domains with respect to GF circuit formation and function.  
14; P[nrg-mutant] animals by intracellular recordings from the TTM using either 
brain or thoracic stimulation to reveal potential GF-TTMn synapse or TTMn NMJ 
phenotypes (Fig. 8 a). Importantly, presence of the wild type nrg construct in nrg null 
mutants (nrg14; P[nrg_wt]) established normal function in the GF-TTMn circuit. We 
observed no significant differences in average response latencies or following frequencies 
after a train of stimulations at 100 Hz when compared to wild type control animals (Fig. 6). 
In contrast, all mutations within the Nrg180 FIGQY motif caused a severe impairment of GF 
circuit function. The average response latency, a measure for synaptic strength, was 
significantly increased (Fig. 6) and mutant animals were not able to follow trains of high 
frequency stimulations when the GF was stimulated in the brain; in some animals we 
observed a complete absence of responses (Fig. 6 b, d). In contrast, when we bypassed the GF 
and stimulated the motoneurons directly with thoracic stimulation, both response latency and 
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ability to follow high frequency stimulation were normal for the TTMn in all tested animals 
(data not shown) indicating that the observed defects were specific to the GF-TTMn synaptic 
connection. Interestingly, we did not observe phenotypic differences between the complete 
deletion of the Nrg180 FIGQY motif and single point mutations that only mildly impaired 
Ank2 binding (e.g. nrg180Y-F
In order to determine the morphological phenotypes and to distinguish between potential 
axon guidance and synaptic defects we co-injected large (Rhodamin-dextran) and small 
(Biotin) fluorescent dyes into the GF. In wild type animals the large dye is confined to the GF 
and reveals the morphology of the synaptic terminal. In contrast, the small dye is able to pass 
through gap-junctions that provide parts of a functional connection to the postsynaptic TTM 
motoneuron and thus dye-couple pre- and postsynaptic neurons. In wild type animals the GF-
TTMn synapse grows to a large presynaptic terminal with mixed electrical and chemical 
synapses 
) indicating that a partial constitutive Nrg180-Ank2 interaction 
was not sufficient for GF synapse function (Fig. 6 c, d). However, all tyrosine mutations 
disrupt the ability to modulate the Nrg-Ank2 interaction via posttranslational phosphorylation 
suggesting that dynamic temporal and spatial regulation of the Nrg180-Ank2 interaction is 
essential to establish a functional GF synapse. In contrast, neither the Nrg167 FIGQY motif 
nor the C-terminal Nrg180 PDZ protein-binding motif are critical for GF circuit function 
(Fig. 6 c, d). 
49. While we observed no major morphological alterations of GF terminals in nrg14; 
P[nrg_wt], nrg14; P[nrg167ΔFIGQY] and nrg14; P[nrg180ΔPDZ] mutant flies, while mutations 
within the Nrg180 FIGQY motif resulted in severely disrupted GF terminals in more than 
80% of analyzed animals (Fig. 7 a, b). The GFs were present within the synaptic target area, 
however, the entire or large parts of the synaptic terminals were either thinner or swollen to 
abnormal sizes and often contained large vacuole-like structures (Fig. 7a insets). Similar to 
the electrophysiological phenotypes, we observed no obvious qualitative or quantitative 
differences between different Nrg180 FIGQY mutations. Next, we directly tested for the 
presence of a synaptic connection between GF and the postsynaptic TTMn using the dye-
coupling assay. Consistent with the electrophysiological data, we found a residual synaptic 
connection in more than 90% of animals carrying mutations in the Nrg 180 FIGQY motif 
(Fig. 7a, c). However, total injection time varied between preparations and dye-coupling was 
often weaker or required longer injection times in mutant animals compared to animals 
rescued with the wild type construct. These results indicate that at least a small number of 
gap junctions are established at the GF terminals of Nrg180FIGQY mutants. When we 
correlated the ability to dye-couple to electrophysiological properties of these synapses, we 
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observed that approximately 40% of Nrg180FIGQY
 
 mutant animals that were positive in the 
dye-coupling assay did not show any functional response (Fig. 7 c). This suggests that the 
synaptic strength in these animals was below the threshold to trigger an action potential in the 
postsynaptic TTMn. In contrast, neither the deletion of the FIGQY motif of Nrg167 nor the 
PDZ protein-binding domain of Nrg180 affected GF morphology or function (Fig. 7). Thus, 
we conclude that the Ankyrin binding motif of Nrg180 but not of Nrg167 is essential for 
normal GF-TTMn synapse maturation and function but is not required for axon guidance or 
synapse targeting. 
Trans-synaptic coordination of pre- and postsynaptic development by Nrg180 
Importantly, the Pacman-based rescue approach allows us to determine both temporal and 
spatial requirements of the Nrg FIGQY motif when we complement it with selective 
expression of wild type Nrg using the Gal4/UAS system. At the GF-TTMn synapse we can 
use distinct Gal4-driver lines to either drive expression simultaneously in the pre- and 
postsynaptic neurons or selectively only in one of the two synaptic partners. In addition, we 
are able to express UAS-constructs at different time points during GF development (Fig. 8 a).  
Simultaneous expression of wild type Nrg180 in pre- and postsynaptic neurons throughout 
GF circuit development was able to completely rescue all electrophysiological and 
morphological defects associated with point mutations (using Y-F and Y-A as representative 
examples) or the deletion of the Nrg180 FIGQY motif (Fig. 8 b-d and data not shown). Thus, 
this assay can be used to determine specific pre- and postsynaptic requirements. To our 
surprise, we were able to rescue the anatomical and physiological phenotypes to a similar 
extent by expressing wild type nrg180 either in the pre- or the postsynaptic neuron (Fig. 8). 
We did not observe any non-responding animals, the average response latency was 
significantly restored and only subtle defects in the ability to follow multiple stimuli at 100 
Hz were seen in few animals (Figure 8 b-d). In addition, the presynaptic morphological 
phenotypes of Nrg180FIGQY mutant animals were not only rescued by presynaptic expression 
in the GF but also by expression in the postsynaptic TTMn (Fig. 8 e). This suggests that Nrg 
has the ability to control GF synapse development in a trans-synaptic manner and that 
Nrg180 with a wild type FIGQY motif on either side of the synapse is sufficient to enable 
normal GF synapse development in Nrg180FIGQY
In order to unravel potential differences in temporal requirements of the Nrg180 FIGQY 
motif during synapse formation, we utilized a Gal4 line that starts expression in the GF only 
after the initial connection between the GF and the TTMn has been established (Fig. 8 a) 
 mutant animals.  
49, 
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52. Despite the phenotypic similarities of the Nrg180 Y-F, Y-A and ΔFIGQY mutants in the 
electrophysiological and morphological assays this “late presynaptic” rescue assay revealed 
unique differences between these mutations. While we were not able to significantly rescue 
the response latencies or the ability to follow high frequency stimulations in nrg14; 
P[nrg180ΔFIGQY] or nrg14; P[nrg180Y-A] mutants (Fig. 8 c, d), we did observe a significant 
rescue of both parameters in nrg14; P[nrgY-F
 
] mutant animals. Almost 80% of the animals now 
displayed wild type electrophysiological properties (Fig. 8 b). Thus, a late presynaptic rescue 
was only possible in animals where Nrg180 retained significant Ank2 binding properties but 
not in animals with a severe impairment of the Nrg-Ankyrin interaction. This suggests that 
Nrg association to the Ankyrin based cytoskeleton is essential during early stages of GF 
synapse development while synapse maturation requires a dynamic regulation of this 
interaction.  
Discussion 
Precise control of synaptic connectivity is essential for the formation, function and 
maintenance of neuronal circuits. Here we identified the L1-type CAM Neuroglian as a key 
regulator of synapse stability in vivo. By combining biochemical, biophysical and genetic 
assays at two complementary model synapses, we demonstrate that regulation of the Nrg-
Ankyrin interaction plays a critical role in controlling synapse growth, maturation and 
stability. Several important findings arise from our work: (1) Control of synapse stability 
requires Nrg mediated cell adhesion, which can be controlled by direct coupling to the 
presynaptic Ankyrin-associated cytoskeleton. (2) Synapse elimination and axonal retraction 
display striking phenotypic similarities to developmentally controlled synapse elimination at 
the vertebrate NMJ suggesting common cellular mechanisms between developmental and 
disease processes. (3) Local regulation of Nrg-Ankyrin binding provides a mechanism to 
gradually control the delicate balance between synapse growth and stability. (4) Trans-
synaptic Nrg signaling contributes to the coordination of pre- and postsynaptic development 
in the CNS. 
 
The L1-type CAM Neuroglian controls synapse stability 
A large number of cell adhesion molecules have been implicated as important mediators of 
synapse development, but the regulatory mechanisms controlling structural synapse plasticity 
and maintenance remain largely unknown. In an unbiased RNAi screen, we identified the 
Drosophila L1-type CAM Neuroglian as essential for synapse stability at the neuromuscular 
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junction. We demonstrate that knock down of presynaptic Nrg induces synapse disassembly 
that share all cellular hallmarks of retractions observed in ank2, spec or hts mutant animals 11-
14. By analyzing individual motoneurons lacking any Nrg expression we verified this 
presynaptic requirement of Nrg for synapse maintenance. In addition, this allowed us for the 
first time to unravel the cellular events occurring in response to loss of cell adhesion at the 
presynaptic nerve terminal. In nrg mutant motoneurons, we observed both synaptic 
retractions and motoneuron axons ending in “retraction bulb” like structures. Excitingly, we 
directly observed mutant NMJs lacking any presynaptic cytoplasmic marker that are still 
connected via traces of clonally marked presynaptic membrane remnants to retraction bulb-
like structures at large distances from the NMJ (> 150 µm). This demonstrates that loss of 
synapse stability can induce a cellular program resulting in the retraction of the motoneuron 
axon accompanied by shedding of presynaptic membrane. This phenotype shares striking 
similarities with developmental synapse elimination at the vertebrate NMJ 53 and points to 
potential similar cellular programs underlying synapse loss in development and disease. It 
will be of particular interest to analyze the contribution of glial cells in this process as they 
are part of a pro-degenerative signaling system at the NMJ and actively clear membrane 
remnants of degenerating or pruning axons in both Drosophila and vertebrates 53-56. It is 
important to note that some of the axonal phenotypes would also be consistent with a stalling 
of the axonal growth cone before reaching the appropriate target. Indeed, prior studies in both 
Drosophila and vertebrates demonstrated a function of Nrg and L1CAM for normal rates of 
neurite outgrowth 21, 23, 42-44
Although Nrg is certainly critical for NMJ maintenance our observation that 50% of larval 
NMJs were still stable in nrg null mutants clearly indicates that redundant mechanisms 
control synapse stability at the level of synaptic cell adhesion molecules. A candidate to 
provide such redundancy would be the Drosophila NCAM homolog FasII, which has been 
previously implicated in NMJ maintenance 
 indicating that both defects in axon growth and loss of synapse 
stability may have contributed to the observed phenotypes.  
57 and can substitute for Nrg during axonal 
outgrowth of ocellar neurons 43
 
. However, our results demonstrate that FasII cannot 
compensate for the loss of presynaptic Nrg at the larval NMJ (Fig. 1 g; Supplementary Fig. 1 
d). The identification of the entire combinatorial code of CAMs contributing to synapse 
stability will be of high interest to understand the mechanisms underlying structural synapse 
plasticity. 
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The Nrg-Ank2 interaction functions as a molecular switch to balance synapse growth 
and stability 
The dynamic nature of many neuronal circuits requires controlled changes in synapse 
assembly and disassembly without a disruption of neuronal circuit function. While 
extracellular interactions of synaptic cell adhesion molecules can clearly maintain synaptic 
connectivity, mechanistic insights regarding the regulation of these proteins to alter trans-
synaptic adhesion are limited to date. The process is probably best understood for Cadherins 
where adhesive properties are modulated either via binding of extracellular Calcium or by 
altering their association with intracellular Catenins via posttranslational phosphorylation 7, 8. 
These changes alter localization, clustering and trans-synaptic signaling of Cadherins leading 
to modulations of synaptic connectivity and function 9, 10. Here we identify the interaction 
between the L1-type CAM Nrg and the adaptor protein Ank2 as a similar control module. 
First, we demonstrate that Nrg directly interacts with Ank2. Second, a series of specific 
mutations in the Ankyrin binding motif FIGQY allowed us to differentially affect the 
Ankyrin-binding capacity of Nrg. We demonstrated that decreasing Ank2-binding capacities 
correlates with an up to 2-fold increase in lateral mobility of Nrg in motoneurons. This is 
consistent with studies in vertebrates demonstrating that phosphorylation of the conserved 
tyrosine of the FIGQY motif reduces or abolishes binding to Ankyrins and increases mobility 
of L1-type CAMs 24-27, 47. Finally, “knock-in” like Nrg mutants with altered Ankyrin binding 
capacity resulted in two striking phenotypes. There was a significant increase in synapse 
retractions in mutants with severely impaired Ank2 binding but not in mutants with partial 
binding (Nrg180Y-F). In addition, we observed increased NMJ growth that correlated with the 
decrease in Ank2 binding capacities and the increase in mobility of different Nrg mutants. 
Thus, impairing Ank2 binding and thereby potentially decreasing the static population as well 
as the adhesive force of Nrg180 decreases synaptic stability but also allows increased 
synaptic growth. We previously identified similar switch-like alterations of synapse growth 
and stability in animals lacking the Spectrin-binding and actin-capping molecule hts/adducin 
12. Importantly, studies of adducin2 mutant mice demonstrated that Adducin2 provides a 
similar function in vertebrates and is essential to mediate changes in synaptic connectivity 
relevant for learning and memory 16, 58. Finally, it should be noted that we do not observe 
significant alterations in presynaptic Nrg or Ank2 levels in these animals similar to previous 
observations for the axonal localization of these proteins 45, 59. However, we found a clear 
dependence on the respective partner protein at semi-stable nrg and ank2 mutant synapses 
that displayed first signs of synapse disassembly. Thus, while Nrg and Ank2 seem not to 
 61 
depend on each other for initial synapse localization, their interaction is required to maintain 
synaptic localization. A similar late loss of AnkyrinG has been observed in neurofascin 
mutant Purkinje cells, demonstrating a function of the L1CAM paralog for maintenance but 
not for initial localization of AnkG to the AIS 31, 33 and likewise AnkG is required for the 
maintenance of Neurofascin 34
 
. Together these data indicate that modulation of the Nrg-Ank2 
interaction balances synapse growth and stability without disrupting synaptic localization of 
both proteins. Changing the interaction via posttranslational phosphorylation could thus 
locally decrease synapse stability thereby allowing the formation of new synapses without 
impairing general neuronal circuit architecture.  
Trans-synaptic Nrg function requires dynamic regulation of the Ankyrin binding 
motif   
Despite our detailed knowledge regarding expression of synaptogenic and potentially 
stabilizing cell adhesion molecules mechanistic insights into trans-synaptic control of synapse 
maturation or function are only recently emerging 1, 2, 9, 10
In contrast to the larval NMJ, all mutations in the intracellular Ankyrin binding domain of 
Nrg180 severely disrupted GF synapse morphology and function. The lack of significant 
differences in phenotypic strength between mutations differentially affecting Ank2-binding 
indicates that normal GF synapse development requires a dynamic temporal-spatial 
regulation of the Nrg-Ank2 interaction via phosphorylation. To address the importance of this 
regulation for trans-synaptic development we selectively reintroduced wild type Nrg180 
either in the pre- or postsynaptic neuron of the GF synapse. Surprisingly, expression of wild 
type Nrg on either side of the synapse was sufficient to restore synaptic function in all 
Nrg180
. Here we provide evidence that 
trans-synaptic coordination of synapse development by Nrg is controlled via dynamic 
regulation of the Ankyrin-binding motif.  
FIGQY mutants. This highlights two important novel aspects of Nrg function at central 
synapses. First it indicates that the dynamic regulation of the Nrg-Ankyrin interaction on one 
side of the synapse provides molecular information that can be superimposed across the 
synapse and compensate for a mutant interaction on the other side. Interestingly, this trans-
synaptic function of Nrg can be initiated equally well from either side of the synapse and 
restores both functional and morphological properties of the GF synapse. Second, because we 
can restore function and morphology at synapses that completely lack Nrg-Ankyrin binding 
on one side it indicates that Nrg can initiate the trans-synaptic signaling cascade necessary for 
synapse development independently of its interaction with Ankyrin. These signaling 
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processes could be mediated through other intracellular domains like the FERM-protein 
binding domain or through potential cis-interaction of the extracellular domain of the mutant 
Nrg. Candidates for such cis-signaling systems are FGF/EGF signaling or Semaphorins that 
have been shown to regulate synaptic connectivity and have been identified as Nrg 
interacting partners in Drosophila 23, 60-62. Nevertheless, the general importance of the Nrg-
Ankyrin interaction is highlighted by our observation that at late stages of GF development 
wild type Nrg in the presynaptic GF neuron rescued Nrg mutants that retained Ank2 binding 
capacities, but not those with severely impaired binding. Together, this indicates that Ank2 
binding is essential during early phases of synapse development but modulation of this 
interaction is required to allow normal synapse growth and maturation. Phosphorylation of 
Nrg prevents either association with Ankyrins to increase mobility of Nrg or enables binding 
to proteins that can only bind phosphorylated Nrg. One candidate would be the microtubule 
binding protein Doublecortin that can specifically bind phosphorylated Neurofascin 63
Our complementary analysis at a peripheral and a central synapse enabled us to identify 
common and divergent mechanisms of Nrg function and regulation during synapse 
development. Both in larval motoneurons and in the Giant Fiber circuit the Ankyrin binding 
motif of Nrg180 does not significantly contribute to axon outgrowth or guidance. In addition, 
at both synapses we did not observe any requirements for the Ankyrin binding motif of 
Nrg167 or of the PDZ-binding motif of Nrg180, which has recently been implicated in 
controlling axonal outgrowth in the mushroom bodies 
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physiological relevance for this interaction in nervous system development is lacking to date.  
48. In contrast, while constitutive Nrg-
Ank2 binding (Nrg180Y-F
 Our data provides new insights into how L1-family proteins contribute to nervous 
system development. A surprising observation from studies of vertebrate L1 family proteins 
was that mutations within the intracellular domain that are linked to human L1/CRASH 
syndrome and neuropathological diseases 
) is sufficient to allow development of presynaptic nerve terminals 
at the NMJ, it is not sufficient at the central Giant Fiber synapse suggesting that regulatory 
mechanisms at these synapses control the phosphorylation status of Nrg180 differently. 
30 resulted in significantly weaker phenotypes in 
mice compared to the complete L1 knockout 21, 35, 64, 65. While extracellular interactions are 
essential for early nervous system development including neurite outgrowth and axon 
targeting 23, here we provide evidence that phosphorylation of the intracellular Ankyrin 
binding motif provides a module to fine tune synaptic connectivity without overall disruption 
of neuronal circuitry. Our finding that the regulation of this interaction functions equally well 
on either side of the synapse indicates that any activity-dependent or developmental pathway 
 63 
could impinge on this system to fine tune connectivity. The expansion of the L1-type CAM 
family to four independent proteins in vertebrates may provide the means to cope with the 
diversity and complexity of synaptic connectivity in the vertebrate CNS. Indeed, while the 
L1CAM Ankyrin motif mutations did not affect overall organization of the nervous system, 
detailed analyses revealed specific impairments within particular circuits and at subsets of 
synapses 35, 64, 65. The functions of the different L1-type proteins may be distinct, partly 
opposing or redundant as evident by an analysis of cerebellar granule cell development in 
L1CAM and NrCAM double mutants 36
 
. The coordinated phosphorylation of a subpopulation 
of synaptic L1 family proteins within the pre- or postsynaptic compartment may thus allow 
differential modulation of biophysical properties of L1 complexes to precisely control distinct 
aspects of synapse development. Elucidating the synaptic L1-family protein code at specific 
synapses and identifying their phosphorylation status during synapse development or in 
response to activity might uncover new mechanisms controlling synaptic plasticity in 
development and during learning and memory. 
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Figure 1 - Presynaptic Nrg is essential for synapse stability.  
 65 
(a-c) NMJs on muscle 4 stained for the presynaptic motoneuron membrane (Hrp, white), the presynaptic active 
zone marker Brp (green) and postsynaptic glutamate receptors (DGluRIII, red). (a) A stable wild type NMJ 
indicated by perfect apposition of pre- and postsynaptic markers. (b) Knock down of presynaptic Nrg resulted in 
severe synaptic retraction indicated by the loss of presynaptic Brp despite the presence of postsynaptic 
glutamate receptors and fragments of the presynaptic membrane. Synaptic retractions caused a characteristic 
fusion of postsynaptic glutamate receptor clusters. (c) Loss of muscle Nrg did not impair synapse stability. (d-f) 
NMJs on muscle 4 stained for the presynaptic motoneuron membrane (Hrp, white), presynaptic vesicles (Syn, 
green) and postsynaptic Dlg (red). Identical phenotypes were observed when using an independent Nrg RNAi 
line and independent pre- and postsynaptic markers. Only presynaptic loss of Nrg resulted in a selective loss of 
synaptic vesicles, a fragmentation of the presynaptic membrane and unopposed postsynaptic bouton profiles. (g) 
Quantification of synaptic retractions in different Nrg RNAi conditions. Neuronal but not muscle specific knock 
down of Nrg using different Gal4 driver combinations or independent RNAi constructs resulted in a significant 
increase in synaptic retractions on muscle 4. The retraction frequency was significantly rescued (P ≤ 0.001) by 
co-expression of UAS-nrg180 but not when we co-expressed either UAS-mCD8-GFP or UAS-fasII. Expression 
of UAS-fasII alone did not result in a significant increase in retractions (genotypes: neu1 = elavC155-Gal4; neu2 = 
elavC155-Gal4; ok371-Gal4; neu3 = elavC155-Gal4; UAS-dcr2; neu4 = elavC155-Gal4; sca-Gal4 UAS-dcr2; mus1 = 
UAS-dcr2; mef2-Gal4; RNAi1 = VDRC6688; RNAi2 = VDRC107991; rescue indicates co-expression of UAS 
construct; n = 6-24 animals). (h) Western blot analysis of the same genotypes as in g probed with an antibody 
against Nrg180 (Nrg180BP104). Neuronal but not muscle specific Nrg RNAi resulted in efficient knock down of 
Nrg180 in larval brains. Nrg180 levels could be rescued by co-expression of Nrg180 but not by co-expression of 
mCD8-GFP. (i-k) Characterization of multiple presynaptic markers in animals lacking presynaptic Nrg. (i) In 
wild type animals presynaptic Ank2 (green) and Brp (red) were present in all synaptic boutons. In the absence of 
Nrg Ank2 was lost prior to Brp at distal parts of an NMJ that was still stable as judged by the continuous 
membrane staining. (j) Similarly, Ank2 was lost prior to the presynaptic vesicle marker DvGlut (red) at a semi-
stable NMJ. (k) In wild type animals the microtubule associated protein Futsch (green) and DvGlut (red) were 
present in all boutons. Knock down of Nrg resulted in a loss of Futsch prior to the disassembly of DvGlut at 
early stages of retraction. Scale bar in a corresponds to a-f, 10 µm, inset 5 µm. Scale bar in i corresponds to i-k, 
5 µm. Error bars represent s.e.m. 
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Figure 2 - MARCM analysis reveals unique requirements of extra- and intracellular 
domains of Nrg180 for synapse stability. 
(a) Overview of the genomic locus of nrg. The Pacman construct spans 92 kb including the endogenous 
enhancer elements up- and downstream of nrg. The Nrg167 and Nrg180 specific exons and the relevant amino 
acid sequences are depicted. The position of the common Ig-domains 3 and 4 is indicated. The isoform-specific 
FIGQY sequences are highlighted in red and the PDZ protein-binding motif of Nrg180 isoform is underlined. 
(b) A nrg14 MARCM clone rescued by a wild type nrg Pacman construct. The motoneuron clone was marked by 
the expression of mCD8-GFP (green). Synaptic vesicles (DvGlut, red) were found opposite postsynaptic Dlg 
(blue) indicating a stable NMJ. (c) A nrg14 MARCM clone showing a severe retraction event. Only fragmented 
remnants of the membrane GFP marker were still present at a nerve terminal that almost completely lacked the 
presynaptic active zone marker Brp (red). Postsynaptic glutamate receptor clusters were still present and showed 
the characteristic fusion of neighboring clusters observed in all synaptic retractions. In addition, the axonal 
membrane prior to the NMJ was also fragmented. (d) A nrg14 MARCM clone expressing a mutated form of 
Nrg180 lacking the FIGQY motif. The GFP-positive NMJ was retracted while a directly neighboring, non-
marked (asterisk), NMJ remained stable. Presynaptic vesicles marked by DvGlut were absent from postsynaptic 
profiles marked by Dlg. The membrane marker was fragmented both at the nerve terminal and prior to the 
innervations. (e) Composite image overview of a nrg14 MARCM clone expressing a mutated form of Nrg180 
lacking the extracellular Ig3-4 domains. Three areas are shown at larger magnification in e1-3. (e1) At the NMJ 
no presynaptic vesicles were present opposite postsynaptic Dlg. The Dlg staining was no longer interconnected 
and only remnants of the presynaptic membrane marker mCD8-GFP were visible indicating a complete 
elimination. (e2) Approximately 150 µm proximal from the NMJ the axon remained intact ending in a “bulb-
like” structure. Between the “bulb-like” axon ending and the NMJ only punctate staining of the membrane 
marker was visible. (e3) At a significant distance from the “bulb” a large axonal swelling was visible that 
contained aggregates of the synaptic vesicle marker DvGlut. (f) Axonal area of a nrg14 MARCM clone rescued 
by a wild type nrg Pacman construct. Within the axon only very low levels of the synaptic vesicle marker 
DvGlut are evident. (g) A “bulb-like” structure in a nrg14 MARCM clone. The axon ended in a large swelling 
that contained increased levels of the active zone marker Brp. (h) A “bulb-like” structure in a nrg14 MARCM 
clone expressing P[nrg180ΔFIGQY]. The axon ended in a large swelling that showed an aberrant accumulation of 
the synaptic vesicle marker DvGlut. Only remnants of the axonal marker were evident distal to this “bulb-like” 
structure. (i) Quantification of mCD8-marked axons that were not connected to target muscles (“retracted 
axons”) in the indicated genetic background. The nrg14 mutant phenotype was significantly rescued by the 
presence of a wild type nrg Pacman construct and partially rescued by P[nrg180ΔFIGQY] but not by P[nrg180ΔIg3-
4]. (j) Analysis of muscle innervation pattern of motoneuron MARCM clones that were connected to 
postsynaptic muscles. In all genotypes we observed normal innervation for all four major classes of 
motoneurons. 
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Figure 3 - Mutations in the FIGQY-Ankyrin binding motif alter the Nrg-Ank2 
interaction and increase Nrg mobility in vivo. 
(a) Immunoprecipitation (IP) of Nrg180-HA proteins using Ank2-S-GFP. Ank2-S pulled down wild type 
Nrg180-HA efficiently. Mutations in the FIGQY domain differentially affected binding efficiency. Western 
blots show IPs and input controls. (b) Quantification of four independent IP experiments demonstrated reduced 
Ank2 binding due to the specific mutations within the FIGQY motif. (c-j) Fluorescence recovery after 
photobleaching experiments (FRAP) using GFP-tagged versions of wild type and mutant forms of Nrg180 at the 
NMJ. Equal levels of all GFP-tagged constructs were expressed in motoneurons (ok371-Gal4) as demonstrated 
by Western blot analysis of larval brain extracts in h using different Nrg180 and GFP specific antibodies. (c) 
Representative images of FRAP experiments performed at the NMJ as indicated in d for Nrg180 wild type and 
Nrg180ΔFIGQY. (e, f) Recovery curves of multiple independent FRAP experiments were fitted to a double 
exponential curve and used to calculate the mobile fraction of Nrg180. Nrg180 was highly immobile at the NMJ 
as less than 10% recover within the 200 s time frame of our experiments. We observed a slight but not 
significant increase in the mobile fraction when the FIGQY motif was deleted (P = 0.11). (g) Representative 
recoveries of FRAP in motoneuron axons for Nrg180wt, Nrg180Y-F and Nrg180ΔFIGQY. (i-j) The recovery curves 
and the quantification of the mobile fraction demonstrate higher mobility of Nrg180 within axonal 
compartments. The mobility of Nrg180 was significantly increased when the FIGQY motif was mutated 
(Nrg180Y-F). An almost 2-fold increase in mobility was observed after deletion of the Ankyrin-binding motif 
(Nrg180ΔFIGQY). The numbers in f and j represent number of independent experiments analyzed. Scale bar in c 
and g represents 5 µm. Error bars represent s.e.m. 
 70 
 
Figure 4 - Impairment of Ank2 binding results in synaptic retractions  
 71 
(a-c) Analysis of synapse stability in nrg null mutant animals expressing different nrg Pacman constructs using 
the presynaptic marker Brp (green), postsynaptic DGluRII (red) and a marker for the presynaptic membrane 
(Hrp, white). (a) Presence of the Nrg wild type Pacman construct in nrg14 animals resulted in wild type levels of 
synapse retractions. (b) The Y-A mutation leads to synaptic retractions (c) Animals lacking the Ank2 binding 
motif FIGQY showed significant levels of synaptic retractions including complete eliminations. (d, e) 
Quantification of retraction frequency and severity demonstrated increasing levels of synaptic retractions 
correlating with the gradual loss of Ank2 binding capacities. The Nrg167-FIGQY motif or the PDZ protein 
binding domain deletions did not show a significant increase in retraction frequency or severity (n = 12-22 
animals). Asterisks indicate P ≤ 0.01 for ** and P ≤ 0.001 for ***. Scale bar in a corresponds to a-c, 10 µm, 
inset 5 µm. Error bars represent s.e.m.   
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Figure 5 - Impairment of Ank2 binding increases NMJ growth.  
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Analysis of NMJ growth in nrg14 mutant animals expressing different mutated nrg Pacman constructs using the 
presynaptic vesicle marker Synapsin (Syn, green), the postsynaptic marker Dlg (red) and a marker for the 
presynaptic membrane (Hrp, blue). (a) Presence of the nrg Pacman wild type construct resulted in wild type 
muscle 4 NMJs. The inset shows individual presynaptic boutons at higher magnification. (b) The Nrg180Y-F 
mutation resulted only in small alterations of NMJ growth. (c) The Nrg180Y-A mutation led to a significant 
increase in NMJ length. (d) Deletion of the Nrg180-FIGQY motif resulted in a significant, almost 2-fold 
overgrowth and a corresponding reduction in the area of individual boutons. (e, f) Quantification of bouton 
number, NMJ length and bouton area. NMJ growth defects correlated with an increasing loss of Ank2 binding 
capacities. No alterations were observed for mutations affecting the PDZ protein binding site or the Nrg167-
FIGQY motif. Values were normalized to wild type rescue. Asterisks indicate highly significant changes (P ≤ 
0.001) for bouton number in e and for bouton area in f (n = 69-176 NMJs for bouton number, n = 20 NMJs for 
NMJ length and n = 10 NMJs for bouton area quantifications). Scale bar in a corresponds to a-d, 10 µm, inset 5 
µm. Error bars represent s.e.m. 
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Figure 6 - Electrophysiological phenotypes of nrg mutants in the giant fiber circuit. (a, 
b) Sample traces of different nrg mutants. (a) TTM responses in nrg mutants (asterisks) upon GF stimulation in 
the brain (solid white line). The average response latency in wild type flies is 0.8 ms (dashed white line). 
Sample traces of nrg14; P[nrgwt], nrg14; P[nrg180Y-F], nrg14; P[nrg180Y-A] and nrg14; P[nrg180ΔFIGQY] are shown. 
Mutations in the Nrg180-FIGQY motif led to a delay or absence of responses at the TTM. (b) As a measure for 
synaptic reliability the ability to follow stimuli at 100 Hz was determined. In contrast to nrg14; P[nrgwt], the GF-
TTM pathway in nrg14; P[nrg180Y-F], nrg14; P[nrg180Y-A] and nrg14; P[nrg180ΔFIGQY] mutants was not able to 
follow stimuli at 100 Hz upon GF stimulation in the brain; only rare responses were observed (asterisks). (c, d) 
Quantifications of electrophysiological phenotypes of nrg mutants. (c) Average latency of wild type and nrg 
mutants. There was no significant difference (P = 0.681, Mann-Whitney Rank Sum Test) in the average 
response latency between control (w1118) and nrg14; P[nrgwt], nrg14; P[nrg167ΔFIGQY] or nrg14; P[nrg180ΔPDZ] 
flies. In contrast, the response latency was significantly increased in all nrg180 mutants with a mutated FIGQY 
motif (Mann-Whitney Rank sum test, P ≤ 0.001). (d) Average following frequencies at 100 Hz in wild type and 
nrg mutants. There was no significant difference (P = 0.841, Mann-Whitney Rank Sum Test) in the average of 
following frequencies at 100 Hz between control flies (w1118) and nrg14; P[nrgwt], nrg14; P[nrg167ΔFIGQY] and 
nrg14; P[nrg180ΔFIGQY]. In contrast, following frequencies were significantly reduced in all nrg180 mutants with 
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a missense mutation in or deletion of the FIGQY motif (Mann-Whitney Rank sum test, P ≤ 0.001). Error bars 
represent s.e.m. 
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Figure 7 - Anatomical phenotypes of the giant fiber synaptic terminals in nrg mutants. 
(a) GF synaptic terminals were visualized by injection of Rhodamine-dextran (red) into the GF. Dye-coupling 
of the GF to its target neurons, the Tergo Trochanteral motoneuron (TTMn) and the peripheral synapsing 
interneuron (PSI) via co-injection of Biotin (green) allows the detection of gap junctions between these neurons. 
In w1118, nrg14; P[nrgwt] and nrg14; P[nrg167ΔFIGQY] a normal, large GF terminal was present and we observed 
dye-coupling with the TTMn and the PSI. In nrg14; P[nrg180Y-F], nrg14; P[nrg180Y-A] and nrg14; P[nrg180ΔFIGQY] 
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mutants the presynaptic terminal of the GF exhibited variable abnormal morphologies. They were thinner or 
swollen and contained large vacuole-like structures. However, in most cases the GF still dye-coupled with the 
postsynaptic target, the TTMn and the PSI. Scale bar 15 µm. (b) Quantification of morphological defects in 
w1118 flies and nrg mutants. Only mutations affecting the Nrg180-FIGQY motif resulted in severe GF terminal 
aberrations. (c) Quantification of GF-to-TTMn dye-coupling (black bars) and comparison to animals with no 
electrophysiological responses (red bars) of the TTM with GF stimulation in the brain. A large percentage of 
animals expressing mutant versions of Nrg180-FIGQY proteins completely lacked electrophysiological 
responses despite the presence of dye-coupling in almost all animals demonstrating a severe functional defect in 
these animals.  
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Figure 8 - Temporal and spatial requirements of trans-synaptic Nrg signaling.  
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(a) Schematic of GF to TTMn synapse development. First dye-coupling between the GF (red) and the TTMn 
(blue) can be demonstrated at 40% of pupal development 49. Positions of stimulating and recording electrodes 
are indicated. Brain stimulation was used to test the GF-TTMn synapse, while thoracic stimulation bypasses the 
GF and allowed testing of the TTMn NMJ directly. Expression profiles of the different Gal4 lines are indicated. 
(b) Rescue of nrg14; P[nrg180Y-F] phenotypes using Gal4/UAS mediated expression of wild type Nrg180. Both 
average response latency and the ability to follow high frequency stimulation could be rescued significantly by 
simultaneous expression of Nrg180 pre- and postsynaptically or on either side of the synapse alone (Mann-
Whitney Rank sum test, P ≤ 0.001). Less than 20% of animals showed an electrophysiological impairment even 
when a late presynaptic Gal4 driver line was used for rescue (right). (c-d) Rescue of nrg14; P[nrg180Y-A]  and 
nrg14; P[nrg180ΔFIGQY] animals using cell autonomous expression of Nrg180. Simultaneous expression of 
Nrg180 pre- and postsynaptically or only on one side of the synapse throughout development significantly 
rescued the response latency (left) and following frequencies (middle) of these mutations. More than 80% of all 
GF-TTMn synapses showed wild type properties (right, Mann-Whitney Rank sum test, P ≤ 0.001). In contrast to 
nrg14;P [nrg180Y-F], late expression of UAS-nrg180 in the GF alone in nrg14; P[nrg180Y-A]  and nrg14; 
P[nrg180ΔFIGQY] animals did not significantly improve the average response latency (left, Mann-Whitney Rank 
sum test, P = 0.061 and P = 0.057, respectively) or the following frequencies (middle, Mann-Whitney Rank sum 
test, P = 0.9 and P = 0.081, respectively). (e) Presynaptic GF terminal morphology was rescued by either pre- or 
postsynaptic expression of Nrg180 in nrg14; P[nrg180ΔFIGQY] mutant animals. Scale bar 15 µm. Error bars 
represent s.e.m. 
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Supplementary Figure 1 - Presynaptic Nrg is essential for synapse stability.  
(a-c) NMJs on muscle 6/7 stained for the presynaptic motoneuron membrane (Hrp, white), the presynaptic 
active zone marker Brp (green) and postsynaptic glutamate receptors (DGluRIII, red). (a) A stable wild type 
NMJ indicated by perfect apposition of pre- and postsynaptic markers. (b) Knock down of presynaptic Nrg 
resulted in severe synaptic retraction indicated by a fragmented presynaptic membrane and the loss of 
presynaptic Brp despite the presence of postsynaptic glutamate receptors. The example shows a complete 
elimination of an entire NMJ at muscle 6/7. Please note the characteristic increase in postsynaptic glutamate 
receptor clusters at sites of retractions (inset). (c) Loss of muscle Nrg did not impair synapse stability. Scale bar 
in a corresponds to a-c, 10 µm, inset 5 µm. (d) Quantification of different nrg RNAi conditions. Neuronal but 
not muscle specific knock down of Nrg using different Gal4 driver combinations or independent RNAi 
constructs resulted in a significant increase in synaptic retractions on muscle 6/7. The retraction frequency was 
significantly rescued (P ≤ 0.001) by co-expression of UAS-nrg180 but not by co-expression of either UAS-
mCD8-GFP or UAS-fasII. Expression of UAS-fasII alone did not result in a significant increase in retractions 
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(genotypes: neu1 = elavC155-Gal4; neu2 = elavC155-Gal4; ok371-Gal4; neu3 = elavC155-Gal4; UAS-dcr2; neu4 = 
elavC155-Gal4; sca-Gal4 UAS-dcr2; mus1 = UAS-dcr2; mef2-Gal4; RNAi1 = V6668; RNAi2 = V107991; rescue 
indicates co-expression of the listed UAS construct; n = 6-24 animals). (e) Quantification of retraction severity 
on muscle 6/7. Only neuronal knock down of Nrg resulted in a significant increase in the severity of synapse 
retractions. (f) Quantification of retraction severity on muscle 4. Only neuronal knock down of Nrg resulted in a 
significant increase in the severity of synapse retractions. A very large fraction of observed retractions represent 
complete presynaptic eliminations. Error bars represent s.e.m.  
 
 
Supplementary Figure 2 - Analysis of pre- and postsynaptic Nrg localization after 
specific knock down of Nrg 
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(a-d) Muscle 4 NMJs stained with an antibody specific to the cytoplasmic tail of Nrg180 (Nrg180BP104, white 
and green) and the presynaptic membrane (Hrp, red). (a) In wild type animals Nrg180 was present in the 
motoneuron axon and within the presynaptic nerve terminal marked by the membrane marker. In contrast to the 
uniform distribution in the axon Nrg was present in a punctate pattern at the terminal and co-localizes with Hrp 
at the ends of small filopodia-like membrane extensions. (b) Neuronally expressed Nrg RNAi resulted in an 
almost complete knock down of Nrg180 in the presynaptic motoneuron. (c) Muscle specific knock down of Nrg 
altered the normal distribution of Nrg180 in the presynaptic nerve terminal. (d) Co-expression of Nrg180 with 
Nrg RNAi resulted in a complete rescue of Nrg180 levels and distribution at the NMJ. (e-f) Muscle 4 NMJs 
stained with an antibody recognizing both Nrg isoforms (Nrg3c1, white and green) and for the presynaptic 
membrane (Hrp, red). (e) In addition to neuronally expressed Nrg180 we observed Nrg167 present throughout 
the postsynaptic muscle and in glial cells surrounding the motoneuron axon. Nrg167 might also be present 
within motoneurons (due to almost complete sequence similarity to Nrg180 no specific antibody exists). (f) 
Muscle specific knock down efficiently eliminated Nrg167 expression in the muscle. Presynaptic Nrg can still 
be detected (asterisk). A tracheal branch expressing Nrg167 is indicated (t). Scale bar in a corresponds to a-e 10 
µm, insets 5 µm. 
  
Supplementary Figure 3 - Analysis of nrg MARCM clones 
(a) A nrg14 MARCM clone rescued by a wild type nrg Pacman construct. The motoneuron clone was marked by 
the expression of mCD8-GFP (green). Synaptic vesicles (DvGlut, red) were found opposite postsynaptic Dlg 
(blue) indicating a stable NMJ (insets). Neighboring NMJs are visible that were not mutant as evident by the 
absence of the clonal marker. (b) A nrg14 MARCM clone expressing a mutated form of Nrg180 lacking the 
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FIGQY motif. A “bulb-like” structure (arrow) was present in close proximity to an NMJ that contained 
postsynaptic profiles marked by Dlg but no presynaptic vesicles. In contrast to the neighboring wild type NMJ 
the postsynaptic Dlg staining was clearly reduced and no longer formed a continuous structure (asterisk, insets). 
While no membrane marker remnants were visible at the eliminated NMJ we observed small GFP-puncta in 
between the NMJ and the retracted axon (arrowhead). (c) Scoring of the innervation pattern of stable NMJs of 
MARCM clones of indicated genotypes. In all cases we observed similar muscle innervation rates. 
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Supplementary Figure 4 - Analysis of the expression of genomic Nrg Pacman rescue 
constructs. 
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(a) Nrg180 expression of different Pacman introduced nrg mutations in the background of the nrg null mutation 
nrg14. All nrg Pacman constructs were expressed at wild type levels at the NMJ. The cytoplasmic domain 
specific antibody Nrg180cyto (green) detected Nrg180 at the NMJ in all different mutations. In contrast, the 
Nrg180-FIGQY specific antibody Nrg180BP104 (white) did not recognize FIGQY mutations of Nrg180. (b) 
Western blot analysis of larval brain extracts of all Nrg Pacman constructs in the background of the nrg null 
mutation nrg14. Equal levels of both Nrg isoforms were detected with Nrg3c1; NrgFIGQY specifically recognizes 
the FIGQY motif of both Nrg isoforms thus the mutated forms were not detected in the Western blot. 
Nrg180BP104 only recognized Nrg180 proteins containing a wild type FIGQY motif. (c) Muscle 4 NMJs stained 
for Nrg167 and Nrg180 (Nrg3c1, green, white). P[nrgwt] rescued Nrg expression and distribution of both Nrg 
isoforms in motoneurons, glial cells and muscles of nrg14 mutant animals. (d) Western blot analysis to assay the 
expression of Nrg lacking Ig3-4 domains. P[nrgΔIg3-4] did not rescue the embryonic lethality associated with the 
nrg14 mutation, therefore we tested if normal levels of mutated Nrg isoforms were expressed from this construct 
in a wild type background. Using isoform specific antibodies we could visualize equal expression levels of 
truncated proteins of both isoforms. (d) Muscle 4 NMJs stained for the Nrg180cyto antibody that specifically 
detects the C-terminal tail of Nrg180 outside the FIGQY motif. In wild type the antibody was present in a 
pattern similar to Nrg180BP104 showing a punctate pattern within the presynaptic nerve terminal. We lost all 
antibody staining at the NMJ in nrg14 mutant animals rescued by P[nrg180ΔC] demonstrating the specificity of 
the antibody and the specificity of the introduced mutation. Scale bar in a 5 µm, c and e 10 µm.  
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Supplementary Figure 5 - Ank2 mutations affect presynaptic localization of Nrg180 
(a) Analysis of Ank2-L levels and distribution in nrg14 mutant animals rescued by different nrg Pacman 
constructs. We did not observe obvious changes in Ank2-L localization or levels at stable synapses in different 
Pacman rescued nrg mutants. (b-d) NMJs on muscle 4 stained for Nrg180 (Nrg180BP104, green, white) and the 
presynaptic membrane (Hrp, red). (b) In wild type Nrg180 was present in a punctate pattern throughout the 
presynaptic nerve terminal co-localizing with the membrane marker Hrp. (c, d) Examples of ank2 mutant NMJs. 
At semi-stable synapses that still have intact presynaptic membranes (as judged by continuous Hrp staining) we 
observed a partial or complete loss of Nrg180. In addition, Nrg180 levels in the axon were severely diminished. 
Scale bar in a 5 µm, b 10 µm.  
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Methods 
Fly stocks 
Flies were maintained at 25 °C on standard food. Crosses and most experiments were 
performed at 25 °C while RNAi assays were performed at 27 °C. The following fly strains 
have been used in this study: w1118 (wild type), nrg14 (nrg1), nrg17 (nrg2), ank2518, α-specrg41, 
Df(3L)RM5-2, UAS-mCD8-GFP, UAS-fasII, elavC155-Gal4, ok371-Gal4, sca-Gal4, mef2-
Gal4, BG57-Gal4, UAS-dcr2, ok307-Gal4 (A307-Gal4), P(hsFLP)86E, P(hsFLP)1, 
P(neoFRT)19A (all Bloomington stock center); c17-Gal4, c42.2-Gal4, shakB-Gal4 52; RNAi 
lines were obtained from the Vienna Drosophila RNAi Center: Nrg RNAi line1 (stock 
ID6688), Nrg RNAi line2 (stock ID107991).  
Generation of Neuroglian UAS and P[acman] constructs 
The full length Nrg180 ORF was amplified from the plasmid pMT-Neuroglian and the 
Nrg167 ORF from cDNA GH03573 (both obtained from the Drosophila Genomic Research 
Center, Indiana, USA). Full length ORFs were cloned into pENTR vector via TOPO cloning 
(Invitrogen). To obtain pUASTattB-10xUAS destination vectors suited for gateway cloning a 
gateway cassette with a C-terminal 3xHA or EGFP tag was introduced into the 
pWALIUM10-moe plasmid (TRiP collection, Harvard Medical School). Final expression 
constructs were generated via gateway cloning using standard procedures (Invitrogen). 
Deletions and point mutations were introduced into pENTR clones using the QuickChange II 
site-directed mutagenesis kit following the manufacturer’s instructions (Agilent 
technologies). All constructs were verified by sequencing (FMI sequencing facility). The 
P[acman] clone CH321-4H20 was obtained from BACPAC Resources Center (BPRC, 
Oakland, California) 38 and modified using galK mediated recombineering 39; NCI Frederick 
National Laboratory). Site-specific integration via the phi-C31 system was used to generate 
insertions at the attP40-landing site for both pUAST and Pacman constructs. Primers used in 
this study are listed below. 
Immunohistochemistry and antibody production 
Wandering third instar larvae were dissected in standard dissecting saline and fixed with 
Bouin’s fixative for 2-3 min (Sigma-Aldrich). Primary antibodies were incubated at 4 °C 
overnight. Primary antibodies were used at the following dilutions: anti-Nrg180 (BP104) 
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1:250, anti-Bruchpilot (nc82) 1:250, anti-Futsch (22c10) 1:500, anti-Synapsin (3c11) 1:100 
(all obtained from Developmental Studies Hybridoma Bank, IA); rabbit anti-Dlg 1: 30 000 
(gift from V. Budnik, Worchester, MA, USA), rabbit anti-DGluRIII 12 1: 2500; rabbit anti-
DvGlut, rat anti-CD8 (Caltag Laboratories) 1:1000, anti-Nrg (3c1, gift from M. Hortsch, Ann 
Arbor, MI, USA) 1:500; rabbit anti-NrgFIGQY (raised against the peptide: 
TEDGSFIGQYVPGKLQP) 1:100, rabbit anti-Nrg180cyto (raised against the peptide: 
NNSAAAHQAAPTAGGGSGAA) 1:500. Monoclonal rat anti-Ank2L 1:40 was generated 
against a protein fragment containing aa 3134-3728 (according to the 4083 aa isoform of 
Ank2-L). Rabbit Ank1-4 antibody used for IPs was generated against the Ankyrin domains 1-
4. Antibodies were generated at David’s Biotechnology (Regensburg, Germany) 
Alexa conjugated secondary antibodies (Invitrogen) were used at 1:1000 for 2 h at RT. 
Directly conjugated anti-Hrp (Alexa or Cy-dyes) were used at 1:100-1000 (Jackson 
Immunoresearch Laboratories). Larval preparations were mounted in Prolong Gold 
(Invitrogen). Images were captured at room temperature using a Leica SPE confocal 
microscope. To process, analyze images and quantify phenotypes Adobe Photoshop, Imaris 
(Bitplane), Image Access (Imagic) and the open source tool FIJI/ImageJ were used. 
Quantification of phenotypes 
Synaptic retractions were quantified using presynaptic Brp and postsynaptic DGluRIII 
staining and counting the number of unopposed postsynaptic footprints. Complete loss of 
presynaptic marker Brp was considered as elimination. N indicates the number of 
independent animals per quantification. 
Bouton area, number and NMJ length were quantified using Synapsin, Dlg and Hrp staining. 
Bouton area and NMJ length were quantified using the Image access software (Imagic). Hrp 
staining was used to visualize the bouton area and 10 A3 muscle 4 NMJs were quantified per 
genotype. To measure NMJ length 20 muscle 4 NMJs (segment A3 and A4, 10 each) were 
analyzed. Bouton number was quantified on muscle 4 in segment A2-A6 using Synapsin/Dlg 
staining. N indicates the number of analyzed NMJs. 
Western Blot and Immunoprecipitation  
Larval brains were dissected and transferred into 2x sample buffer (Invitrogen). 5 brains per 
lane were analyzed on NuPage gels (Invitrogen) according to standard procedures. Primary 
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antibodies were incubated overnight at 4 °C. Secondary Hrp-conjugated goat anti-mouse and 
goat anti-rabbit antibodies were used at 1:10 000 (Jackson Immunoresearch) for 2 h at RT. 
Membranes were incubated with ECL substrate (SuperSignal West Pico Kit, Thermo 
scientific) and developed on film (Fujifilm). 
For immunoprecipitation experiments S2 cells were cotransfected with act5C-Gal4, 
UASAnk2-S-EGFP (Pielage at al., 2008) and UAS-Nrg-3xHA plasmids using Fugene 
(Roche) following manufacturer’s instructions. IP`s were analyzed using mouse anti-HA 
(12CA5) 1:200, rabbit anti-GFP (Molecular Probes) 1:500 and rabbit anti-Ank2 (rabbit anti-
Ank1-4) 1:1000 antibodies for IP and input. Quantification of Ank2 binding between mutants 
was performed using four independent IP experiments and Odyssey2.1 software (LI-COR).  
Fluorescence Recovery after Photobleaching (FRAP) 
Wandering third instar larvae expressing Nrg-EGFP via ok371-Gal4 were dissected in HL3 
saline and prepared for live imaging using a magnetic pinholder device. 1-Naphthylacetyl-
spermin-trihydrochloride (NSH) (100 mM; Sigma, St Louis, MO) was added to the HL3 
saline to block postsynaptic glutamate receptor activation and muscle contractions, ensuring 
accurate image acquisition during the experiments. 6-9 motoneuron axons/NMJs from 3-4 
independent experiments were photobleached in a strip spanning over the whole axon/bouton 
width using the Zeiss LSM700 by scanning the region for 30 iterations at 100% laser-power 
of the 488 nm line. 10 images were acquired before the bleach and 40 after the bleach with a 
time interval of 5 s.  
Images from the FRAP series were corrected for animal movement with the FIJI registration 
plugin using the StackReg option. The fluorescence at each time point was subtracted from 
the background outside the axon and the minimum fluorescence in the bleached area.  This 
value was then normalized to the fluorescence in the control region that was also subtracted 
from the background fluorescence outside of the axon. 
The recovery curves were fit to a double exponential curve as follows: 
y = a + b*(1-exp(-c*tx))+ d*(1-exp(-e*tx)) 
The maximum was calculated from the fitting curve (maxfitting). To calculate the real max 
value the following formula has been used: 
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Fmax= (F-BGt*maxfitting) + Funbleached 
The mobile fraction was calculated using the following formula: 
MF= (Fmax-Funbleached)/ (Fbeforebleach)-Funbleached) 
MARCM analysis  
The nrg null mutation nrg14 was recombined with the P(neoFRT)19A  chromosome. The 
stock was crossed to P(hsFLP)1, P(neoFRT)19A, tubGal80; ok371-Gal4, UAS-CD8-GFP; 
MKRS, P(hsFLP)86E. Embryos were collected for 2 h, aged for 3 h and heat shocked for 1 h 
at 37 °C.  
Statistical analysis 
All statistical analyses were performed using Microsoft Office Excel and an online source for 
unpaired student`s t-test (http://www.physics.csbsju.edu/stats/t-test.html). P ≤ 0.05 was 
accepted as statistically significant (* ≤ 0.05, ** ≤ 0.01, *** ≤ 0.001). 
Giant fiber preparation  
Adult Drosophila nervous system was dissected, dye filled and fixed as previously described 
50. Young 2-5 days old flies were used for all the experiments. To visualize the morphology 
of giant fiber-TTMn connection either a 10mM Alexa Fluor 568 Hydrazide (Molecular 
Probes) in 200 mM KCl or a dye solution of 10% w/v Neurobiotin (Vector labs) and 
tetramethyl rhodamine-labeled dextran (Invitrogen) in 2M potassium acetate was injected 
into the GF axons by passing hyperpolarizing or depolarizing current respectively. 
Preparation of GF samples for confocal microscopy has been described previously 50. 
Samples were analyzed using a Nikon C1si Fast Spectral Confocal system. Images were 
processed using Nikon Elements Advance Research 4.0 software. 
Electrophysiology 
Electrophysiological recordings from the giant fiber circuit were obtained as described in 
detail in 66. The flies were given 10 single pulses at 30-60 mV for 0.03 ms with a 5 second 
interval between the stimuli and the shortest response latency of each fly was averaged. To 
determine the reliability of the circuit, the ability to follow frequencies at 100 Hz was 
determined. For this 10 trains of 10 stimuli were given at 100 Hz with an interval of 2 
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seconds between the trains and percent of the total responses was calculated. All the traces 
were recorded, stored and analyzed using pClamp 10 (Molecular Devices) software. Mann-
Whitney Rank sum test was used to determine significant differences between different 
genotypes in average response latencies and following frequencies (Sigma Plot 11 software). 
Data for Figure 1 and Figure Supplementary Figure 1 
RNAi                                                            Retraction frequency [%] 
UAS Gal4 mu4 p mu6/7 p mu12 mu13 n 
ctrl neu2 0.8 ± 0.8  0.8 ±  0.8  0.0 ± 0.0 0.0 ± 0.0 12 
RNAi1 neu1  30.0 ± 6.8 ≤ 0.0001 23.3 ± 7.1 0.0004 8.3 ± 4.0 20.0 ± 6.3 6 
 neu2 33.4 ± 4.3 ≤ 0.0001 18.3 ± 2.9 0.0002 27.5 ± 3.7 30.4 ± 4.5 24 
 neu3  63.9 ± 3.3 ≤ 0.0001 44.5 ± 4.8 ≤ 0.0001 27.0 ± 3.4 35.7 ± 3.9 20 
 mus1 1.7 ± 0.8 ns 0.4 ± 0.4 ns 0.0 ± 0.0 0.0 ± 0.0 24 
         
RNAi2 neu2 31.8 ± 5.6 ≤ 0.0001 23.3 ± 5.0 ≤ 0.0001 15.5 ± 2.7 22.7 ± 3.6 13 
 neu3  38.6 ± 4.7 ≤ 0.0001 21.4 ± 4.4 ≤ 0.0001 18.4 ± 4.0 31.2 ± 4.0 12 
 neu4  51.0 ± 4.5 ≤ 0.0001 41.7 ± 7.5 ≤ 0.0001 33.0 ± 7.0 48.5 ± 7.0 13 
 mus1 3.8 ± 2.4 ns 6.1 ± 2.1 ns 5.3 ± 2.4 4.6 ± 2.4 13 
RNAi rescue                                                                                   Retraction frequency [%] 
RNAi1;Nrg180 neu2 9.3 ± 2.0 0.0002 5.0 ± 2.9 0.0014 0.7 ± 0.7 1.4 ± 1-0 14 
RNAi1;CD8-GFP neu2 56.7 ± 4.6 0.0008 28.3 ± 4.9 0.074 35.6 ± 6.3 21.1 ± 4.0 18 
RNAi1;FasII neu2 37.5 ± 4.3 ns 15.0 ± 3.8 ns 25.0 ± 6.2 20.0 ±7.2 12 
UAS-FasII neu2 4.4 ± 1.6 ≤ 0.0001 0.9 ± 0.9 ≤ 0.0001 0.9 ± 0.9 0.0 ± 0.0 11 
 
Legend: ctrl = w1118 x elavC155-Gal4; ok371-Gal4, p-valuesRNAi are in comparison to ctrl, p-valuesRNAi rescue are in 
comparison to neu2RNAi1 (all unpaired student`s t-test). Gal4 drivers: neu1 = elavC155-Gal4, neu2 = elavC155-
Gal4; ok371-Gal4, neu3 = elavC155-Gal4; UAS-dcr2, neu4 = elavC155-Gal4; sca-Gal4UAS-dcr2, mus1 = UAS-
dcr2; mef2-Gal4, n = number of animals (segments A2 to A6 were scored in each animal). Errors represent 
SEM. 
 
Data for Figure 2 
Genotype # NMJs 
# affected 
axons 
total # % affected  
axons  
p n 
FRT19A 290 3 293 1.5 ± 1.0  23 
nrg14, FRT19A 152 162 314 53.5 ± 3.7 ≤ 0.0001 26 
nrg14, FRT19A; P[nrg_wt] 167 5 172 2.1 ± 1.0 0.65 18 
nrg14, FRT19A; P[nrg180∆FIQGY] 209 46 255 18.4 ± 3.3 0.0005 22 
nrg14, FRT19A; P[nrg∆Ig3/4] 78 69 147 49.5 ± 4.5 ≤ 0.0001 21 
 
Legend: p-values are in comparison to FRT19A (all unpaired student`s t-test), n = number of animals. % 
retracted axons. Errors represent SEM. 
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Data for Figure 4 
Pacman mutations amino acid sequence 
P[nrg_wt] QFTEDGSFIGQYVPGKLQPPVSPQ-//-AAGAVATYV* 
P[nrg180Y-F] QFTEDGSFIGQFVPGKLQPPVSPQ-//-AAGAVATYV* 
P[nrg180Y-D] QFTEDGSFIGQDVPGKLQPPVSPQ-//-AAGAVATYV* 
P[nrg180Y-A] QFTEDGSFIGQAVPGKLQPPVSPQ-//-AAGAVATYV* 
P[nrg180∆FIQGY] QFTEDGS-----VPGKLQPPVSPQ-//-AAGAVATYV* 
P[nrg180∆C] QFTEDGS(****)73* 
P[nrg167∆FIQGY] GMNEDGS-----GRKGL*  
P[nrg180∆PDZ] QFTEDGSFIGQYVPGKLQPPVSPQ-//-AAGAVA---*  
 
Legend: Pacman constructs are listed with the corresponding amino acid sequence with single amino acid 
changes (bold) and deletions (underlined). The domains are highlighted in bold in P[nrg_wt]. 
 
Data for Figure 4 
Retraction frequency [%] 
Genotype mu4 p mu6/7 mu12 mu13 n 
w1118 1.3 ± 0.6  2.4 ± 0.8 0.4 ± 0.4 0.4 ± 0.4 25 
nrg14/y; P[nrg_wt] 1.3 ± 0.9 0.9 * 0.7 ± 0.7 0.0  ± 0.0 0.0  ± 0.0 15 
nrg14/y; P[nrg180Y-F] 3.7 ± 1.8 0.3 11.0 ± 3.7 0.5 ± 0.5 2.0 ± 0.9 20 
nrg14/y; P[nrg180Y-D] 7.5 ± 1.6 0.0044 8.6 ± 1.8 5.5 ± 1.4 3.0 ± 1.1 20 
nrg14/y; P[nrg180Y-A] 8.3 ± 2.7 0.013 6.7 ± 1.9 1.7 ± 1.1 2.5 ± 1.3 12 
nrg14/y; P[nrg180∆FIQGY] 8.1 ± 1.8 0.012 11.7 ± 2.2 7.4 ± 1.6 6.3 ± 1.2 28 
nrg14/y; P[nrg180∆C] 11.3 ± 2.3 0.0015 11.0 ± 1.9 4.8 ± 1.5 1.4 ± 1.0 21 
nrg14/y; P[nrg167∆FIQGY] 0.0 ± 0.0 0.0 3.2 ± 1.2 0.9 ± 0.6 0.9 ± 0.6 22 
nrg14/y; P[nrg180∆PDZ] 1.6 ± 0.9 0.85 1.6 ± 0.9 0.0 ± 0.0 2.6  ± 1.3 19 
 
Legend: p-values are in comparison to nrg14/y; P[nrg_wt], * = p-value in comparison to w1118 (all unpaired 
student`s t-test),  n = number of analyzed animals (segments A2-A6 were scored in each animal). Errors 
represent SEM. 
 
Data for Figure 5  
NMJ growth defects 
Genotype NMJ length p Bouton area p Bouton no. p n 
w1118 106.9 ± 4.4  6.9 ± 0.3  16.6 ± 0.3  123 
nrg14/y; P[nrg_wt] 103.5 ± 6.2  5.7 ± 0.3  15.7 ± 0.5  98 
nrg14/y; P[nrg180Y-F] 110.7 ± 6.3 0.42 6.7 ± 0.3 0.037 18.5 ± 0.5 0.0003 109 
nrg14/y; P[nrg180Y-D] 128.9 ± 6.5 0.048 5.0 ± 0.2 0.56 22.0 ± 0.7 
≤ 
0.0001 
142 
nrg14/y; P[nrg180Y-A] 119.9 ± 5.0 0.076 5.4 ± 0.3 0.1 20.9 ± 0.8 
≤ 
0.0001 
69 
nrg14/y; P[nrg180∆FIQGY] 156.6 ± 9.1 ≤ 0.0001 4.3 ± 0.2 0.0002 29.3 ± 0.9 
≤ 
0.0001 
112 
 93 
nrg14/y; P[nrg180∆C] 155.1 ± 9.4 ≤ 0.0001 4.4 ± 0.2 0.0013 28.2 ± 0.8 
≤ 
0.0001 
137 
nrg14/y; P[nrg167∆FIQGY] 100.8 ± 3.9 0.71 6.2 ± 0.3 0.2 17.4 ± 0.3 0.0048 176 
nrg14/y; P[nrg180∆PDZ] 98.1 ± 5.2 0.5 5.9 ± 0.3 0.65 17.3 ± 0.4 0.016 115 
 
Legend: p-values are in comparison to nrg14/y; P[nrg_wt] (all unpaired student`s t-test), nNMJ length = 20 NMJs 
(segments A3 and A4,), nbouton area = 10 NMJs (segment A3), nbouton no. = number of NMJs as indicated (segments 
A2-A6 were scored in each animal). Errors represent SEM. 
 
Primer List 
Primer  DNA-sequence 
Nrg180-ENTR-N-term 5`CACCATGTGGCGGCAGTCAACG 
Nrg180-ENTR-C-term 5`TTAGACGTAGGTGGCCACG 
Nrg180-ENTR-C-term-tagged 
(HA, EGFP) 
5`GACGTAGGTGGCCACGGCTC 
Nrg180Y-F 5`GGCTCCTTCATTGGCCAATTTGTTCCTGGAAAGCTCC 
Nrg180Y-D 5`GGCTCCTTCATTGGCCAAGACGTTCCTGGAAAGCTCC  
Nrg180Y-A 5`GGCTCCTTCATTGGCCAAGCTGTTCCTGGAAAGCTCC 
Nrg180∆FIGQY 5`AATTTACCGAGGATGGCTCCGTTCCTGGAAAGCTCCAACC 
P[nrg180Y-F] 5`TCTTTCTAATCCCAGGACAATTTACCGAGGATGGCTCCTTCATTGG
CCAATTCGTTCCTGGAAAGCTCCAACCGCCGGTTAGCCCACAGCCAC
TGAACAATTC 
P[nrg180Y-D]  
 
5`TCTTTCTAATCCCAGGACAATTTACCGAGGATGGCTCCTTCATTGG
CCAAGACGTTCCTGGAAAGCTCCAACCGCCGGTTAGCCCACAGCCAC
TGAACAATTC 
P[nrg180Y-A]           
 
5`TCTTTCTAATCCCAGGACAATTTACCGAGGATGGCTCCTTCATTGG
CCAAGCCGTTCCTGGAAAGCTCCAACCGCCGGTTAGCCCACAGCCAC
TGAACAATTC 
P[nrg180∆FIQGY] 5`ATATTGTATATATCTTTCTAATCCCAGGACAATTTACCGAGGATGG
CTCCGTTCCTGGAAAGCTCCAACCGCCGGTTAGCCCACAGCCACTGA
ACAATTC      
P[nrg180∆C]   5`ATATTGTATATATCTTTCTAATCCCAGGACAATTTACCGAGGATGG
CTCCTAAGAGGCGTGGCTGGGATTCACTTGCCCCATTGTTCTCCTGAT
TTTCTA        
P[nrg180∆PDZ]  5`CCGGAGGAGCAGCTGCCAGCAATGGAGGAGCTGCAGCCGGAGCCG
TGGCCCCTGTTGACAATTAATCATCGGCA 
P[nrg167∆FIQGY] 5`ACAATCACAATCAATATTAAATCGACAACGACAACCAATATCCAG
GCATGAATGAAGATGGATCCGGACGCAAAGGACTTTGATTTAATTAG
TAAGCAGCGCACCGCAACAGCAA 
P[nrg∆Ig3/4] 5`CCTCGGTGTTTCGCAGTGAATACAAGATTGGCAACAAGGTGCTCCT
CGATGCTGAGCCGCCAACGATTTCCGAAGCTCCAGCAGCTGTATCCA
CTGTCGA 
Check and seq primer Forward primer Reverse primer 
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pENTR_nrg180wt, Y-F, Y-A, Y-
D, ∆FIGQY (check mutations in 
FIGQY motif) 
5`AATCGGGGCGGAAAGTACG 5`CAGGAAACAGCTATGAC 
pENTR_nrg180wt (start and stop) 5`TGTAAAACGACGGCCAGT 5`CAGGAAACAGCTATGAC 
pENTR/pUAST nrgwt, Y-F, Y-A, 
Y-D, ∆FIGQY (sequencing of 
complete ORF, primer 1-8) 
5`TGCTCTTCAAAGTGGCGC 
5`GTTAGTGCCTCGCAGAAC 
5`TAACTACGGTTGCAACGC 
5`GATTCGTGAAGACCAATG 
5`CCGAAATCGAGCACAATG 
5`ACAATGGACGCTTCAATG 
5`TGGATACGCGAGAATGAG 
5`CGATACTGATTCGATGGC 
5`CCCGATCCTCCGGCAGTT 
5`CAATGAACCATCCGGCAT 
5`CCATCTTCATGCGTGTGA 
5`CATTGTGAAGTTGGTGGG 
5`GGCGTGAACGATGTATTG 
5`CACCGTTAGCTTGGACAT 
5`CACGTCGCAGGTGTATGT 
5`GTGGCCGTTCCGAATTCA 
10xpUAST_Nrg_HA (check) 5`AATCGGGGCGGAAAGTACG 5`GGCATTCCACCACTGCTCCC 
10xpUAST_Nrg_EGFP (check) 5`TATAAATAGAGGCGCTTCGT 5`CAAGTCCGCCATGCCCGAAG 
P[acman] check primer 
(Nrg180FIGQY mutations) 
5`AACTGACGCATTTGCCAGG 5`GCAGACACTTAAAGCAGTT 
P[acman] seq primer 
(Nrg180FIGQY mutations) 
5`CATATCATTTTGCACCGGC 5`ACGATGCTCCACCCGATGCT 
P[acman] check (∆C) 5`AACTGACGCATTTGCCAGG 5`GCTTTAAATTCATGCGAG 
P[acman] seq (∆C) 5`CATATCATTTTGCACCGGC 5`GCAGACACTTAAAGCAGTT 
P[acman] check (∆PDZ) 5`GAGGATGGCTCCTTCATTG 5`GCTTTAAATTCATGCGAG 
P[acman] seq (∆PDZ) 5`CACTGAACAATTCCGCTGC 5`GCAGACACTTAAAGCAGTT 
P[acman] check (Nrg167∆FIGQY) 5`AGCCACTTGCCGTTATAAG 5`GGCAGTATTGATTTGCAT 
P[acman] seq (Nrg167∆FIGQY) 5`GTGTTCCTTGTTATGTGT 5`AGTCGTGGTGTTTGCACTT 
P[acman] check (Nrg∆Ig3/4) 5`CGAGCTGAATGCCTTCAAG 5`GGAGTTAACATTCAGAATGATG
G 
P[acman] seq (Nrg∆Ig3/4) 5`GATCCTGAGGGTAATCTCTG 5`GTTATTCGATCGCTCCACTG 
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3.3. Additional data Neuroglian 
3.3.1. Neuroglian controls synaptic stability 
3.3.1.1. Developmental time course of the retraction phenotype after Nrg RNAi 
A hallmark of neurodegenerative diseases is the progressive nature of the phenotype as it has 
been shown for example in ALS and Huntington`s disease (Boillee et al., 2006, Dion et al., 
2009). To address the question if the retraction phenotype observed after nrg RNAi also has a 
progressive nature, I analyzed 2nd and early 3rd instar larvae and compared them to late 3rd 
instar larvae. I observed a significant increase in the number of retraction during larval 
development (Figure 17). Interestingly, already in 2nd instar larvae a high number of 
retractions including complete eliminations of muscle 4 NMJs can be observed  
(Figure 17 c, b). 
 
Figure 17 - Progression of synapse instability during development after presynaptic Nrg 
RNAi 
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(a-b) Muscle 4 NMJ of 2nd instar larvae stained for active zone marker Brp (green), glutamate 
receptors (red) and the presynaptic membrane (Hrp, blue). (a) An control muscle 4 NMJ with 
opposing pre- and postsynaptic markers and an intact presynaptic membrane (control: elavC155-Gal4; 
UAS-dcr2 x w1118). (b) A muscle 4 NMJ after RNAi mediated knock down of Nrg. An almost 
complete elimination is shown. Only glutamate cluster shows opposing Brp staining but no 
connection to the motoneuron axon can be observed. Remnants of clustered glutamate receptors and 
the presynaptic membrane show that the NMJ was properly formed and became instable due to the 
loss of Nrg. (c) Quantification of retraction frequency after nrg RNAi using elavC155-Gal4; UAS-dcr2 
on muscle 4 during development from the 2nd instar larval stage to the late 3rd instar larval stage. A 
progressive increase in the retraction frequency can be observed. Importantly already in 2nd instar 
larvae a significant number of retractions can be observed (P ≤ 0.0001 , n = 10-20 animals analyzed in 
segment A2-A6). (d) Quantification of retraction frequency after presynaptic nrg RNAi on muscle 6/7 
during development from the 2nd instar larval stage to the late 3rd instar larval stage (Gal4 driver line: 
using elavC155-Gal4; UAS-dcr2). A progressive increase in the retraction frequency can be observed. 
Here in the early 3rd
Thus, we can conclude that Nrg is required for the maintenance of the presynaptic nerve 
terminal and the loss of Nrg results in a progressive loss of synapses.  
 instar larvae a significant number of retractions can be observed (n = 10-20 
animals analyzed in segment A2-A6). Scale bar in (a) corresponds to (a) and (b), 10µm. Error bars in 
(c) and (d) represent SEM. 
3.3.1.2. Postsynaptic knock down of Nrg in Ank2 binding mutants results in synaptic 
retractions 
Next, I tried to further analyze the contribution of postsynaptic Neuroglian for the 
stabilization of NMJs. As discussed in the submitted manuscript, neither postsynaptic nrg 
RNAi nor the deletion of the Ankyrin binding motif of the Nrg167 isoform has an impact on 
synapse stability. However, by combining these two techniques, I can show here that indeed 
the homophilic interaction of Nrg contributes to synapse stability. I knocked down Nrg in the 
muscle via RNAi in the background of either nrg14/y; P[Nrgwt] or nrg14; P[Nrg180∆FIGQY]. 
Only in the background of the Ank2 binding mutant I observed a significant increase in 
synaptic retractions in comparison both conditions alone (Figure 18). Exemplary images for 
muscle 4 and muscle 6/7 are shown (Figure 16 b, d). Not only the frequency of retraction but 
also the severity of retractions was significantly increased (Figure 16 f). 
From this experiment I can conclude that homophilic interactions of Nrg between the 
motoneuron and the muscle indeed contribute to the synapse stabilization function of 
Neuroglian at the NMJ. 
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Figure 18 - Postsynaptic knock down of Nrg in Ank2 binding mutants results in an 
increase in synaptic retractions 
(a-d) Larval muscle 6/7 and mu4 NMJ stained for presynaptic active zone marker Brp (green) and 
postsynaptic glutamate receptors (DGluRIII, red) as well as the presynaptic membrane (Hrp, white). 
(a, c) Larval muscle 6/7 and muscle 4 NMJs of animals that lost postsynaptic Nrg167 due to RNAi 
mediated knock down in the background of nrg14; P[Nrgwt] (post Gal4 line: BG57-Gal4). Pre- and 
postsynaptic markers are nicely opposing each other and the membrane is intact. (c-d) In contrast, 
muscle nrg RNAi in the background of nrg14; P[Nrg180ΔFIGQY] leads to severe synaptic retractions. (d) 
Quantification of retraction frequency on muscle 6/7 and 4. Loss of Nrg167 in the muscle leads to a 
significant increase (P ≤ 0.0001 for muscle 4 and P = 0.015 for muscle 6/7 nrg14; P[Nrg180ΔFIGQY] in 
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comparison to nrg14; P[Nrg180ΔFIGQY
3.3.1.3. Neuroglian in glial cells contributes to synapse stability at the NMJ 
]; post Nrg RNAi , n = 6-28). (e) Quantification of retraction 
severity based on the number of unopposed DGluRIII cluster. Scale bar in (a) corresponds to (a-d), 10 
µm, insets 5 µm. Error bars (e) and (f) represent SEM. 
Studies at the Drosophila larval NMJ and the vertebrate NMJ highlighted the role of glial 
cells during synapse maintenance and elimination (Feng et al., 2005; Keller et al., 2011). At 
the Drosophila NMJ a prodegenerative glial-derived signaling framework has been described 
and mutants of this signaling complex can partially suppress the retraction phenotype of ank2 
and spec mutants (Keller et al., 2011). Since Neuroglian is also highly expressed in glial 
cells, I tested the potential requirement of glial Nrg for synapse stability. Using a glial 
specific Gal4 line, I knocked down Nrg selectively in glial cells (Xiong et al., 1994). As 
shown in Figure 19, I observed a significant increase in retractions after glial knock down of 
Nrg (Figure 19). The phenotype was enhanced when co-expressing dcr-2 (Figure 19 c). To 
analyze the potential contribution of an Nrg-Ank interaction, I also knocked down Ankyrin1 
in glial cells. However, I did not observe a significant number of retractions in these animals 
(Figure 19 c). This construct was used in a previous study to knock down Ank1 in the muscle 
showing the efficiency of this particular genetic tool (Pielage et al., 2006). 
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Figure 19 - Knock down of Neuroglian in glial cells results in instable NMJ in L3 larvae 
(a-b) Muscle 4 NMJ stained for active zone marker Brp (green), glutamate receptors DGluRIII (red) 
and the presynaptic membrane (Hrp, blue, white). (a) A wild type muscle 4 NMJ with opposing pre- 
and postsynaptic markers and an intact presynaptic membrane. The asterisk indicates the area shown 
in the insets below. (b) A muscle 4 NMJ after glial nrg RNAi. The presynaptic marker Brp is lost 
completely from one NMJ terminal, the membrane is fragmented and the glutamate receptors clusters 
together whereas the other NMJ terminal seems to be stable. The asterisk indicates the area shown in 
the insets below. (c) Quantification of retraction frequency on muscle 4. Gal4 driver legend: glia1= 
repo-Gal4, glia2 = UAS-drc2; repo-Gal4. RNAi1 line = VDCR6688. Control: glia1 x w1118. The knock 
down of Nrg167 in glial cells leads to a significant increase in synaptic retractions which is increased 
upon co-expression of Dcr-2, whereas knock down of Ank1 does not impair synapse stability (P ≤ 
0.0001 for glia1/2Nrg RNAi1 in comparison to glia1wt, P = 0.049 glia1wt versus glia1
These results indicate that not only presynaptic but also glial Nrg is involved in synapse 
stabilization and that this function is Ank1 independent. This is in accordance with the 
observation from the “knock-in” mutation analysis where no retractions have been observed 
ank1 RNAi, n = 
5-12). d) Quantification of retraction severity based on the number of unopposed DGluRIII cluster. 
Scalebar in (a) corresponds to (a, b), 10 µm, insets 5 µm. Error bars in (c) and (d) represent SEM. 
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in nrg14; P[Nrg167∆FIGQY] animals that cannot bind Ankyrin1. In addition, it has been shown 
that the Gal4 line elavC155 might also express Gal4 in glial cell (Berger et al., 2007; Robinow 
and White, 1988; Robinow and White, 1991; Yao and White, 1994), thus the loss of Nrg in 
glial cells might contribute to the synaptic retractions observed in the RNAi assay.  
3.3.2. Neuroglian controls synapse growth at the NMJ 
I identified the interaction between Neuroglian and Ankyrin2 as important for growth 
regulation as an impairment of this interaction led to an almost 2-fold increase in bouton 
number and NMJ length and a corresponding decrease in bouton area (chapter 3.2, submitted 
manuscript). Further analyses of the RNAi phenotype of Nrg, “knock-in” Nrg mutations, 
hypomorphic Nrg mutations and the overexpression of Nrg-Ank2 binding mutants in respect 
of NMJ growth described here confirmed these results. 
3.3.2.1 RNAi mediated loss of Neuroglian increases bouton number 
Firstly, I analyzed growth related defects after the RNAi knock down of Nrg. As shown in 
Figure 20, the reduction of presynaptic Nrg levels led to a significant increase in bouton 
number (Figure 20 c, d). In addition, a significant increase of membrane protrusions has been 
observed (Figure 20 b, c, e, Table 30) after both pre- and postsynaptic knock down of Nrg. 
This phenotype has been described recently for the actin capping molecule hts and further 
demonstrates the control of growth by nrg (Pielage et al., 2011). A similar number of these 
protrusions has been observed in the nrg14; P[Nrg180∆FIGQY] animals (Table 31). This 
indicates that the growth defects observed after RNAi mediated knock down of Nrg are 
caused by the reduction of Nrg-Ank2 binding in the presynaptic motoneuron. 
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Figure 20 - Pre- and postsynaptic knock down of Neuroglian results in growth defects 
(a-c) Muscle 4 NMJs stained for the presynaptic active marker Brp (green), postsynaptic glutamate 
receptors (red) and the presynaptic membrane (Hrp, blue, white). (a) A control muscle 4 NMJ with a 
normal size and a nicely formed terminal bouton highlighted in the insets below (asterisk). (b) A 
muscle 4 NMJ after postsynaptic knock down of Nrg. The NMJ terminal is normally size however 
shows a membrane protrusion at the terminal bouton highlighted in the inset below (asterisk). (c) A 
muscle 4 NMJ after presynaptic knock down of Nrg. The NMJ shows an increase in bouton number 
and membrane protrusion at the terminal bouton highlighted in the inset below. (d) Quantification of 
bouton number after presynaptic knock down of Nrg based on Synapsin/Dlg staining. A significant 
increase of bouton numbers can be observed for both knock down conditions (P = 0.013 and ≤ 0.001 
respectively, n = 50-123 NMJs segment A2-A6) (d) Quantification of protrusion frequency at still 
stable synapses. Both pre and postsynaptic knock down of Nrg resulted in a highly significant 
increase of membrane protrusions (P ≤ 0.0001 for neu 2RNAi2 and mus2RNAi1, P = 0.0062 for 
neu2RNAi1, n = 8-16 animals). Legend Gal4 driver lines: neu1 = elavC155-Gal4; neu2 = elavC155-Gal4; 
ok371-Gal4; mus2 = UAS-drc2; BG57-Gal4. Legend RNAi lines: RNAi1 = VDRC6688, RNAi2
3.3.2.2. Analysis of hypomorphic Neuroglian mutants 
 = 
VDRC107991. Scale bar in (a) corresponds to (a-c), 10 µm, insets 5 µm. Error bars (d) and (e) 
represent SEM. 
To further validate our RNAi and MARCM results, I analyzed hypomorphic nrg mutations 
that have been shown to be important for synapse formation and function in the adult fly, 
nrg849 and nrg305 (Boerner and Godenschwege, 2010; Godenschwege et al., 2006). I analyzed 
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both homozygous hypomorphic mutants and in combination with the nrg14 null mutant. Both 
mutations showed a strong growth related phenotype with an increase in NMJ size and a 
decrease in the bouton area (Figure 21 c, d, Figure 22 e, g-I, Table 32). Interestingly, only the 
nrg305 mutations showed a significant number of synaptic retractions (Figure 22 e, f). The 
analysis of the Nrg levels in larval brains of these mutants revealed that only in the nrg305 
mutation the levels of Nrg are highly reduced (compare Figure 21 b and 22 c). This is in 
accordance with previous studies (Godenschwege et al., 2006; Yamamoto et al., 2006). 
Whereas nrg305 affects Nrg levels nrg849 partially affects homophilic binding (Godenschwege 
et al., 2006; Yamamoto et al., 2006). 
 
Figure 21 - Instability and growth defects in hypomorphic nrg849 mutants 
(a) Quantification of synaptic retractions on muscle 4. Homozygous nrg849 and in combination with 
nrg14 did not lead to a significant increase in synaptic retractions at muscle 4 (P = 0.39 and P = 0.1 
respectively, n = 8-25 animals). (b) Western blot analysis of larval brain extracts. Wild type larval 
brains are compared to nrg849 and nrg14/849 brains for the expression level of Nrg180 using the 
Nrg180BP104 antibody. Tubulin was used as a loading control. No change in Nrg180 levels has been 
observed for both mutant combinations. (c, d) Quantification of growth related phenotypes of nrg849 
and nrg14/849 animals. Bouton number and bouton area are significant changed in these mutants  
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(P ≤ 0.0001 for bouton area, P = 0.021 and P ≤ 0.0001 respectively for bouton number, n = 45 -123 
NMJs analyzed). Error bars in (a, c, d) represent SEM. 
 
 
Figure 22 - Hypomorphic Nrg mutations affect NMJ growth and stability 
(a-c) Analysis of Nrg protein levels in hypomorphic nrg305 and nrg305/14 mutant animals using 
immunohistochemistry and western blots. (a) Wild type muscle 4 NMJ stained for Nrg180 
(Nrg180BP104, green, white) and the presynaptic membrane (Hrp, red). Nrg is present throughout the 
presynaptic nerve terminal. (b) A nrg305/14 mutant NMJ demonstrating a severe reduction in axonal 
and synaptic Nrg180 levels. (c) Western blots of larval brains demonstrating that the nrg305 mutations 
equally reduces the levels of Nrg167 and Nrg180 caused by the insertion of a GFP-trap transposon in 
the intron upstream of the Nrg167 exon encoding the Ank2 binding motif. Blots are shown testing 
either only Nrg180 (Nrg180BP104) or both isoforms (NrgFIGQY and Nrg3c1). FasII is used as a loading 
control. (d, e) Analysis of NMJ growth and stability using the presynaptic vesicle marker Synapsin 
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(Syn, green), postsynaptic Dlg (red) and the presynaptic membrane marker Hrp (white). (d) In wild 
type synaptic vesicles are found in apposition to the postsynaptic marker Dlg indicating a stable NMJ. 
(e) A nrg305/14 mutant NMJ is shown. An overgrown type-Ib NMJ can be seen next to a retracting 
Type Is NMJ identified by Dlg staining that is no longer opposed by synaptic vesicles and a 
fragmentation of the presynaptic membrane. Scale bar in (a) corresponds to (a, b, d, e), 10 µm, inset  
5 µm. (f) Quantification of retraction frequencies. A highly significant increase in the number of 
retraction events can be observed in homozygous nrg305 animals and in heterozygous nrg305/14 
3.2.2.3. Overexpression of Ank2 binding mutants impairs normal growth at the NMJ 
mutant 
animals (P ≤ 0.001 respectively, n = 12-13). The rate of retractions was similar to the one observed for 
Pacman mediated mutations of the Ank2 binding domain. (g-i) Quantifications of growth related 
phenotypes. Hypomorphic nrg mutations resulted in a significant increase in bouton number, NMJ 
length and a corresponding decrease in bouton area (P ≤ 0.0001, n = 123 -144 for g; P ≤ 0.001, n = 20 
for h; P ≤ 0.0001, n = 10 for i). Scale bar in (a) corresponds to (a, b), scale bar in (d) corresponds to 
(d, e), 10 µm. Error bars in (f-j) represent SEM. 
Finally, I tested whether overexpression of Nrg180wt or Nrg180∆FIGQY can affect NMJ 
development. I observed a significant increase in bouton number and NMJ length in animals 
overexpressing Nrg180∆FIGQY but not Nrg180wt (Figure 23, Table 33). This demonstrates, 
that Nrg that cannot bind Ank2 can act as dominant negative construct disrupting NMJ 
growth control. 
 
 110 
Figure 23 - Overexpression of Nrg-Ank2 binding mutants affect NMJ growth 
(a) A muscle 4 NMJ overexpressing Nrg180wt protein stained for vesicle marker Synapsin (green) 
and postsynaptic density marker Dlg (red) as well as for the presynaptic membrane (Hrp, blue, white). 
This leads to normally sized NMJ. (b) Muscle 4 NMJ overexpressing Nrg180∆FIGQY protein stained 
for Synapsin, Dlg and Hrp. An excess of protein with impaired Ank2 binding capacities led to an 
almost 2-fold increase in NMJ size. (c-d) Quantification of bouton number and NMJ length at muscle 
4, an excess of Nrg180∆FIGQY protein resulted in a significant increase in bouton number and NMJ 
length respectively (P ≤ 0.0001 respectively, n = 114 -118 NMJs for bouton number, 20 NMJs for 
NMJ length). Scale bar in (a) corresponds to (a, b), 10µm. Error bars in (c) and (d) represent SEM. 
3.3.3. Genetic interactions of Neuroglian 
To gain more insights into the mechanism how Nrg controls NMJ growth and stability, I 
performed genetic interaction experiments using mutations of genes previously identified as 
essential for NMJ stability and growth. Candidate genes included ank2 as a direct interaction 
partner of nrg and α-spec as a stabilization protein (Garver et al., 1997; Pielage et al., 2005; 
Tuvia et al., 1997). Additionally, I analyzed mutants of the TGF-beta signaling pathway that 
regulate growth and stability at the larval NMJ (Aberle et al., 2002; Eaton and Davis, 2005; 
Rawson et al., 2003) and genes important for NMJ stability that are currently under 
investigation in the lab. 
3.3.3.1. Neuroglian interacts genetically with ank2 and α-spectrin 
Ank2 and α- and β-Spec are part of a molecular network underlying the cell membrane that is 
important for synaptic stability (Koch et al., 2008; Pielage et al., 2008; Pielage et al., 2005; 
Pielage et al., 2006, Figure 9). I showed that the loss of Ank2-Nrg interaction results in 
synaptic retractions. To analyze a potential genetic interaction of ankyrin and spectrin with 
nrg I combined the Pacman rescue assay with the classical mutations ank2518 and α-
spectrinrg41. I considered a genetic interaction if in the nrg14/y; P[Nrg180ΔFIGQY]  animals with 
the respective mutation in heterozygosity the number of retractions was more than 2-fold 
increase in comparison to the sum of the retraction from nrg14; P[Nrgwt] and nrg14/y; 
P[Nrg180ΔFIGQY] together (material and methods chapter 4.2.5.). Interestingly, I observed a 
highly significant increase in synaptic retractions for both mutations (Figure 24 c, Table 34). 
Thus, only the reduction of either Ank2 or α-Spec levels in nrg14/y; P[Nrg180ΔFIGQY] but not 
in nrg14; P[Nrgwt] background impaired synapse stability. Exemplary images also 
demonstrate the increase in retraction severity (Figure 24 a, b, d). 
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Figure 24 - Genetic interaction of Neuroglian with Ank2 and α-Spectrin  
(a-b) Larval muscle 4 NMJ stained for presynaptic active zone marker Brp (green) and postsynaptic 
glutamate receptors (DGluRIII, red) as well as the presynaptic membrane (Hrp, white). (a) A nrg14; 
P[Nrgwt] NMJ with reduced Ank2 levels due to the introduction of the ank2518 mutation in 
heterozygosity. Pre- and postsynaptic markers are opposing each other and the membrane is intact 
(inset) indicating a stable NMJ. (b) A nrg14; P[Nrg180ΔFIGQY] NMJ with reduced Ank2 levels due to 
the introduction of the ank2518 mutation in heterozygosity. This NMJ is completely eliminated based 
on the loss of all Brp protein, the few visible highly clustered glutamate receptors and the highly 
fragmented membrane. (c) Quantification of retraction frequency. The introduction of one copy of 
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either the ank2518 mutation or the α-specrg41 mutation in the nrg14; P[Nrg180ΔFIGQY] background leads 
to highly significant increase in retraction number in comparison to nrg14; P[Nrg180ΔFIGQY
These experiments further demonstrate that the Nrg-Ank2 interaction is essential for synapse 
stability and that impairing the interaction generates a genetic background that is highly 
sensitive to protein levels of other stability genes.  
] alone (P ≤ 
0.0001, n = 8-25 animals). (d) Also the severity of retractions is increased based on the number of 
unopposed glutamate receptor cluster. Scale bar in (a) corresponds to (a-b), 10µm, insets 5 µm. Error 
bars in (c) and (d) represent SEM. 
3.3.3.2. TGF-beta signaling modulates Neuroglian functions 
 
Figure 25 - TGF-beta signaling in Drosophila 
Retrograde TGF-beta signaling at the Drosophila larval NMJ controls synapse growth and stability. 
The BMP ligand Glass bottom boat (Gbb) is released from the muscle and binds to the tetrameric 
TGF-beta receptors containing type-I and type-II receptor subunits (Type I: Thickveins and 
Saxophone, Type II: Wishful thinking and Punt). Subsequently, the R-SMAD Mad becomes 
phosphorylated, binds to the Co-SMAD Med and translocates to the nucleus. Here, they act as a 
transcription factor controlling gene expression important for growth and stability. Negative 
regulators of TGF-beta signaling like Daughters against decapentaplegic (Dad) become expressed 
upon activation of TGF-beta signaling and inhibit further signaling. 
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At the Drosophila larval NMJ TGF-beta signaling is involved in NMJ growth regulation and 
mutations downregulating TGF-beta signaling have a reduced NMJ size and display synaptic 
retractions (Aberle et al., 2002; Eaton and Davis, 2005; Wan et al., 2000). Are TGF-beta 
signaling molecules potential interaction partners contributing to synaptic phenotypes 
observed in nrg14/y; P[Nrg180∆FIGQY] animals? To answer this question, I combined mutants 
of the TGF-beta signaling pathway with the Pacman assay. Here, I would like to highlight 
two interesting preliminary findings. Firstly, the reduction of neither the TGF-beta receptor 
type II Wishful thinking (Wit) nor the SMAD Mad did led to a significant increase in 
synaptic retractions as observed for Ank2 and α-Spec (Figure 26). In contrast the reduction of 
the TGF-beta receptor type I Thickveins (Tkv) did lead to a highly significant increase in 
synaptic retractions frequency and severity (Figure 28). Secondly, I observed a significant 
increase of bouton number when Wit was reduced in both nrg14/y; P[Nrg180∆FIGQY] and 
nrg14; P[Nrgwt] animals (Figure 27). This increase in bouton number was not observed when 
Ank2 levels were reduced (Figure 27). 
These preliminary results indicate that selective members of the TGF-beta signaling pathway 
contribute to the synapse stabilization and growth regulating function of Nrg. It will be 
interesting to see how and if other members of this pathway are involved as well. 
 
Figure 26 - Genetic interaction of Neuroglian with Wit and Mad  
(a) Quantification of retraction frequency. The introduction of wit mutations in the Pacman rescued 
nrg14 background leads to an increase in synaptic retraction for P[Nrgwt] and P[Nrg180ΔFIGQY]. There 
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is no significant difference between nrg14; P[Nrgwt]; witmut and nrg14; P[Nrg180ΔFIGQY]; witmut animals 
for both mutations (PB11 = 0.57 and PA12 = 0.84, n = 6-11). (b) The same result has been obtained 
when mad mutations (mad1-2 and madk237
 
) have been introduced into the Pacman rescue background 
(n= 4-15). Error bars in (a) and (b) represent SEM. 
 
Figure 27 - Reduction of wit signaling in Nrg pacman rescued animals influences NMJ 
growth 
Quantification of bouton number in nrg14; P[Nrgwt] or nrg14; P[Nrg180ΔFIGQY] animals that have 
reduced levels of the adaptor molecule Ank2 or the TGF-beta type II receptor Wishful thinking. The 
reduction of Ank2 does not have an additional influence on bouton number (P = 0.19, n = 76-98 
NMJs analyzed) in comparison to the Pacman rescues. In contrast the reduction of Wit in the 
background of nrg14; P[Nrgwt] leads to an significant increase of bouton number (P ≤ 0.0001 in 
comparison to nrg14; P[Nrgwt] and nrg14; P[Nrgwt]; ank2518, n=70-98 NMJs in segment A2-A6 
analyzed). In the nrg14; P[Nrg180ΔFIGQY] rescue background the introduction of the witB11 mutation 
resulted in a significant increase of bouton number in comparison to nrg14; P[Nrg180ΔFIGQY]  
(P ≤ 0.0001, n = 46-122 NMJs in segment A2-A6 analyzed). Error bars represent SEM. 
 115 
 
Figure 28 - Genetic interaction between the TGF-beta receptor type I Thickveins and 
Neuroglian  
(a-c) Muscle 4 NMJ stained for presynaptic active zone marker Brp (green), postsynaptic glutamate 
receptors (DGluRIII, red) and the presynaptic membrane (Hrp, blue, white). (a) Muscle 4 NMJ of the 
genotype nrg14; P[Nrgwt]/tkv1. The apposition of Brp and DGluRIII as well as the intact membrane 
indicate a stable NMJ. The asterisk points to the area of the insets shown below. (b) Example of 
instable muscle 4 NMJ of the genotype nrg14; P[Nrg180ΔFIGQY]/tkv1 with a complete loss of Brp and 
the fragmentation of the membrane. Asterisk indicates the area shown in the insets. (d) Quantification 
of synaptic retraction frequency. Introduction of one copy of the tkv1 hypomorphic mutation led to an 
highly significant increase in retractions (P ≤ 0.0001 , n = 9-11). The viable homozygous tkv1 mutants 
did not display any destabilization effects (P = 0.75, n = 11-15 animals analyzed). (e) Quantification 
of the retraction severity. The number of boutons without Brp staining were counted and grouped into 
four categories. The percentage of these categories of all NMJs has been blotted for all genotypes in 
(d). Also an increase in retraction frequency can be observed upon tkv1 introduction into  
nrg14; P[Nrg180ΔFIGQY]. Scale bar in (a) corresponds to (a-c), 10µm, insets 5 µm. Error bars in (d) and 
(e) represent SEM. 
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3.4. The transcription unit CG31708 encodes an Ig-domain protein 
important for synapse stability 
3.4.1. CG31708 is important for synapse stability at the neuromuscular junction 
In the RNAi screen I identified the Ig-domain protein CG31708. Pre- but not postsynaptic 
knock down of CG31708 resulted in severe synaptic retraction in 3rd instar larvae (Figure 29). 
The observed phenotype has some interesting characteristics which I would like to highlight 
here. No genetic or biochemical characterization of CG31708 has been performed so far. 
Since I identified CG31708 based on its retraction phenotype indicating a glue like function 
at the NMJ I named this gene “uhu” based on the famous German glue brand.  
I observed two different phenotypes after presynaptic knock down of Uhu. On one hand 
classical retractions as described for other genes involved in NMJ maintenance (Figure 29 c) 
and on the other hand I observed motoneuron terminals where the presynaptic marker Brp 
was lost in proximal or central parts but still present in distal parts of a branch (Figure 29 b). 
This phenotype has never been described for other stability genes so far and might be either 
caused by synapse formation defects or characterizes a novel retraction mechanism. However 
the phenotype also shares features with classical retraction phenotypes including the aberrant 
clustering of glutamate receptors and the fragmentation of the presynaptic membrane (Figure 
29 c). Thus the observed phenotype after uhu RNAi can either represent a novel retraction 
mechanism or combines synapse formation and stabilization defects. 
In addition, the uhu phenotype displays motoneuron specificity. Whereas we observe a strong 
phenotype on muscle 6/7, 12 and 13, no retractions or formation defects can be observed on 
muscle 4 (Figure 29 d). So far ,all identified genes controlling synapse stability are required 
in all muscles and only differ in the retraction severity between muscles. Nrg RNAi for 
example displays the strongest phenotype at muscle 4 with 80% of all observed retractions 
being complete eliminations. 
To understand the process of this special synapse destabilization/formation mechanism in 
more detail, I analyzed three different larval stages during larval development from 2nd instar 
larvae to late 3rd instar larvae. Interestingly, the retraction/formation phenotype observed and 
described above only develops in the last steps of larval development, since no significant 
increase of synaptic retractions can be observed in 2nd instar and early 3rd instar larvae 
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(Figure 30). In contrast, after nrg RNAi I observed already in 2nd instar larvae a significant 
number of retractions for example on muscle 4 (Figure 17 c). These observations strengthen 
the argument for the identification of a novel fast acting retraction mechanism. 
 
Figure 29 - Presynaptic knock down of Uhu leads to severe synaptic retractions at a 
selection of NMJs 
(a) A wild type muscle 6/7 NMJ stained for active zone marker Brp (green) and postsynaptic 
glutamate receptors (DGluRIII, red). In addition the presynaptic membrane is stained using Hrp 
(white, blue). Pre- and postsynaptic markers are opposing each other and the membrane is 
continuously formed. This shows that this NMJ is stable. The asterisk indicates the region shown in 
the inset. (b) A muscle 6/7 NMJ after presynaptic uhu RNAi. Parts of the NMJ lost the presynaptic 
marker Brp and the membrane is partially fragmented. In the inset (asterisk) a part of a NMJ branch is 
shown where Brp was lost in proximal parts of the NMJ but still present in distal parts. (c) A muscle 
6/7 NMJ after presynaptic uhu RNAi that lost the presynaptic marker Brp almost completely. *1 is 
shown in higher magnification in the inset. *2 indicates remaining Brp staining. (d) Quantification of 
retractions in ctrl (elavC155-Gal4; ok371-Gal4 x w1118) and after pre- and postsynaptic uhu RNAi. At 
muscle 6/7, 12 and 13 a highly significant number of retractions can be observed after presynaptic 
knock down (P ≤ 0.0001, n = 6-12). In contrast, no synaptic retractions have been observed at muscle 
4 and after postsynaptic knock down of Uhu. (e) Quantification of the retraction severity after 
presynaptic knock down of  Uhu on muscle 6/7. The number of unopposed postsynaptic 
varicosities were counted and grouped into categories indicated in the legend. No complete 
eliminations have been observed. Gal4 driver legend: pre = elavC155-Gal4; ok371-Gal4, post = mef2-
Gal4. Scale bar in (a) corresponds to (a-c), 10 µm, insets 5 µm. Error bars in (d) and (e) represent 
SEM. 
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Figure 30 - Development of retraction phenotype of Uhu during larval development on 
muscle 6/7 
Quantification of retraction frequency after presynaptic uhu RNAi during development from 2nd instar 
larvae to 3rd
In summary, the RNAi mediated knock down of Uhu showed that presynaptic Uhu is 
important at distinct larval NMJs and the unique features of the phenotype imply a novel 
mechanism of synapse disassembly. However, additional experiments have to be performed 
to validate this hypothesis. 
 instar larvae is shown. Only in the last steps of larval development NMJs become 
instable. Error bars represent SEM. 
3.4.2. Analysis of Uhu expression at the neuromuscular junction 
To characterize a gene in more detail it is important to describe the expression pattern of the 
protein. Therefore, I generated an antibody against the last 150 amino acids of Uhu. 
Unfortunately, this antibody did not recognize wild type levels of Uhu either due to low 
levels of Uhu at the NMJ or to a low affinity of the antibody. Since we observe a phenotype 
after presynaptic knock down I can assume that Uhu has to be present at the NMJ. Thus, I 
cloned an UAS construct of Uhu and generated transgenic flies. This construct was used to 
overexpress Uhu either in the motoneuron or in the muscle and analyze if Uhu has the 
potential to localize to the NMJ. In the future it will be e.g. used for tissue-specific rescue 
experiments of uhu mutants. The presynaptic expression revealed an interesting feature of 
Uhu. Uhu was expressed weakly in the motoneuron axon and the nerve bundle but localized 
efficiently to the NMJ terminal (Figure 31 a). Within the bouton, I observed a honey-comb 
like structure (Figure 31 a). A similar expression pattern has been described for the Ig-
domain protein FasII, which indicates that Uhu can be highly organized in subdomains of the 
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bouton and thus resembles features of other cell adhesion molecules. In addition, Uhu can 
also localize to the muscle side of the NMJ with a strong accumulation directly around the 
NMJ terminal and a more diffuse pattern on the muscle surface (Figure 32 b). Further 
analyses using co-stainings with markers for different synaptic and muscle departments are 
needed to characterize the expression pattern of Uhu in more detail. Importantly, no NMJ 
phenotype has been observed after pre- or postsynaptic overexpression of Uhu. 
 
Figure 31 - Analysis of Uhu expression in motoneurons and muscles 
(a) Presynaptic overexpression of Uhu using the Gal4 driver line elavC155-Gal4; ok371-Gal4. A 
muscle 4 NMJ is shown which is stained for Uhu with the Uhu specific antibody (green) and the 
presynaptic membrane (Hrp, red). The inset shows the last boutons of a branch indicated by the 
asterisk. Uhu localized predominantly to the NMJ terminal and weaker to the motoneuron axon and 
the bypassing nerve. (b) Postsynaptic overexpression of Uhu using the Gal4 driver mef2-Gal4. A 
muscle 4 NMJ is shown stained with the Uhu specific antibody and Hrp to mark the presynaptic 
membrane. Uhu strongly accumulates in the muscle membrane directly around the NMJ terminal and 
was more diffusely distributed over the muscle. Scale bar in (a) corresponds to (a-b), 10 µm, Scale 
bar in the insets corresponds to 5 µm. 
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In summary, Uhu has the potential to localize to both sides of the NMJ and might interact 
homophilically, however I could only identify a presynaptic function of Uhu so far. 
3.4.3. Analysis of Uhu characteristics using bioinformatical tools 
Uhu belongs to the class of Ig-like domain proteins. The Ig-domains belong to the I- and V-
set family of Ig-domains as analyzed using Pfam (Punta et al., 2012). The first Ig-like domain 
of Uhu is classified as a V-set domain (PF07686) followed by two I-set domains (PF07679). 
I-set Ig domains are very common among cell adhesion molecules like NCAM, tyrosine 
protein kinase receptors and others. Hence, Uhu has the potential to act as a cell adhesion 
molecule based on the domain structure.  
The RNAi mediated knock down of Uhu only affected a subset of motoneurons. Which genes 
are important to provide stability to the other motoneuron synapses? Is Uhu part of a 
molecular code controlling synapse stability at the larval NMJ? One possibility for such a 
code could be a number of proteins with a similar domain structure. Therefore, I analyzed the 
Drosophila genome (Flybase release 5.19) and searched for all Ig-like domain proteins with 
three Ig-domains. I found 27 genes that fitted this criterion. A more detailed analysis of these 
genes using multiple online bioinformatical tools revealed a cluster of 10 proteins with a high 
similarity to Uhu (Supplementary Figure 1 and 2). From these 10 proteins one displayed high 
similarity to Uhu based on the sequence and nature of the Ig-like domains (Supplementary 
Figure 1 and 2). This protein is encoded by the uncharacterized gene CG42368. The RNAi 
line targeting CG42368 did not give a phenotype at the larval NMJ. As this might be due to 
the failure to knock down CG42368 efficiently, a specific mutation has to be generated to 
assess potential functions at the NMJ. 
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Figure 32 - Analysis of structural characteristics of Uhu 
(a) The full length protein sequence of Uhu (CG31708-PB) was used to perform a Phoebius 
prediction. This program predicts signal peptides and transmembrane domains. The signal peptide of 
Uhu is predicted from amino acid 1-19 (red) and the transmembrane domain from amino acid 504-523 
(grey). CG31708 has a relative short predicted cytoplasmic domain of 8 amino acids  
(aa 524-532, green) and a long extracellular domain from amino acid 19-503 (blue).(b) The full length 
protein sequence of Uhu (CG31708_PB) was analyzed for a potential GPI anchor using the online 
tool GPISOM. The program predicts a GPI anchor for Uhu as indicated by the cross in a green field of 
the prediction (highlighted by an arrowhead). (c) The predicted Uhu domain structure based on 
multiple bioinformatical tools: Uhu is a small protein of 512-532 amino acids depending on the 
isoform. A signal peptide has been identified in the very N-terminus for the localization to the 
endoplasmatic reticulum. One V-set Ig like domain and two I-set Ig-like domains are encoded in the 
uhu sequence. However it is unclear if Uhu has a GPI anchor or passes the membrane with a single 
transmembrane domain. 
Next, I analyzed the structure and domains of Uhu and CG42368 in more detail (results of the 
other 9 genes are found in the Table 38). Using different prediction tools like Phoebius or 
SignalP (Kall et al., 2004; Petersen et al., 2011) I found that both Uhu and CG42368 have a 
signal peptide in the N-terminus region (Figure 32 a, c, Table 4). A signal peptide is often 
found in transmembrane, membrane-bound or secreted proteins. In contrast to the clear result 
concerning the signal peptide and the Ig-like domains, no final conclusion could be made 
about a potential transmembrane domain or a GPI-anchor (Table 4, Figure 32 c). Experiments 
addressing potential anchoring are required to address this question. 
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Table 4 - Result of SignalP and Phoebius prediction 
CG number SignalP Phoebius GPI-SOM 
 Prediction SP TM GPI anchor 
CG42368-PA Signal peptide yes yes/no yes 
CG31708-PB Signal peptide yes yes yes 
Uhu and CG42368 have been analyzed using the prediction tools SignalP, Phoebius and GPISOM. 
The outcome of these predictions is summarized for the presence of signal peptides (SP), 
transmembrane domains and GPI anchors. Both predictions agreed on the same result concerning the 
presence of a signal peptide. Signal peptides are about 19 amino acid long sequences at the N-
terminus of proteins and are important for the localization to the endoplasmatic reticulum where 
posttranslational changes occur. Uhu has a predicted transmembrane domain whereas CG42368 did 
not give a clear result. The GPISOM prediction indicated a GPI anchor for both proteins. 
What are potential homologs of Uhu in vertebrates? All 11 proteins that clustered around Uhu 
were blasted against the human refSeq. The best hit for all 11 proteins was an isoform of the 
Ig-domain protein Neurotrimin. Neurotrimin belongs to a family of GPI-anchored Ig-domain 
proteins called IgLONs (named after the first three identified members in rodents LAMP, 
OBCAM, Neurotrimin). In addition to Neurotrimin, opioid-binding CAM (OBCAM, named 
OPCML in human), Kilon (a kindred of IgLON) and limbic-system associated protein 
(LAMP) belong to this family (Funatsu et al., 1999; Levitt, 1984; Marg et al., 1999; Pimenta 
et al., 1996; Schofield et al., 1989). Members of this family have been implicated in memory 
formation (Qiu et al., 2010), axon targeting, neurite outgrowth (Marg et al., 1999; Pimenta et 
al., 1995; Schafer et al., 2005) and cell adhesion (McNamee et al., 2002). For Drosophila the 
gene lachesin has already been proposed to be a potential homologue of the IgLON family 
(Strigini et al., 2006). Lachesin has been described as required for the formation of the blood-
brain barrier and controls tracheal tube size and epithelial integrity (Llimargas et al., 2004). 
Interestingly, lachesin has been identified in the screen based on a weak retraction phenotype 
(Table 25) suggesting a role for this gene class in synapse stabilization. 
In summary, Uhu is a novel Ig-like domain protein in Drosophila with a signal peptide in the 
very N-terminus and a potential GPI/TM domain (Figure 32 c) and represents a potential 
invertebrate member of the IgLON protein family required for synapse stability. 
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3. Discussion and Outlook 
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The aim of this study was the identification of cell adhesion molecules controlling synaptic 
stability and the characterization of potential underlying regulatory mechanisms. Here I will 
discuss and highlight results of this study not included and discussed in the submitted 
manuscript. These are:  
(1) The ability to identify novel players in synapse stability using an RNAi-based screen.  
(2) Integration of the identified candidates into a molecular network. 
(3) Additional data about Neuroglian function during synapse stability and growth. 
(4) The identification of the novel Ig-like domain protein Uhu. 
(5) The existence of redundant mechanisms controlling synapse stability. 
3.1. The RNAi-based screen allows the identification of novel cell adhesion 
molecules important for synapse development and stability 
To identify novel cell adhesion molecules involved in neuronal circuit development at the 
Drosophila NMJ an unbiased RNAi screen was combined with a high resolution assay that 
allows the analysis of NMJs at single synapse resolution. I selected entire classes of cell 
adhesion molecules based on previous proposed functions during nervous system 
development such as synapse formation for Ig-domain proteins and LRRTMs (Biederer et al., 
2002; Linhoff et al., 2009) and axon guidance for Cadherins and Semaphorins 
(Godenschwege and Murphey, 2009; Hummel and Zipursky, 2004; Petros et al., 2008). 
The RNAi-based screening of candidates has several advantages compared to classical 
forward screening assays such as EMS- or P-element based screens. Firstly, the VDRC RNAi 
library (Dietzl et al., 2007) allows the screening of a specific subset of candidate genes of 
interest. Secondly, it allows spatial and temporal control of gene knock down using specific 
Gal4 driver lines (Brand and Perrimon, 1993), thus circumventing the early lethality caused 
by some mutations constraining the analysis of gene functions in later stages of development. 
However the technique also has some drawbacks like the potential knock down of off-targets 
and the limited knock down efficiency dependent on the tissue and the RNAi construct. To 
circumvent this problem I co-expressed a member of the RNAi pathway dcr-2 in the nervous 
system which enhances the RNAi efficacy (Dietzl et al., 2007; Valakh et al., 2012).  
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An important question was whether the RNAi technique would allow me the identification of 
genes important for synapse stability at the Drosophila larval NMJ. To control the RNAi 
conditions, I tested a number of positive controls that have been previously identified as 
important for NMJ development and maintenance as e.g. β-spectrin (Pielage et al., 2005), 
bruchpilot (Fouquet et al., 2009; Kittel et al., 2006; Wagh et al., 2006), ankyrin2 (Koch et al., 
2008; Pielage et al., 2008), mother of decapentaplegic (mad) and medea (med) (Eaton and 
Davis, 2005). Importantly I identified 80% of these positive controls. Most of them have been 
previously identified using classical mutations like ank2, med and mad. Thus, I can conclude 
that the RNAi technique is a valid assay to identify essential genes for the Drosophila larval 
NMJ. Recently a number of screens using RNAi-based knock down of candidate genes in 
muscles, epidermis and at the larval NMJ have been published (Lesch et al., 2010; Schnorrer 
et al., 2010; Valakh et al., 2012). In addition, to synapse stability defects our assay allows the 
characterization of other features including formation and morphology defects as I 
demonstrated the synaptic overgrowth induced by highwire RNAi (McCabe et al., 2004).  
However, it has to be noted that most positive controls did not belong to the transmembrane 
protein class. A particular difficulty for the analysis of transmembrane proteins might be 
lower protein turn over compared to cytoplasmic proteins (Rasse et al., 2005; FRAP 
experiments in submitted manuscript). Indeed, I was not able to completely knock down 
FasII using different RNAi lines (data not shown). 
In summary, I can conclude that the RNAi technique allows the identification of novel 
candidate genes important for NMJ development and stability however the knock down of 
cell adhesion molecules might be less efficient than the knock down of cytoplasmic proteins. 
3.2. Candidate genes identified in the screen important for synapse stability 
In the screen I identified the Ig-like domain proteins Neuroglian and CG31708 (Uhu) as 
novel candidate genes controlling synapse stability (chapter 3.3. and 3.4.). In addition, I 
identified three other genes involved in NMJ maintenance. These are the 4.1 protein Coracle, 
Insomniac and a so far uncharacterized LRR protein CG5195 that I will discuss in the 
following sections. 
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3.2.1. Coracle is important for synapse stability in the presynaptic motoneuron 
I identified Coracle (Cora) as an important protein for synapse stability in the presynaptic 
motoneuron using two RNAi lines targeting the same DNA sequence. The protein belongs to 
the CAM interaction group and harbors a FERM domain which is found in a number of 
cytoskeleton associated proteins that interact with cell adhesion molecules (Neisch and 
Fehon, 2011). Importantly, the L1-type Neuroglian has a FERM binding domain in the 
cytoplasmic tail thus Cora could be a potential interaction partner of Nrg providing an 
additional link to the cytoskeleton contributing to the stabilizing function of Nrg. At the 
larval NMJ Cora has previously been described to control the selective anchoring of 
Drosophila glutamate receptors at the NMJ (Chen et al., 2005). 
3.2.2. Presynaptic Insomniac controls synapse stability 
Presynaptic RNAi mediated knock down of Insomniac resulted in severe synapse retractions. 
Inc encodes a small protein with a BTB/POZ (BR-C, ttk, bab and Pox virus and Zinc finger) 
domain which can be found in potassium channels as well as in transcription factors. In 
potassium channels this domain is important for protein tetramerization acting as a protein-
protein interaction domain (Bixby et al., 1999). Transcription factors with BTB/POZ domains 
often act as transcriptional repressors (Neisch and Fehon, 2011; Wong and Privalsky, 1998). 
Thus, two scenarios are possible how Inc controls synapse stability. Firstly, Inc could act as a 
linker protein required for the clustering of proteins like CAMs and others in subdomains of 
the cell membrane, which are essential for synapse stability. A similar function has been 
described for AnkyrinG which regulates the localization of Neurofascin and voltage-gated 
Na-channels to the AIS controlling the ability of the AIS to initiate action potentials (Zhou et 
al., 1998). Secondly, Inc could act as a transcription factor. Many transcription factors have 
been identified to control different aspects of larval NMJ development including growth and 
stability. For example the overexpression of the transcription factor FoxO leads to the 
destabilization of microtubules and synaptic instability (Nechipurenko and Broihier, 2012) 
and the SMAD transcription factor Mad has been implicated in NMJ growth regulation as 
well as synapse stability (Eaton and Davis, 2005; Rawson et al., 2003). 
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3.2.3. Postsynaptic CG5195 is required for synapse stability 
Finally, I would like to highlight the identification of the LRR protein CG5195, which is the 
only candidate identified in the screen required in the postsynaptic muscle promoting 
synaptic stability at the larval NMJ. The retractions are accompanied by severe muscle and 
bouton formation defects. Importantly, other candidates in the screen showed muscle defects 
but no retractions. This indicates that these two phenotypes do not necessarily depend on 
each other. Using online bioinformatical tools I analyzed the domain structure of CG5195 in 
more detail. CG5195 contains 29 LRR domains that have been identified to be important for 
protein-protein interactions. The absence of a transmembrane domain or a GPI-anchor but the 
presence of a signal peptide indicates that CG5195 could be a secreted LRR protein similar to 
the neuronal LRR proteins Slit (Chen et al., 2001; Wong et al., 2002) and leucine-rich glioma 
inactivated (LGI1/4) (Owuor et al., 2009). Many LRR proteins are essential for nervous 
system development and function (Ko et al., 2009; Linhoff et al., 2009).  
Multiple scenarios how CG5195 could control presynaptic stability from the muscle side are 
considerable. First of all, muscle derived CG5195 could act as a signaling activator through 
binding of pre- and postsynaptic receptors and a subsequent signaling cascade would control 
synapse stability and muscle development. A similar mechanism has been described for the 
Drosophila TGF-beta homolog Glass bottom boat (Gbb) that activates TGF-beta signaling 
and thereby regulates NMJ growth and stability (Eaton and Davis, 2005; McCabe et al., 
2003). Secondly, the secreted protein CG5195 could interact with cell adhesion molecules on 
both sides of the NMJ and provide a functional linker required for synaptic stability. The 
secreted protein CBln1 for example interacts with both Neurexin and GluRδ2 and forms a 
bridge required in cerebellar granule cells and Purkinje cells during synaptogenesis in mice 
(Matsuda et al., 2010; Uemura et al., 2010). 
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3.3. The L1CAM homologue Neuroglian controls synapse stability and 
growth 
In the main part of my study I focused on the L1-type CAM Neuroglian. In the RNAi screen I 
identified Neuroglian as key regulator of synapse stability in vivo. Neuroglian has the 
potential to interact with the adaptor molecule Ank2 in a regulated fashion (Garver et al., 
1997). In a detailed analysis using biochemical, biophysical and genetic assays, I analyzed 
the requirement of the Nrg-Ank2 interaction for synapse development. I showed that the 
synapse stability of the larval neuromuscular junction depends on the extracellular Ig-
domains and the intracellular Ankyrin interaction motif of Nrg. Impairment of Ankyrin 
binding causes an increase in Nrg mobility that correlates with increased synaptic growth and 
decreased stability.  
Here, I would like to discuss interesting aspects of Nrg not included in the manuscript. (1) 
Neuroglian expressed in glial cells contributes to synapse stability at the larval neuromuscular 
junction. (2) Homophilic and heterophilic interactions of Nrg control synapse stability. (3) 
Loss of Ank2-Nrg interaction sensitizes the neuromuscular junctions for the reduction of 
proteins important for synapse stability. (4) The TGF-beta receptor Wit interacts genetically 
with Nrg during synapse growth regulation. 
3.3.1. Glial Neuroglian contributes to synapse stability at the larval 
neuromuscular junction. 
Glial knock down of Nrg resulted in an increase in synaptic retractions at the larval NMJ. 
Perineurial and subperineurial glial cells extend processes into the synaptic region of the 
synaptic terminal but do not cover it completely (Brink et al., 2012). Recently Keller and 
colleagues (2011) identified a role of glial cells during NMJ elimination at the larval NMJ 
(Keller et al., 2011). They postulate the existence of a prodegenerative glial derived signaling 
framework consisting of TNF-α and TNF-α-receptor and the downstream activation of 
caspases and mitochondria-dependent signaling pathways. Mutants of TNF-α and the TNF-α-
receptor can ameliorate the synaptic retraction phenotype of ank2 and spectrin mutants 
(Keller et al., 2011). In vertebrates perisynaptic Schwann cells interact closely with the NMJ 
terminal and are important for proper formation and function as well as maintenance of the 
NMJ (Feng et al., 2005; Koirala et al., 2003).  
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Neuroglian has been identified as a cell adhesion molecule expressed in neurons and glial 
cells (Bieber et al., 1989). In the embryonic peripheral nervous system homophilic 
interactions between neurons and glial cells are required to establish the complex dendritic 
arbors of mechanosensory neurons (Yamamoto et al., 2006). This indicates that indeed the 
loss of homophilic Nrg interaction between motoneuron and glial cell could result in a loss of 
synaptic stability. An additional level of potential functional regulation provided by the L1-
type CAM Neuroglian is the interaction with Ankyrins. I showed in this study that this 
interaction is important for the regulation of synapse stability in the presynaptic motoneuron. 
However in glial cells the interaction with Ank1 seems not be required for this function. 
Neither the deletion of the FIGQY Ankyrin binding motif of Nrg167, the only Nrg isoform 
present in glial cells, nor the RNAi mediated knock down of glial Ank1 impaired synapse 
stability. Thus, this interaction does not contribute to the glial regulation of synapse stability. 
However, other interaction domains like the FERM protein binding domain of Nrg167 could 
provide a regulatory system used in glial cells. A potential candidate to test would be the 4.1 
protein Coracle that I identified in this study. 
3.3.2. Homophilic and heterophilic interactions of Nrg contribute to synapse 
stability. 
Neuroglian and L1CAMs have been shown to mediate homo- and heterophilic interactions 
through their extracellular Ig-domains and Fn-type III domains (Castellani et al., 2002; 
Felding-Habermann et al., 1997; Oleszewski et al., 1999; Volkmer et al., 1996; Yamamoto et 
al., 2006; Zhao et al., 1998). At the larval NMJ Neuroglian is expressed in motoneuron and 
muscles. Thus, homophilic interactions through the extracellular Ig-domains could contribute 
to the synapse stabilization function of Nrg. However, I showed that RNAi mediated knock 
down of Nrg in muscles did not impair synapse stability. From this result one can conclude 
that at the NMJ rather heterophilic interactions with so far unknown molecules are important. 
By combining the RNAi approach with the “knock-in” mutations, I could demonstrate that at 
least partially homophilic interactions of Nrg are involved in the control of synapse stability. 
Knock down of postsynaptic Nrg in animals expressing only Nrg180ΔFIGQY presynaptically 
(nrg14/y; P[Nrg180ΔFIGQY]) resulted in a significant increase in synaptic retractions. Thus, a 
combination of homo- and heterophilic interactions of the extracellular domain of Nrg might 
be needed to promote synapse stability. It will be interesting to identify these heterophilic 
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interaction partners, which could include other cell adhesion molecules including receptor 
protein tyrosine kinases (RPTK) or ion channels.  
3.3.3. Loss of the Ank2 Nrg interaction sensitizes the NMJ for important for 
genetic perturbations of proteins controlling synapse stability. 
To analyze a potential genetic interaction between Nrg and members of the molecular 
network essential for synapse stability (Pielage et al., 2011; Pielage et al., 2008; Pielage et al., 
2005; Pielage et al., 2006), I combined the “knock-in “ mutations with loss-of-function 
mutations of ank2518 and α-spectrinrg41. I observed a genetic interaction in the background of 
the nrg14; P[Nrg180ΔFIGQY], when I removed one copy of ank2 or α-spec. This result provides 
additional evidence that Nrg acts upstream of the Ank2/Spectrin network to control synapse 
stability. A similar effect could be demonstrated for additional candidates including the TGF-
beta receptor type I Tkv. TGF-beta signaling has been shown to influence synaptic stability 
(Eaton and Davis, 2005). However, two other candidates from the TGF-beta signaling 
pathway Wit and Mad did not result in this synergistic increase of synaptic retractions 
indicating a novel role of Tkv in an Nrg-dependent signaling pathway. Interestingly, both Nrg 
and Tkv have been implicated in MAP kinase signaling. Loss of Tkv during eye development 
increases MAP kinase signaling and MAP kinase signaling results in the phosphorylation of 
the FIGQY Ank2 binding motif of Neuroglian (Vrailas et al., 2006; Whittard et al., 2006). It 
will be interesting to analyze the effect of other TGF-beta signaling molecules like the 
SMAD Med or the other TGF-beta type I receptor Saxophone (Sax) on synapse stability in 
the nrg14; P[Nrg180ΔFIGQY] background. 
In summary, these results indicate that the deletion of the FIGQY Ank2 binding motif in the 
“knock-in“ assay can serve as a sensitized background to screen for other candidates 
controlling synapse stability in a Nrg Ank2 dependent manner. 
3.3.4. The TGF-beta receptor Wishful thinking interacts genetically with Nrg 
during synapse growth regulation 
Mutations in TGF-beta signaling result in growth impairment of the larval NMJ (Aberle et 
al., 2002; Eaton and Davis, 2005; McCabe et al., 2003). In contrast, the loss of Nrg-Ank2 
interaction leads to an increase in NMJ size. Using a combination of loss-of-function 
mutations of the TGF-beta receptor type II Wit and the Nrg Pacman “knock-in” mutations, I 
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aimed to analyze a potential suppression of the synaptic overgrowth in Ank2 binding mutants 
through the reduction of TGF-beta signaling. However, I observed the opposite phenotype: A 
reduction of the TGF-beta receptor type II Wit in the background of nrg14; P[Nrgwt] and 
nrg14; P[Nrg180ΔFIGQY] resulted in an further increase of bouton numbers. Importantly, the 
reduction of Ank2 level did not result in the same increase indicating a specific effect due to 
the wit mutation. This result could indicate first of all, that Wit is potentially part of another 
signaling pathway that restricts synaptic growth in contrast to the growth promoting effect of 
TGF-beta signaling and secondly, that this involves an FIGQY independent function of Nrg. 
Further experiments are required to confirm these preliminary results. 
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3.4. The potential IgLON homolog Uhu is important for synapse stability 
In the RNAi screen I identified CG31708 as an important player in synapse stability at the 
Drosophila larval NMJ. I named CG31708 “uhu” to describe its role of a glue-like function 
between motoneuron and muscle. Uhu is essential presynaptically to control synapse 
stabilization. The phenotype of presynaptic knock down of Uhu has unique characteristics 
that I would like to discuss here in detail:  
(1) In addition to synaptic retractions observed in other genotypes, I observed NMJ branches 
where the presynaptic marker Brp was lost in proximal parts but still present in more distal 
parts. This has never been described for other retraction phenotypes. Importantly, I could 
confirm this observation using an additional set of pre- and postsynaptic markers thereby 
excluding marker specific defects (data not shown). There are two possible explanations for 
this phenomenon: either a novel mechanism of synapse disassembly or the combination of 
two distinct defects of synapse formation and synapse stability.  
(2) The observed phenotype developed between the early 3rd instar larval stage and the late 
3rd instar larval stage. This argues for a novel, fast acting mechanisms of synapse disassembly 
because one would expect to observe potential synapse formation defects already in earlier 
larval stages. We will apply life-imaging in the future to monitor the progression of these 
novel types of retraction events. 
(3) I demonstrated that presynaptic Uhu is controlling synapse stability only at a subset of 
NMJs. In contrast, Neuroglian is essential in all motoneurons to control synapse stability. 
This result implies the presence of a protein code of cell adhesion molecules to selectively 
promote synapse stability. There is no evidence for such a code for synapse stability but 
during other neurodevelopmental processes either multiple isoforms of the same gene as for 
Dscam or the expression of specific ligands binding to an receptor like for Neurexins have 
been described (de Wit et al., 2009; Schmucker et al., 2000; Uemura et al., 2010). Another 
option would be the usage of proteins with a similar domain structure that interact homo- and 
heterophilically. However, no other Ig-domain protein controlling synapse stability at a 
subset of NMJs has been identified in the screen.  
A potential candidate to perform this function has been found using bioinformatical tools. 
CG42368 is closely related to Uhu based on the sequence and domain structure. The RNAi 
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knock down of CG42368 did not result in synaptic retractions. However, this can be due to 
inefficient knock down of CG42368 as discussed above. A possible mechanism to provide 
this kind of specificity is the differential expression in subsets of muscles or motoneurons. In 
situ hybridization studies would allow testing this hypothesis. Using Blast-based search for 
potential homologs of Uhu in vertebrates, I identified the Ig-domain IgLON family. The four 
members of this family (OBCAM, Kilon, LAMP and Neurotrimin) also harbor three Ig-
domains in the extracellular domain and are described as GPI-linked glycoproteins (Funatsu 
et al., 1999). They have been implicated in a number of functions within the nervous system 
including neurite outgrowth, cell adhesion and memory formation (Akeel et al., 2011; Gil et 
al., 1998; Hashimoto et al., 2008; McNamee et al., 2002; Schafer et al., 2005). Detailed 
analyses of interactions within this family are available. Interestingly, they have been shown 
to interact homo- and heterophilic (Gil et al., 2002; Lodge et al., 2000; Marg et al., 1999; 
Zhukareva and Levitt, 1995). In addition, members of the IgLON family are differential 
expressed. This is necessary since specific homo- and heterophilic interactions are important 
for particular functions. For example the homophilic interactions of LAMP or Neurotrimin 
are important to promote neurite outgrowth whereas heterophilic interactions of Neurotrimin 
with other IgLON members inhibit neurite outgrowth (Gil et al., 1998).  
The analysis of the subcellular localization of Uhu indicates that Uhu can localize to the NMJ 
pre- and postsynaptically. However, our antibody did not recognize wild type levels of Uhu. 
When overexpressed in motoneurons, the Uhu was predominantly detected at the NMJ and a 
weaker in the axon and the nerve bundles. Within the bouton, I observed a structured 
localization similar to the honey-comb like pattern of FasII staining (Pielage et al., 2008). 
This indicates that Uhu can localize to specific substructures within boutons like other 
CAMs. Using postsynaptic overexpression I showed that Uhu can accumulate in the muscle 
area that directly surrounds the NMJ. These results indicate that presynaptic Uhu potentially 
controls synapse stability as a homophilic cell adhesion molecules. However, I could not 
demonstrate a postsynaptic function for Uhu at the Drosophila larval NMJ. Thus, it is likely 
that also heterophilic interactions with so far unknown interaction partners might control Uhu 
dependent synaptic stabilization. For many CAMs both homo- and heterophilic interactions 
have been described as e.g. within the Ig-domain family (Blaess et al., 1998; Castellani et al., 
2002; Sugie et al., 2010) or the Neurexins that can interact with Neuroligins and LRRTMs 
(de Wit et al., 2009; Ko et al., 2009; Soler-Llavina et al., 2011; Uemura et al., 2010).  
 134 
Finally, Uhu seems to be required in other parts of the nervous system since the knock down 
of Uhu using the elavC155-Gal4 line which expresses Gal4 in all postmitotic neurons 
(Robinow and White, 1991; Yao and White, 1994) results in sick larvae prior to the 
appearance of the synaptic retraction phenotype in late 3rd instar larvae. It will be interesting 
to analyze CNS requirements of Uhu in the future. 
3.5. Redundant mechanisms to control synapse stability at the larval NMJ 
In a recent publication of the embryonic neuromuscular junction Koper and colleagues (2012) 
demonstrated that even the knock down of entire classes of CAMs does not impair NMJ 
stability. Since these proteins are expressed at the NMJ the authors propose a redundant 
mechanism for the control of synapse maintenance (Koper et al., 2012). During early nervous 
system development in vertebrates a functional redundancy has been described for Neuroligin 
and LRRTMs (Soler-Llavina et al., 2011). Thus, redundancy is probably a common 
mechanism to ensure a functional nervous system controlled at multiple levels.  
During my study, I obtained additional data that are in agreement this hypothesis. In my 
RNAi screen I identified a relatively low number of cell adhesion molecules essential for 
synapse stability. In fact only two of the five top candidates can act as classic cell adhesion 
molecules by directly connecting two neighboring neurons: the transmembrane protein L1-
type CAM Neuroglian and the GPI anchored Ig-like protein Uhu. However, this could also be 
a result of a low knock down efficacy of some RNAi constructs as I observed an inefficient 
knock down of Nrg using the VDRC line 27201 (data not shown) or the low turnover of 
transmembrane proteins in comparison to cytoplasmic proteins (Rasse et al., 2005).  
After RNAi mediated knock down of both stability genes or in the nrg14 MARCM clones I 
still observed a high number of stable synapses indicating that other CAMs compensate the 
loss of Nrg and Uhu at these synapses. A potential candidate was the NCAM homolog FasII. 
During the outgrowth of ocellar neurons in Drosophila FasII can compensate for the loss of 
Nrg (Kristiansen et al., 2005). However, I could not confirm the same function of FasII 
during synapse stabilization mediated by Nrg. A potential approach to unravel such 
redundant CAMs could be an candidate-based interaction screen using the nrg14/y; 
P[Nrg180∆FIGQY] animals as a sensitized background. 
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4. Material and Methods 
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4.1. General 
4.1.1. Fly stocks 
4.1.1.1. Fly stocks used 
Fly stocks used in the submitted manuscript: see method section in the submitted manuscript 
Additional fly strains used in this study: 
PBac{WH}ank2f00518 (ank2518); w*; ru1 α-Specrg41 st1 es/TM6B, Tb1 (BL31999, α-specrg41); 
tkv1 (BL427); bw1; witB11 st1/TM6B, Tb1 (BL5174, witB11); bw1; witA12 st1/TM6B, Tb1 
(BL5173, witA12), w*; Mad1-2 P{neoFRT}40A/CyO (BL7323, mad1-2); y1 w67c23; 
P{lacW}Madk00237/CyO (BL10474, madk237); nrg849 (BL35827); P{w[+mC]=PTT-
GA}NrgG00305 (BL6844, later referred to as nrg305); w[*]; P{w[+mC]=UAS-nrg[180]}28b 
(UAS-Nrg180, BL24169); w1118; P{GAL4}repo/TM3, Sb1 (BL7415, repo-Gal4), y1 w1118; 
PBac{y+-attP-3B}VK00033 (BL9750, attPVK33); y1 v1 P{nos-phiC31\int.NLS}X; 
P{CaryP}attP40 (BL25709, attP40) (all Bloomington stock center (BL# = stock id), bold 
names are the nomenclature used in the study, 2nd chromosomal lines were rebalanced to 
either CyO-GFP or CyO-Wee-P, 3rd chromosomal lines were rebalanced to TM6B); VDRC 
lines used for screening are listed in the Appendix (Vienna Drosophila RNAi center). 
4.1.1.2. Flystocks generated 
The following fly strains have been generated and used in this study 
Table 5 - List of generated constructs and transgenic flies generated in this study 
Name Integration site Project 
pUAST-5xUAS-nrg180wt attP40 Neuroglian 
pUAST-5xUAS-nrg180Y-F attP40 Neuroglian 
pUAST-5xUAS-nrg180Y-D attP40 Neuroglian 
pUAST-5xUAS-nrg180Y-A attP40 Neuroglian 
pUAST-5xUAS-nrg180∆FIGQY attP40 Neuroglian 
pUAST-5xUAS-nrg167∆FIGQY attP40 Neuroglian 
pUAST-10xUAS-nrg180wt_HA attP40 Neuroglian 
pUAST-10xUAS-nrg180_GFP attP40 Neuroglian 
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pUAST-10xUAS-nrg180Y-F_GFP attP40 Neuroglian 
pUAST-10xUAS-nrg180Y-D_GFP attP40 Neuroglian 
pUAST-10xUAS-nrg180Y-A_GFP attP40 Neuroglian 
pUAST-10xUAS-nrg180∆FIGQY_GFP attP40 Neuroglian 
1 pUAST-10xUAS-nrg167_GFP attP40 Neuroglian 
CH321-4H20_ P[nrgwt]  attP40 Neuroglian 
CH321-4H20_ P[nrg180Y-F]  attP40 Neuroglian 
CH321-4H20_ P[nrg180Y-D]  attP40 Neuroglian 
CH321-4H20_ P[nrg180Y-A]  attP40 Neuroglian 
CH321-4H20_ P[nrg180∆FIQGY] attP40 Neuroglian 
CH321-4H20_ P[nrg180∆C]   attP40 Neuroglian 
CH321-4H20_ P[nrg180∆PDZ] attP40 Neuroglian 
CH321-4H20_P[nrg167∆FIQGY]  attP40 Neuroglian 
CH321-4H20_ P[nrg∆Ig3/4]   attP40 Neuroglian 
5xpUASTCG31708 attPVK33 Uhu 
5xpUASTCG31708_EGFP attPVK33 Uhu 
CH321-92N22 attPVK33 Uhu 
CH321-50F13 attPVK33 Uhu 
All Neuroglian transgenes have been integrated in the attP40 site, Uhu Pacman and pUAST constructs 
have been integrated into the attPVK33
4.1.2. Primer 
 site. 
4.1.2.1. General primer 
Table 6 - List of general primers used in this study 
Primer name Sequence Used 
M13fw 5`-TGTAAAACGACGGCCAGT pENTR 
M13rev 5`-CAGGAAACAGCTATGAC pENTR 
Svr 5`-GGCATTCCACCACTGCTCCC pUAST 
GalK ORF fw 5`-CGTATGGGCGAGTTGATGGCG Nrg Pacman 
GalK ORF rev 5`-GTGCGACAATGGGCGCATCGAG Nrg Pacman 
Em-7 f 5`-GTGACAATTAATCATCGGCATAG Nrg Pacman 
hspfw 5`- TATAAATAGAGGCGCTTCGT pUAST 
GFPrev 5`-CTTCGGGCATGGCGGACTTG pUAST_GFP tagged 
Primers that are not construct but vector specific and have been used for PCR based verification of 
constructs and sequencing 
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4.1.2.2. Primer for the generation of pENTR constructs 
Table 7 - List of primers used for the generation of pENTR clones for Neuroglian and 
CG31708 
Primer name Sequence Gene 
Nrg180-ENTR-N-term 5`-CACCATGTGGCGGCAGTCAACG Neuroglian 
Nrg180-ENTR-C-term 5`-TTAGACGTAGGTGGCCACG Neuroglian 
Nrg180-ENTR-C-term-tagged 5`-GACGTAGGTGGCCACGGCTC Neuroglian 
CG31708pENTR fw 5`-CACCATGTTGCCCCCGTCCTGGCATC CG31708 
CG31708pENTR-C-term 5`-TAACATAGACTTAGGCTATGG CG31708 
CG31708 pENTR-C-term-tagged 5`-ACATAGACTTAGGCTATGGCTAG CG31708 
4.1.2.3. Primer for antibody production 
Table 8 - List of primers used to generate pENTR for the antibody fragment of 
CG31708 
Primer name Sequence 
CG31708 Hisfw 5`-CACCGGCGAGGGACCAATCATACA 
CG31708 Hisrev 5`-CTAGTGACCCCGGGCCCCGTTGGATTCC 
Primers used for the generation of the His-tagged CG31708 construct used for antibody production in 
rats 
4.1.2.4. Primer for the site directed mutagenesis 
Table 9 - List of primers used for site directed mutagenesis of Nrg constructs 
Primer name Sequence 
Nrg180Y-F 5`-GGCTCCTTCATTGGCCAATTTGTTCCTGGAAAGCTCC  
Nrg180Y-D:                         5`-GGCTCCTTCATTGGCCAAGACGTTCCTGGAAAGCTCC  
Nrg180Y-A: 5`-GGCTCCTTCATTGGCCAAGCTGTTCCTGGAAAGCTCC  
Nrg180∆FIGQY: 5`-AATTTACCGAGGATGGCTCCGTTCCTGGAAAGCTCCAACC   
Primers used for site-directed mutagenesis of pUAST constructs of Neuroglian. For the point 
mutations (Y-F, Y-A, Y-D) the three amino acids of the tyrosine where the change was introduced are 
underlined. For the Nrg180∆FIGQY deletion-construct the sequence before the deletion is underlined. 
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4.1.2.5. Primer for galK insertion 
Table 10 - List of primer used to insert galK into CH321-4H20.  
Primer name Sequence 
04H20-Hindge GalK fw 5`- 
ACAAGATTGGCAACAAGGTGCTCCTCGATGTCAAACAGATGGGCGTTAGTcctgttgaca
attaatcatcggca 
04H20-Hindge GalK rev 5`- 
GACTGGCGACGGGAAACATATTGACGCACGGGCGGATGCTTGTTCTGCGAtcagcactgt
cctgctcctt 
04H20-FERM GalK fw 5`-
TCATCCTCTTCATCATCATCTGCATTATCCGACGCAATCGGGGCGGAAAGcctgttgacaa
ttaatcatcggca 
04H20-FERM GalK rev 5`-
TCTTCGGGATAATCCCGCCGGCCGTTGGCCAGCTCCCGATCGTGGACATCtcagcactgtc
ctgctcctt 
04H20-PDZ GalK fw 5`-
CCGGAGGAGCAGCTGCCAGCAATGGAGGAGCTGCAGCCGGAGCCGTGGCCcctgttgac
aattaatcatcggca 
04H20-PDZ GalK rev 5`-
TAGAAAATCAGGAGAACAATGGGGCAAGTGAATCCCAGCCACGCCTCTTAtcagcactg
tcctgctcctt 
04H20-FIGQY180 GalK fw 5`-
TCTTTCTAATCCCAGGACAATTTACCGAGGATGGCTCCTTCATTGGCCAAcctgttgacaat
taatcatcggca 
04H20-FIGQY180 GalK fw2 5`-
TAAAAACTAATATTGTATATATCTTTCTAATCCCAGGACAATTTACCGAGcctgttgacaat
taatcatcggca 
04H20-FIGQY180 GalK fw3 5`-
AATGAATCGAGAATTGTAAATAGAATAAAAACTAATATTGTATATATCTTTCTAAT
CCCAGGACAATTTACCGAGGATGGCTCCTTCATTGGCCAAcctgttgacaattaatcatcggca 
04H20-FIGQY180 GalK fw4 5`-
CACAATTGCAATGGGGTTGTAATAGAATGAATCGAGAATTGTAAATAGAATAAAA
ACTAATATTGTATATATCTTTCTAATCCCAGcctgttgacaattaatcatcggca 
04H20-FIGQY180 GalK rev 5`-
GAATTGTTCAGTGGCTGTGGGCTAACCGGCGGTTGGAGCTTTCCAGGAACtcagcactgt
cctgctcctt 
04H20-FIGQY167 GalK fw 5`-
TTTTTCTTTTTCCTAAACACGTAAAATAAACACAATCACAATCAATATTAAATCGAC
AACGACAACCAATATCCAGGCATGAATCCTGTTGACAATTAATCATCGGCA 
04H20-FIGQY167 GalK fw2 5`-
AAATAAACACAATCACAATCAATATTAAATCGACAACGACAACCAATATCCAGGC
ATGAATGAAGATGGATCCTTTATTGGCCAACCTGTTGACAATTAATCATCGGCA 
04H20-FIGQY167 GalK rev 5`-
TTGCTGTTGCGGTGCGCTGCTTACTAATTAAATCAAAGTCCTTTGCGTCCtcagcactgtcc
tgctcctt 
04H20-FIGQY167 GalK rev2 5`-
GGGGTTAAGGGCTCGGTTTCGATATTATTTTTGAGTTGCTGTTGCGGTGCGCTGCTT
ACTAATTAAATCAAAGTCCTTTGCGTCCtcagcactgtcctgctcctt 
The following galK constructs have been generated Hindge_galK, FERM_galK, PDZ_galK and 
FIGQY180_galK and FIGQY167_galK. Hindge_galK was used to generate the ∆Ig3/4 construct. 
FERM_galK was used to generate the FERM domain deletion, PDZ_galK for the PDZ domain 
deletion. FIGQY180_galK was used to generate all mutations of the Ank2 binding site of the Nrg180 
domain, FIGQY167_galK was used to generate the deletion of the FIGQY167 domain. 
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4.1.2.6. Oligos for the generation of Pacman mutants 
Table 11 - List of oligos used for the generation of Pacman mutants  
Oligo name Sequence 
P[nrg180Y-F] 
5`-
TCTTTCTAATCCCAGGACAATTTACCGAGGATGGCTCCTTCATTGGCCAATTCGTTCCTGGA
AAGCTCCAACCGCCGGTTAGCCCACAGCCACTGAACAATTC 
P[nrg180Y-D] 
5`-
TCTTTCTAATCCCAGGACAATTTACCGAGGATGGCTCCTTCATTGGCCAAGACGTTCCTGGA
AAGCTCCAACCGCCGGTTAGCCCACAGCCACTGAACAATTC 
P[nrg180Y-A] 
5`-
TCTTTCTAATCCCAGGACAATTTACCGAGGATGGCTCCTTCATTGGCCAAGCCGTTCCTGGA
AAGCTCCAACCGCCGGTTAGCCCACAGCCACTGAACAATTC 
P[nrg180∆FIQGY] 
5`-
ATATTGTATATATCTTTCTAATCCCAGGACAATTTACCGAGGATGGCTCCGTTCCTGGAAAG
CTCCAACCGCCGGTTAGCCCACAGCCACTGAACAATTC      
P[nrg180∆C] 
5`-
ATATTGTATATATCTTTCTAATCCCAGGACAATTTACCGAGGATGGCTCCTAAGAGGCGTGG
CTGGGATTCACTTGCCCCATTGTTCTCCTGATTTTCTA 
P[nrg180∆PDZ] 
5`-
CCGGAGGAGCAGCTGCCAGCAATGGAGGAGCTGCAGCCGGAGCCGTGGCCCCTGTTGACA
ATTAATCATCGGCA 
P[nrg167∆FIQGY] 
5`-
ACAATCACAATCAATATTAAATCGACAACGACAACCAATATCCAGGCATGAATGAAGATG
GATCCGGACGCAAAGGACTTTGATTTAATTAGTAAGCAGCGCACCGCAACAGCAA 
P[nrg∆Ig3/4] 
5`-
CCTCGGTGTTTCGCAGTGAATACAAGATTGGCAACAAGGTGCTCCTCGATGCTGAGCCGCC
AACGATTTCCGAAGCTCCAGCAGCTGTATCCACTGTCGA 
P[nrg∆FERM] 
5`-
TCATCCTCTTCATCATCATCTGCATTATCCGACGCAATCGGGGCGGAAAGCCTGTTGACAAT
TAATCATGGCA 
Oligos used for the mutagenesis via recombineering of the Neuroglian Pacman CH321-4H20. Only 
the forward oligos are shown, reverse oligos are complementary to the forward oligos. 
 4.1.2.7. Sequencing primer 
Table 12 - List of sequencing and check primers for the different pENTR, pUAST and 
Pacman constructs.  
Construct Forward primer Reverse primer 
pENTR_nrg180wt, Y-F, Y-A, Y-D, ∆FIGQY 
(check mutations in FIGQY motif) 
5`-AATCGGGGCGGAAAGTACG 5`-CAGGAAACAGCTATGAC 
pENTR_nrg180wt (start and stop) 5`-TGTAAAACGACGGCCAGT 5`-CAGGAAACAGCTATGAC 
pENTR/pUAST nrgwt, Y-F, Y-A, Y-D, 
∆FIGQY (sequencing of complete ORF, primer 
1-8) 
5`-TGCTCTTCAAAGTGGCGC 
5`-GTTAGTGCCTCGCAGAAC 
5`-TAACTACGGTTGCAACGC 
5`-GATTCGTGAAGACCAATG 
5`-CCGAAATCGAGCACAATG 
5`-ACAATGGACGCTTCAATG 
5`-TGGATACGCGAGAATGAG 
5`-CGATACTGATTCGATGGC 
5`-CCCGATCCTCCGGCAGTT 
5`-CAATGAACCATCCGGCAT 
5`-CCATCTTCATGCGTGTGA 
5`-CATTGTGAAGTTGGTGGG 
5`-GGCGTGAACGATGTATTG 
5`-CACCGTTAGCTTGGACAT 
5`-CACGTCGCAGGTGTATGT 
5`-GTGGCCGTTCCGAATTCA 
10xpUAST_Nrg_HA (check) 5`-AATCGGGGCGGAAAGTACG 5`-GGCATTCCACCACTGCTCCC 
10xpUAST_Nrg_EGFP (check) 5`-TATAAATAGAGGCGCTTCGT 
5`-
CAAGTCCGCCATGCCCGAA
G 
Pacman_Hindge galK check 5`-CGAGCTGAATGCCTTCAAG 
5`-
GGAGTTAACATTCAGAATG
ATGG 
Pacman_Hindge galK seq 5`-GATCCTGAGGGTAATCTCTG 5`-GTTATTCGATCGCTCCACTG 
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Pacman_FERM galK check 5`-TCCATGTACAGGATCAAGG 
5`-
ACTCTAACCTGTATCGCCAT
C 
Pacman_FERM galK seq 5`-CTTTAACACGGAGAGTGCCAC 
5`-
GATTTTGGGACTTACGGTTG
C 
Pacman_PDZ galK check 5`-GAGGATGGCTCCTTCATTG 5`-GCTTTAAATTCATGCGAG 
Pacman_PDZ galK seq 5`-CACTGAACAATTCCGCTGC 5`-GCAGACACTTAAAGCAGTT 
Pacman_FIGQY167 galK check 5`-AGCCACTTGCCGTTATAAG 5`-GGCAGTATTGATTTGCAT 
Pacman_FIGQY167 galK seq 5`-GTGTTCCTTGTTATGTGT 5`-AGTCGTGGTGTTTGCACTT 
Pacman_FIGQY180 galK check 5`-AACTGACGCATTTGCCAGG 5`-GCAGACACTTAAAGCAGTT 
Pacman_FIGQY180 galK seq 5`-CATATCATTTTGCACCGGC 5`-ACGATGCTCCACCCGATGCT 
P[acman] check (Nrg180FIGQY galK and 
mutations) 5`-AACTGACGCATTTGCCAGG 
5`-
GCAGACACTTAAAGCAGTT 
P[acman] seq(Nrg180FIGQY galK and 
mutations) 5`-CATATCATTTTGCACCGGC 
5`-
ACGATGCTCCACCCGATGCT 
P[acman] check (∆C) 5`-AACTGACGCATTTGCCAGG 5`-GCTTTAAATTCATGCGAG 
P[acman] seq (∆C) 5`-CATATCATTTTGCACCGGC 5`-GCAGACACTTAAAGCAGTT 
P[acman] check (∆PDZ) 5`-GAGGATGGCTCCTTCATTG 5`-GCTTTAAATTCATGCGAG 
P[acman] seq (∆PDZ) 5`-CACTGAACAATTCCGCTGC 5`-GCAGACACTTAAAGCAGTT 
P[acman] check (Nrg167∆FIGQY) 5`-AGCCACTTGCCGTTATAAG 5`-GGCAGTATTGATTTGCAT 
P[acman] seq (Nrg167∆FIGQY) 5`-GTGTTCCTTGTTATGTGT 5`-AGTCGTGGTGTTTGCACTT 
P[acman] check (Nrg∆Ig3/4) 5`-CGAGCTGAATGCCTTCAAG 
5`-
GGAGTTAACATTCAGAATG
ATGG 
P[acman] seq (Nrg∆Ig3/4) 5`- GATCCTGAGGGTAATCTCTG 5`-GTTATTCGATCGCTCCACTG 
pENTR/pUAST CG31701 (sequencing of 
complete ORF, primer 1-4) 
5`-GTTCCAAACTTCGGTGGAGC 
5`-CCTAAACGTTGTCGTTCC 
5`-CGAAGGTTTCAACGTCACC 
5`-GCGATCGATTTATGCGCAGG 
5`-
TTGGATTCCGCATCCGCCT 
5`-
GATGAGGCAGTGGTTGGAG 
5`-
GGTATAAGCAGCATTGGAG
G 
5`-
CTGATGCGCGGATTGCGCGT
G 
Forward and reverse primers PCR are listed to check the indicated constructs and to sequence vectors 
for final verification.  
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4.1.3. Pacman constructs generated in this study 
Table 13 - List of Nrg Pacman constructs generated in this study 
Pacman Integration site Transgenic flies 
CH321-4H20_ P[nrg180Y-F]  attP40 yes 
CH321-4H20_ P[nrg180Y-D]  attP40 yes 
CH321-4H20_ P[nrg180Y-A]  attP40 yes 
CH321-4H20_ P[nrg180∆FIQGY] attP40 yes 
CH321-4H20_ P[nrg180∆C] 
  attP
40 yes 
CH321-4H20_ P[nrg180∆PDZ] 
  attP
40 yes 
CH321-4H20_P[nrg167∆FIQGY]  attP40 yes 
CH321-4H20_ P[nrg∆Ig3/4] 
  attP
40 yes 
CH321-4H20_ P[nrg∆FERM] - no 
CH321-4H20_ P[nrg167/180∆FIQGY] - no 
Pacman mutations have been generated using recombineering. All constructs have been integrated 
into the some genomic locus using the attP40
4.1.4. cDNAs used in this study 
 landing site. No transgenic flies could be obtained from 
CH321-4H20_ P[nrg∆FERM] and CH321-4H20_ P[nrg167/180∆FIQGY]. 
Table 14 - List of the cDNA clones used in this study to generate pUAST constructs 
Name Vector Gene 
RE08554 pFLC1 CG31208 
pMT-neuroglian pRMHa3 Nrg180 
GH03573 pOT2 Nrg167 
cDNA clones used to generate pUAST constructs of Neuroglian180 and 167 isoform and CG31708. 
All are obtained from the Drosophila Genomics Resource Center. 
4.1.5. Vectors used in this study 
Table 15 - List of pENTR and pDEST vectors used in this study 
Name Project used 
pENTR/D-TOPO Uhu/Neuroglian 
pUAST-5xUAS-rfa Uhu/Neuroglian 
pUAST-5xUAS-rfa-EGFP Uhu/Neuroglian 
pUAST-10xUAS-rfa* Neuroglian 
pUAST-10xUAS-rfa-EGFP* Neuroglian 
pUAST-10xUAS-rfa-HA* Neuroglian 
pDEST17 Uhu 
pDEST-HisMBT Uhu 
pDEST-periHisMBT Uhu 
Vectors used for cloning of pENTR and pUAST constructs of Uhu and Neuroglian. * Not published 
vectors (submitted manuscript for details). 
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Table 16 - List of P[acman] constructs used in this study  
Name Gene of interest 
CH321-4H20 neuroglian 
CH321-92N22 CG31701 (uhu) 
CH321-50F13 CG31701 (uhu) 
All Pacman vectors used in this study to generate transgenic flies and to generate modifications. All 
Pacmans have been ordered at BACPAC resources center (BPRC). 
4.1.6. Web pages and programs 
Web pages used in this study 
Pubmed:   http://www.ncbi.nlm.nih.gov/pubmed/ 
Flybase:   http://flybase.org/ 
Student t-test:   http://www.physics.csbsju.edu/stats/t-test.html 
BLAST:   http://www.ncbi.nlm.nih.gov/blast/  
Bloomington:   http://flystocks.bio.indiana.edu 
VDRC:   http://stockcenter.vdrc.at 
Nigfly:   http://www.shigen.nig.ac.jp 
SMART:   http://smart.embl-heidelberg.de/ 
Expasy:   http://www.expasy.org/tools/ 
Pacman:   http://www.pacmanfly.org/ 
BPRC   http://bacpac.chori.org/ 
Hybridoma Bank:  http://dshb.biology.uiowa.edu/ 
DGRC:   https://dgrc.cgb.indiana.edu/ 
FMI:    http://iwww.fmi.ch/ 
Leo:    http://dict.leo.org/ 
Google:   http://www.google.ch 
Microsynth  http://www.microsynth.ch/ 
Pfam   http://pfam.sanger.ac.uk/ 
Phoebius  http://phobius.sbc.su.se/ 
Prosite   http://prosite.expasy.org/ 
Mobyle  hhtp://mobile.pasteur.fr 
ProteinArchitekt http://www.proteinarchitect.net 
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Programs used in this study 
Quantifications and evaluations: 
Microsoft Office (Excel) 
Image acquisition and processing: 
Adobe Design Standard CS4 (Photoshop CS, Adobe Illustrator CS4)  
ImageAccess (Imagic), Bitplane Imaris, Zeiss ZEN, FIJI (ImageJ, opensource) 
Molecular working:   
CLC Main Workbench5 
Presentations and Posters: 
Microsoft Office (Word, PowerPoint) 
Adobe Design Standard CS4 (Photoshop CS, Adobe Illustrator CS4) 
4.1.7. Media 
Dissecting saline 1x (1 l, no calcium) 4.08 g NaCl 
4.08 g MgCl2 6H2O 
0.36 g KCl 
1.2 g HEPES 
0.84 g NaHCO3 
39.2 g Sucrose 
40 ml EGTA (0.5M) 
Adjust to pH 7.0 with NaOH 
HL3 saline (0.5 l) 2.04 g NaCl 
0.186 g KCl 
2.03 g MgCl2 . 6H20 
0.42 g NaHCO3  
0.8 g Trehalose  
0.6 g HEPES 
19.6 g Sucrose 
Dissolve in 400 ml H2O (5/4x), adjust to pH 
7.2, prior to use add the following to the 
amount needed: 
20 mM MgCl2 
0.5 mM CaCl2 
Injection buffer (1 l) 1.2 g Tris 
Adjust to pH 8.0 
PBS 10x (1 l) 75.97 g NaCl 
9.94 g Na2HPO4 
4.14 g NaH2PO4 
Adjust to pH 7.0 autoclave 
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To make 10x PBT, add 
10 ml Triton X-100 
TBS 1x (1 l) 2.4 g Tris 
8.77 g NaCl 
Adjust tp pH 7.4, autoclave 
TBST 1x (1 l) 1 l TBS (1x) 
0.5 ml tween-20 
Mix and stir until completely dissolved 
M9 medium (1 l) 6 g Na2HPO4 
3 g KH2PO4 
1 g NH4Cl 
0.5 g NaCl 
autoclave 
M63 medium 5x (1 l) 10 g (NH4)2SO4 
68 g KH2PO4 
2.5 mg FeSO4·7H2O 
Adjust to pH 7.0 
M63 minimal plates (1 l) 15 g agar 
800 ml H2O 
Autoclave and cool down 
200 ml 5x M63 medium 
1 ml MgSO4-7H2O 
Cool down to 50 °C 
10 ml Carbon source (galactose or 2-deoxy-
galactose) 
5 ml biotin (0.2mg/ml) 
4.5 ml leucine (10 mg/ml) 
Add antibiotics and use 25 ml per plate 
Lysis buffer (1 l) 12 g Tris, pH 7.0 
37.2 g EDTA 
1% SDS 
Standard fly food (30 l) 130 g Fadenagar 
80 g USB agar 
Dissolve in 10 l hot water 
1070 g corn meal (in 2.5 l warm water) 
1070 g malt 
600 g treache (in 1.5 l warm water) 
270 g soy meal (in 2 l warm water) 
480 g try yeast 
Mix all ingredients and cook for 10 min, cool 
down to 72 °C 
64 g methyl hydroxyl benzoate (solved in 350 
ml ethanol) 
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105 ml propionic acid 
Apple juice plates (2 l) 24 g Sucrose 
60 g agar agar 
Autoclave an cool down 
40 ml 100% ethanol 
20 ml 100% acetic acid 
4.1.8. Chemicals 
All consumables and instruments used are from the following companies if not otherwise 
stated: 
VWR (Radnor, PA, USA), Invitrogen (Paisley, UK), Agilent Technologies (Santa Clara, CA, 
USA), Millipore (Bedford, USA), Carl Roth GmbH (Karlsruhe, Germany), Promega 
(Madison, WI, USA), Roche Diagnostics GmbH (Mannheim, Germany), Fisher Scientific 
(Waltham, MA, USA), Leica Microsystems GmbH (Solms, Germany), Carl Zeiss AG (Jena, 
Germany), Bio-Rad Laboratories GmbH (Munich, Germany), Sigma-Aldrich GmbH 
(Steinheim, Germany), Greiner Bio-One GmbH (Frickhausen, Germany), Eppendorf 
(Hamburg, Germany), MBI Fermentas (Vilnius, Lithuania,) New England Biolabs (Ipswich, 
USA)  
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4.2. Drosophila Methods 
4.2.1. Drosophila breeding 
Drosophila melanogaster were kept on standard fly food at 18-27 °C. Stock collection was 
kept at 18 °C, working stocks at RT. Crosses to establish stocks and experiments other than 
RNAi experiments were carried out at 25 °C, RNAi experiments at 27 °C. 
4.2.2. Drosophila genetics 
Crosses were performed using different marker and balancer combinations. The most 
common balancers used are FM6-act-GFP for the X-chromosome, Cyo-GFP or –Wee-P for 
the 2nd chromosome and TM6B for the 3rd chromosome. Female virgins were crossed to 
males and the outcome was screened for the right genotype. 
4.2.3. RNAi experiments at the larval NMJ 
The establishment of the genome wide RNAi library allows the knock down of any gene of 
interested (Dietzl et al., 2007). RNAi in Drosophila is cell autonomous (Van Roessel et al., 
2002) and can be triggered by the expression of a long double-stranded hairpin RNA 
(Kennerdell and Carthew, 2000; Martinek and Young, 2000). This construct is under the 
control of the UAS sequence and therefore can be expressed in a controlled temporal and 
spatial pattern via specific Gal4 driver lines. In this study virgins of the Gal4 line are crossed 
to males from the VDRC lines. Crosses were performed at 27°C and wandering L3 larvae 
were dissected. 
4.2.4. Design of the RNAi screen 
To identify novel cell adhesion molecules important for synapse development and stability I 
performed an unbiased RNAi screen at the Drosophila neuromuscular junction. Here I would 
like to describe the screening conditions in more detail. The Gal4 driver line elavC155-Gal4; 
UAS-dcr2; BG57-Gal4 was used to knock down genes of interest pre- and postsynaptically. 
Virgins have been collected from this stock and crossed to males from the respective RNAi 
stocks from the Vienna Drosophila RNAi Center (VDRC). Entire classes of cell adhesion 
molecules important for neuronal development have been screened. A detailed list of all 
VDRC lines can be found in the appendix in Table 17-24. All crosses were performed at 27 
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°C. Wandering 3rd instar larvae were dissected and stained for the presynaptic active zone 
marker Brp (Bruchpilot), postsynaptic glutamate receptors (DGluRIII) and the presynaptic 
membrane using Hrp. Three 3rd instar larvae were analyzed for the total number of retractions 
and notes about muscle and morphology phenotypes like protrusions were made. 
4.2.5. Genetic interaction experiments 
To test potential interactions between Nrg and other important genes at the larval NMJ, I 
combined the Pacman rescue assay with classical mutations. Therefore, I crossed females of a 
stable stock of the Pacman rescued Nrg null mutation nrg14 (nrg14; P[Nrgwt] and nrg14; 
P[Nrg180ΔFIGQY]) to males from the respective mutations. I analyzed male larvae selected 
based on the absence of specific balancers. A genetic interaction is considered if the 
retraction frequency in the nrg14; P[Nrg180ΔFIGQY] background is more than double the sum 
of the retraction frequencies of nrg14; P[Nrgwt] and nrg14; P[Nrg180ΔFIGQY] including SEMs  
((1.33 ± 0.91) + (8.12 ± 1.8) = 12.16 x 2 = 24.32).  
4.2.6. Generation of FRT recombinants 
Nrg14 null mutation females were crossed to the P[FRT19A] males. Female P[FRT19A]/nrg14 
were crossed to FM6GFP males. After pre-mating for 2 days on normal food flies were put 
on G418 (neomycin) containing food. Because of the neomycin resistance in P[FRT19A] 
only FRT19A positive flies survive. The food was melted in the microwave, cooled down and 
150 µl G418 (30 mg/ml stock solution) were added to 10 ml of food by stirring gently. The 
potential recombinant stocks were established and further selected based on the nrg14 
embryonic lethality. Loss of Nrg protein was checked using embryonic staining with 
Nrg180BP104. 
4.2.7. Generation of transgenic flies 
Transgenic flies were generated either in the lab or at specialized companies (BestGene, 
Drosophila embryo injection service, Chino Hills, CA, USA). DNA was prepared using the 
Qiagen MIDI Kit for pUAST constructs or the Macherey-Nagel BAC100 Kit for P[acman] 
constructs. P[acman] constructs are injected with a concentration of 10-15 ng/10 kB. 
Embryos of attPVK33 and attP40 were used for site specific integration using Phi-C31 integrase 
(Bateman et al., 2006). 30 min old embryos were dechorinated using 50% bleach and aligned 
on tape-extract covered cover slips. After drying for 3-5 min on air, the embryos were 
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covered with 10S Voltalef oil to protect embryos from drying out. The DNA mix was 
injected using the FemtoJet devise (Eppendorf). After injection the embryos were transferred 
to 18 °C until hatching. The hatched larvae were transferred to food vials and kept at 25 °C 
until hatching. The hatched flies were crossed to second or third chromosomal balancers 
(IF/CyO-WeeP or TM3/TM6B respectively) and progeny was screened for w+ positive flies. 
Transgenic stocks were established over the respective balancer. 
4.2.8. Preparation of genomic DNA 
Genomic DNA was prepared for the sequencing of transgenic Nrg Pacman flies. The 
following protocol was used: 
• 40-50 flies were frozen at -20 °C in 100 µl lysis buffer (see list of media 2.1.7) in a 1.5 ml 
eppendorf tube 
• Flies were homogenized using a pestle and 700 µl lysis buffer are added 
• Incubate at 60 °C for 30 min and invert several times 
• Add 150 µl 7.5 M KAc and incubate 30 min on ice 
• Centrifuge 30 min at 10 000 rpm 
• Transfer supernatant to a 1.5 ml eppendorf tube and centrifuge again 
• Transfer supernatant in a new tube containing 700 µl of isopropanol 
• Add 75 µl 2 M NaCl, mix gently and centrifuge at 13 000 rpm for 25 min at RT 
• Discard supernatant and wash with 300 µl 70% EtOH at 13 000 rpm for 5 min at RT 
• Dry pellet and resuspend in 40-100 µl RNAse-H2O (0.2 µg/ml) 
4.2.9. Dissection of larval NMJ 
3rd instar larvae were dissected in ice-cold standard dissecting saline (see list of Media 4.1.7.) 
under the stereo microscope using two forceps, a scissor (FST, Switzerland) and thin insect 
pins (Austerlitz, square meter 0.1 mm). The larvae were fixed ventral side up in the posterior 
and anterior part of the body using the insect pins. A small cut was made in the posterior part 
and the larvae were opened along the midline. Fatbody and organs were carefully removed to 
minimize the damage to the nervous system. Insect pins were used to open the larvae 
completely. Larvae were fixed using Bouins fixative for 2-3 min, washed in PBT and 
transferred to an eppendorf tube.  
4.2.10. Immunohistochemistry at larval NMJ 
See Material and Methods in the submitted manuscript 
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Uhu antibodies generated in this study: clones Uhu59G and Uhu 62D, 1:50 
4.2.11. Immunohistochemistry of whole mount embryos 
Flies were kept in cages for 2-3 days prior to embryo collection to accustom the flies to lay 
eggs on apple juice plates. For embryo collection depending on the age of embryos required, 
the embryos were aged accordingly. The following protocol was used to fix and stain 
embryos: 
Fixation 
• Embryos were washed from apple juice plates using PBT and collected in a mesh 
prepared tube 
• Embryos were dechorinated for  5-6 min with 50% NaOCl and washed with H2O to 
remove chloride 
• Embryos were transferred into a falcon tube using PBT  
• PBT was removed completely and 2.25 ml Heptane and 2.25 ml PBS and 500 µl 
Formaldehyde (37%) (4% FA) were added 
• Fixation for 20-30 min shaking at RT  
• The watery phase (lower phase) was removed and 2 ml methanol were added 
• Embryos were shaked intensively for 30 sec 
• The upper organic phase was removed, methanol added again and shortly shaked 
• Embryos are washed three times with methanol and three times with 96% ethanol 
 
AB staining 
• Embryos are washed 3 times 5min and 3 times 20 min with PBT at RT 
• Blocking with 10% goat serum/PBS for 1 hr at RT 
• Primary AB ON at 4 °C at least 15 h 
• 3x short and 3x 20 min washing with PBT at RT 
• Secondary AB 2 h at RT 
• 3x short and 3 times 20 min washing with PBT at RT 
• PBT is taken off and Vectashield H1000 was added (Vector Laboratories, inc. 
Burlingsame, CA 94010) as mounting medium 
 
4.2.12. Mosaic analysis with repressible cell markers (MARCM) 
The Nrg null mutation nrg14 was recombined with the P(neoFRT)19A  chromosome. The 
stock was crossed to P(hsFLP)1, P(neoFRT)19A, tubGal80; ok371-Gal4, UAS-CD8-GFP; 
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MKRS P(hsFLP)86E four days before the experiment. At the day of the experiment two 
hours of egg laying at 25 °C are followed by three hours at 25 °C. The embryos are then heat 
shocked for one hour at 38.5 °C to induce the flipase expression and shifted to 18 °C over 
night to slow down development. To increase the number of clones also two flipases (hsFLP1 
and hsFLP86) have been used. These two features led to a higher number of CD8-GFP 
positive motoneuron clones. The next day the embryos were shifted to 25 °C again and 
wandering female 3rd instar larvae were selected based on GFP positive patches in the brain 
and dissected as described before. Animals were stained with an rtCD8 antibody to visualize 
the motoneuron clones and different combinations of pre- and postsynaptic markers as stated 
in the experiments. 
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4.3. Molecular methods 
4.3.1. TOPO cloning 
Directional TOPO cloning was performed following the manufacturers protocol (Invitrogen). 
In brief, a PCR is performed with primers to produce a 5`-CACC overhang at the PCR 
product. The plasmid provided from the company has a 5`-GTGG overhang and a covalently 
bound Topoisomerase I. This ensures the right directionality of the pENTR clones. Colonies 
are screened using the primer m13fw and rev with the corresponding primers in the construct 
(Primer sequences listed in Table 6 and Table 7). After sequencing the pENTR clone is 
shuffled into the pUAST vector following the manufacturer protocol (Invitrogen). Obtained 
colonies have been checked using the SVrev primer or GFP rev primer and a corresponding 
forward primer within the construct (primer sequences listed in Table 6 and Table 12). 
4.3.2. Site-directed Mutagenesis 
The QuikChange Site-directed mutagenesis Kit (Statagene) was used to generate point 
mutations and small deletions following the manufacturer’s manual. In brief, primers 
containing the desired mutation were designed (list of primers in Table 9) and annealed to the 
plasmid. Pfu-Turbo DNA polymerase is used to extend and incorporate the mutagenic 
primers. DpnI digests parental DNA as it is specific for methylated DNA. DNA extracted 
from almost all E.coli strains is methylated and therefore susceptible for DpnI digestion. The 
mutagenised vectors are transformed into competent cells and checked for mutations using 
appropriate primer-pairs (primer sequences listed in Table 12). 
4.3.3  DNA preparation and purification 
DNA of pUAST constructs of CG31708 and Neuroglian are prepared either using the 
Quiagen Midi Kit or the Macherey and Nagel Mini Kit according to the manufacturers’ 
protocol in the manual. The only change to the protocols was the use of H2O instead of TE 
Buffer to elute the DNA. To purify fragments of digested DNA or PCR products the sample 
was run on an agarose gel and purified using the Gel purification kit from Quiagen using the 
manufacturers protocol. PCR products were also purified with the PCR-purification Kit if one 
clear single band could be obtained. Again H2O was used for the elution step. 
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4.3.4. Mutagenesis of P[acman] vectors using Recombineering 
A modified protocol from Søren Warming was used to generate mutations in the Nrg 
P[acman] CH321-4H20 via recombineering. In a first step the galK cassette is inserted into 
the P[acman] (primer sequences used to generate the galK constructs are listed in Table 10). 
This galK cassette is then substituted by an oligo or PCR product with homology flanking the 
cassette (Oligo sequences listed in Table 11). If the galK cassette is lost the bacteria are 
resistant to 2-deoxy-galactose (DOG). DOG is harmless until it gets phosphorylated by the 
galK and turns into 2-deoxy-galactose-1-phosphate, which is toxic. 
• galK primers are designed with 50 bp homology to the area flanking the target region for 
galK insertion.. Sequence underlined is from galK. Primers are listed in Table 10). 
• fw: 5` ----50 bp---- CCTGTTGACAATTAATCATCGGCA 
• rev: 5` ---- 50 bp (complementary strand) ---- TCAGCACTGTCCTGCTCCTT 
• Oligos with the desired point mutations or small deletions are designed Primers are listed 
in Table11. 
• P[acman] has been ordered from BPRC resources (vector: attB-P[acman]-CmR-BW, cells: 
SW102) 
• The galK cassette has been amplified using the primers designed above and a proof 
reading polymerase. 1-2 µl DpnI are added per 25 µl reaction and incubated at 37 °C for 1 
h to remove all plasmid DNA. The PCR product was purified on a gel. 
• Overnight culture (5 ml with 12.5 µg/ml chloramphenicol) of SW102 with the P[acman] 
are inoculated and incubated at 32 °C. 
• 500 µl overnight culture are diluted in 25 ml LB and incubated on 32 °C until the OD 
reaches 0.6 (app. 3-4 h). 
• Recombination events are induced in a waterbath via heat shock at 42 °C for exactly 15 
min, importantly cool down the culture immediately in a ice/waterbath slurry. 
• Cultures are transferred into 15 ml falcon tubes and pelleted using 5000 rpm at 0 °C for 5 
min. 
• 1 ml ice-cold ddH2O is added and the pellet is gently resuspended by swirling in the 
ice/waterbath slurry. No pipetting and vortexing should be done at this step. 9 ml ice-cold 
water are added and the bacteria are pelleted again. This step is repeated twice. 
• All supernatant is removed and cells are kept on ice until transformed. The following 
parameters are used for the transformation 25 mF, 1.75 kV and 200 ohms. After the 
transformation the cells are allowed to recover in 1 ml LB (15ml Falcon tube) for 1 h at 
32 °C. 
• After the recovery, the cells are washed twice with M9 salts: 1 ml culture is pelleted in a 
2 ml eppendorf tube at 13200 rpm for 15 sec. Supernatant is removed and pellet is 
resuspended in M9 again. This step is repeated 3 times in total. After the last washing the 
cells are diluted in a series in M9 salts (1:10 and 1:100) and plated on M63 minimal 
plates (see above). 
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• Plates are incubated for 3 days at 32 °C. 
• A few colonies are streaked on MacConkey + galactose + Choramphenicol indicator 
plates. GalK positive colonies appear to be bright red due to a pH change resulted from 
fermented galactose. This step is repeated in order to get a single colony. 
• 5 ml LB (Chloramphenicol) are inoculated with a single bright red colony and incubated 
over night at 32 °C. 
• The steps from above to obtain electrocompetent cells are repeated. 
• The oligos designed above are thaw and annealed in vitro after the following protocol: 10 
mg of each oligo are mixed with 100 µl PCR buffer. Mix is boiled for 5 min and cooled 
down to RT within 30 min (use PCR machine). 10 µl 3M NaAC and 250 µl EtOH are 
added for precipitation, the annealed oligos are pelleted via centrifugation and washed 
once with 70% EtOH. After air drying the pellet is resuspended in 100 µl H2O. 1-3 µl 
oligos are used per transformation (200 ng). 
• Bacteria are transformed and allowed to recover in 10 ml LB in 50 ml baffled conical 
flasks for 3-4 h. 
• The bacteria are washed using M9 salts there dilution are made (1:10, 1:100, 1:1000). The 
dilutions are plated on M63 minimal plates with glycerol, leucine, biotin, DOG and 
Chloramphenicol 
• Plates are incubated for three days at 32 °C 
• Colonies are screened by PCR directly or after miniprep 
• After a correct clone is isolated the DNA is transformed into EPI300 for induction of high 
copy numbers of the construct at 37 °C. 
 
4.3.5. DNA preparation of P[acman] construct 
The following protocol is used for the P[acman] miniprep: 
• 5ml overnight culture was pelleted for 5 min at 5000 rpm 
• Pellet is dissolved in 250 µl resuspension buffer and transferred into an eppendorf tube 
• Add 250 µl lysis buffer and mix immediately by inversion 
• Add 250 µl neutralization buffer and incubate after mixing for 5 min on ice 
• Clear the supernatant twice by centrifugation at 13200 rpm for 5 min 
• Precipitate DNA using 750 µl isopropanol, incubate 10 min on ice and centrifuge 10 min 
at 13 200 rpm. 
• Wash once with 70% ethanol and dry on air 
• Resuspend in 50 µl H2O 
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4.3.6. Induction of P[acman] constructs 
The EPI300 cells are special cells that can be induced to produce of a high copy number of 
the large Pacman constructs, which are normally on low copy number. To induce P[acman] 
constructs for DNA preparation in large scale the following two protocols were used.  
AutoFos induction solution 
• inocculate a  preculture (5 ml) during the day (7-8 hours, until approximately saturation) 
in LB with appropriate antibiotic. 
• Transfer 500 µl of preculture to 500 ml LB with appropriate antibiotic. 
• Add 1000 µl AutoFos Induction Solution (1:500) and induce overnight shaking for 17-18 
hours at 37 °C. 
 
CopyControl solution 
• Transfer 50 µl of preculture or single colony to 50 ml LB with appropriate antibiotic and 
let it shake for 17 hours overnight at 37 °C. 
• Next day, add the overnight culture to 450 ml LB with appropriate antibiotic and it induce 
for 5 hours at 37 °C shaking by adding 100 µl CopyControl Induction Solution (1:5000) 
• Transfer culture to centrifugation tube, spin for 15 min at ~5.500 rpm at 4 °C in rotor 
JA14 (4.600 g) and remove all LB. 
 
Store the pellet at -80 °C overnight (recommended for at least a little while) and proceed with 
the protocol as stated in the manual (Nucleobond, BAC 100, Macherey-Nagel). The 
following option has been used during the protocol. To clarify the suspension, the suspension 
was filtered through a NucleoBond Folded Filter and the lysate was not centrifuged before. 
Pellets were dissolved directly in injection buffer (Tris-HCl, pH 8.0). To confirm DNA 
quality a test restriction was made before injection. 
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4.4. Biochemistry 
4.4.1. Western Blot 
Larval brains from wandering L3 larvae were dissected and transferred into 2x sample buffer 
(Invitrogen). 5 brains per lane were analyzed on NuPage gels (Invitrogen) according to 
standard procedures. Primary antibodies were incubated overnight at 4 °C. Secondary Hrp-
conjugated goat anti-mouse and goat anti-rabbit antibodies were used at 1:10 000 (Jackson 
Immunoresearch) for 2 h at room temperature. Membranes were incubated with ECL 
substrate (SuperSignal West Pico Kit (Thermo scientific)) and subsequently exposed to on 
film (Fujifilm).  
Additional (to the submitted manuscript) antibodies used in the study: rtUhu59G, rtUhu62D, 
1:50 (test of expression in larval brains to test different clones of the antibody) 
4.4.2. Generation of Antibodies 
Monoclonal antibodies against Uhu were generated in the monoclonal facility of the FMI. 
• A Uhu fragment (amino acid 350-500) was cloned and transferred into the pDEST17 
vector for the expression of a His-tagged Uhu fragment 
• A first test induction revealed that the Uhu protein fragment was not soluble and could 
not be made soluble using modified version of the vector pDESTHisMBT and 
pDESTperiHisMBT (Austin et al., 2009; Nallamsetty et al., 2005) 
• The Uhu fragment was then solubilized under denaturating conditions using 5M Urea in 
0.1M TrisCl pH 8.5 
 
Induction of the protein expression: 
• Add 5 ml overnight culture to 250 ml fresh LB medium (Ampicilin) 
• Grow up to OD 600 
• Add 1mM IPTG and induce protein expression for 3-4 h 
• Harvest bacteria by centrifugation for 30 min at 4 °C with 5000rpm 
 
Purification of the protein: 
• The protein was purified using Ni-IDA columns (Protino) after the manufacturers 
protocol (buffers provided by the company) 
• To test protein expression samples of each step were collected and analyzed using 
coomassie staining 
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• Protein was dialyzed directly with ice-cold PBS over night and samples again analyzed 
on a Coomassie gel 
• Rats were immunized four (2nd time after 4 weeks, then 2 times in after another 4 weeks). 
An adjuvant was added to enhance the immune response the first two immunizations. 
 
Peptide antibodies were produced at Davids Biotechnologie (Regensburg, Germany). 
Peptides were synthesized using Festphasensynthese. High-performance liquid 
chromatography (HPLC) and mass spectrometry are used for quality controls and the purity 
is between 70-98% for immunizations.  Peptide antibodies are tested via Dot blots (protocol 
below) after delivery. 
4.4.3. Dot blots 
To analyze the specificity of the newly generated phospho antibodies, dot blots were 
performed using the following protocol: 
• The top layer of paper on top of the nitrocellulose is removed. Using a pencil and ruler, 
grids of 1 cm by 1cm are marked on the nitrocellulose.   
• The nitrocellulose membrane is placed in a petri-dish and 2-5 µl of  the peptide are applied to the membrane (phosphorylated and nonphosphorylated)  
• The dots are dried completely 
• The membrane is blocked with 5% skim milk (made in TBST) for 1 hour.  
• Then rinsed twice with TBST 1 min. each.  
• Primary antibody incubation: 10 ml total, primary antibody diluted to the appropriate 
concentration in TBST + 1% BSA at 4 °C over night.  
• Then rinsed twice with TBST 1 min. each.  
• Secondary antibody incubation for 2 h at RT 
• Then rinsed twice with TBST 1 min. each.  
• Membrane is rinsed again with TBS + 1% Triton X-100 30 min each and then developed 
to film 
• Nitrocellulose membrane was incubated with ECL substrate (SuperSignal West Pico Kit 
(Thermo scientific)) and subsequently exposed to on film (Fujifilm). 
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4.5. Microscopy 
4.5.1. Quantification of phenotypes 
Synaptic retractions were quantified using presynaptic Brp and postsynaptic DGluRIII 
staining by counting the number of unopposed postsynaptic footprints. The percentage of 
retractions was calculated and used to make the statistical analysis using the unpaired 
student`s t-test The classification to score the retraction severity was 1-3 bouton, 4-8 boutons, 
> 8 bouton and complete eliminations. Complete loss of presynaptic marker Brp was 
considered as elimination. 
Bouton area, number and NMJ length were quantified using Synapsin (Syn), Dlg and Hrp 
staining. Bouton area and NMJ length were quantified using the Image access (Imagic) 
measurement tool. For bouton area the Hrp staining was used to visualize the bouton area and 
10 A3 muscle 4 NMJ were quantified per genotype. To measure NMJ length 20 muscle 4 
NMJ (segment A3 and A4, 10 each) were analyzed for the length of the NMJ (overlap of Dlg 
and Hrp staining). Bouton number was quantified under the microscope using a two-color 
filter and the 40x objective. The number of Syn/Dlg varicosities was counted per NMJ in the 
segments A2-A6.  N is the number of NMJs scored. Numbers were normalized to wild type 
values. 
4.5.2. Image acquisition 
All images shown in this study are either taken at the Leica TCS SPE or the Zeiss LSM700 
confocal microscope. Usually, the 63x oil objective (HCX PL APO, aperture 1.4-0.6) was 
used however some overgrowth phenotypes required the usage of the 40x oil objective (HCX 
PL APO, aperture 1.25-0.75). The images were taken with a resolution of 1024 x 2056 pixels. 
4.5.3. Measurement of protein levels using FIJI 
To analyze protein levels at the NMJ a Macro for the open source tool FIJI was generated 
together with Laurent Gelman from the imaging facility of the FMI. Hrp is used as the mask 
as is surrounds the NMJ and the axon. Only protein levels within the masking area are used 
for measurements. Regions of interest (ROI) were defined in the masking channel and these 
ROIs were used in the quantifying channel to analyze the protein level. Depending on the 
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genotype measurements are made in the axon bundle passing muscle 4, the motoneuron axon 
going to muscle 4 or at individual boutons within the NMJ terminal.   
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5. Appendix 
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5.1. Abbreviations 
A  alanine 
aa  amino acid 
AEL  after egg laying 
AIS  axon initial segment 
ALS  amyotrophic lateral sclerosis 
ank  ankyrin 
AP  action potential 
 
BG  background 
BM  bristle mechanosensory 
bp  base pairs 
brp  bruchpilot 
 
C. elegans Caenorhabditis elegans 
CAM  cell adhesion molecule 
cDNA  complementary DNA 
CHL1  close homolog of L1 
CNS  central nervous system 
cora  coracle 
CRASH Corpus callosum hypoplasia, Retardation, Adducted thumbs, Spastic 
paraplegia, Hydrocephalus 
 
D  aspartate 
dcr2  dicer-2 
dda  dorsal dendritic arborization 
DGRC  Drosophila genome research center 
DNA  desoxy-ribonucleic acid 
DOG  2-desoxy-galactose 
Dpp  decapentaplegic 
Dscam  Down syndrome cell adhesion molecule 
 
ECL  enhanced chemi uminescence 
EGF  epidermal growth factor 
EGFP  enhancer green fluorescent protein 
EGFR  epidermal growth factor receptor 
EMS  ethyl-methanesulfonate 
EPL  extensor pollicus longus 
 
F  Fluorescence 
F  phenylalanine 
fasII  fasciclin2 
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FERM  F = 4.1 protein, E = ezrin, R = radixin, M = moesin 
FGFR  fibroblast growth factor receptor 
FMI  Friedrich Miescher Institute 
Fn  Fibronectin 
FRAP  Fluorescence recovery after photobleaching 
 
gbb  glass-bottom boat 
GF  giant fiber 
GPI  glycosyl-phosphatidyl-inositol 
 
h  hours 
hiw  highwire 
HPLC  high-performance liquid chromatography 
Hrp  horse radish peroxidase  
hts  hu-li tai shao 
 
Ig  immunoglobulin 
inc  insomniac 
IP  immunoprecipitation 
IP3  inositol triphosphate 
ISN  intersegmental nerve 
 
kb  kilobase 
kDA   kilo Dalton 
 
LB  luria bertani 
LGI  leucine-rich glioma inactivated 
LON  LAMP, OBCAM, Neurotrimin 
LRRTM leucine rich repeat transmembrane 
 
mad  mother against dpp 
MAPK  mitogen activated protein kinase 
MARCM mosaic analysis with repressible cell marker 
MASA  Mental retardation, Aphasia, Shuffling gait, Adducted thumbs 
med  medea 
MF  mobile fraction 
min    minute 
mus  muscle 
 
NCAM neural CAM 
neu  neuronal 
NgCAM neuron-glia cell adhesion molecule 
NGFR  neuronal growth factor receptor 
NMJ  neuromuscular junction 
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NrCAM NgCAM related CAM 
nrg  neuroglian 
NSH  Naphthylacetyl-spermin-trihydrochloride 
 
OD  optical density 
OP  ocelar pioneer 
ORF  open reading frame 
 
PBS  phosphate-buffered saline  
PCR  polymerase chain reaction 
pre  presynaptic 
 
RNAi  RNA interference 
ROI  region of interest 
rpm  rounds per minute 
RT  room temperature 
 
sax  saxophone 
SN   segmental nerve 
spec  spectrin 
SSR  sub 
 
TBS  Tris-buffered saline  
TGF  transforming growth factor 
tkv  thickveins 
TM  transmembrane 
TTM  tergo-tochanteral muscle 
 
UAS  upstream activating sequence 
VDRC  Vienna Drosophila RNAi center 
VNC  ventral nerve cord 
WB  western blot 
wit  wishful thinking 
Y  Tyrosine 
 
Physical units are used according to the système international d’unités.  
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5.2. RNAi lines used for screening 
5.2.1. Positive controls 
Table 17 - VDRC lines of the positive controls used in the RNAi screen 
Symbol Name Annotation ID Transformant ID Construct ID 
brp bruchpilot CG34146 21135 10046 
cac cacophony CG1522 5551 3326 
cpa capping protein alpha CG10540 18648 7009 
cpb capping protein beta CG17158 45668 9299 
chic chickadee CG9553 102759  
ena enabled CG15112 43056 8910 
Ephrin Ephrin CG1862 105139  
Gl Glued CG9206 3785 1455 
Glu-RIB Glutamate receptor IB CG4481 42891 3584 
GluRIIA Glutamate receptor IIA CG6992 101686 105437 
GluRIIB Glutamate receptor IIB CG7234 7878 917 
GluRIIC Glutamate receptor IIC CG4226 51438 796 
GluRIIE Glutamate receptor IIE CG31201 49547 16345 
hiw highwire CG32592 28163 14101 
Liprin-α Liprin-α CG11199 51707 7232 
Med Medea CG1775 19688 1483 
Mad Mothers against dpp CG12399 12635 4121 
Atpα Na pump α subunit CG5670 12330 3093 
nrv2 nervana 2 CG9261 2660 960 
ser serrate 
FlyBase Gene Report: 
Dmel\Ser 
27172 14453 
Syn Synapsin CG3985 46480 17037 
syt4 synaptotagmin CG10047 33317 2842 
tkv thickveins CG14026 3059 2549 
wg wingless CG4889 13351 5007 
α-Spec α Spectrin CG1977 25387/103709 9695/100689 
β-Spec β Spectrin CG5870 42053 11790 
5.2.2. Ig-domain proteins 
Table 18 - VDRC lines of Ig-domain proteins used in the RNAi screen 
Symbol Name Annotation ID Transformant ID Construct ID 
ama amalgam CG2198 22944 12733 
beat-Ia beaten path Ia CG4846 4544 1386 
beat-Ib beaten path Ib CG7644 101662 105368 
beat-Ic beaten path Ic CG4838 45873 64 
beat-IIa beaten path IIa CG14334 18990 2587 
beat-IIb beat-IIb CG4135 17815 6761 
beat-IIIa beat-IIIa CG12621 45866 15037 
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beat-IIIb beat-IIIb CG33179 4784 2557 
beat-IIIc beat-IIIc CG15138 27137 6812 
beat-IV beat-IV CG10152 52413 16933 
beat-Va beat-Va CG10134 35715 13423 
Beat-Vb Beat-Vb CG31298 17832 6774 
beat-Vc beat-Vc CG14390 22736 12847 
beat-VI beat-VI CG14064 27205 14468 
boi brother of iHog CG32796 869 60 
bt bent CG32019 46252 14482 
btl breathless CG32134 27106 14439 
CG11320 CG11320 CG11320 18054 7268 
CG12484 CG12484 CG12484 25576 10005 
CG12950 CG12950 CG12950 10011 2880 
CG14141 CG14141 CG14141 43017 8239 
CG14372 CG14372 CG14372 16636 5643 
CG14521 CG14521 CG14521 104056 112589 
CG14964 CG14964 CG14964 43603 8498 
CG16857 CG16857 CG16857 24479 101 
CG17839 CG17839 CG17839 36314 14436 
CG31190 CG31190 CG31190 6685 74 
CG31431 CG31431 CG31431 1128 93 
CG31646 CG31646 CG31646 100781 108592 
CG31708 CG31708 CG31708 38261 6597 
CG31714 CG31714 CG31714 7654 1052 
CG32387   1100 111 
CG33515 CG33515 CG33515 30093 14652 
CG33543 CG33543 CG33543 17859 67 
CG34371 - CG34371 44997 2175 
CG3624 CG3624 CG3624 956 90 
CG3624 CG3624 CG3624 36304 14416 
CG4814   42353 15074 
CG6490 CG6490 CG6490 6683 73 
CG6490 CG6490 CG6490 24477 73 
CG7607 CG7607 CG7607 9208 3870 
CG8964 CG8964 CG8964 29908 14400 
cont contactin CG1084 28294/40613 12610 
dpr 
defective proboscis 
extension response CG13439 33816 15383 
dpr10 dpr10 CG32057 18919 6130 
dpr11 dpr11 CG33202 23243 13301 
dpr12 dpr12 CG34385 44740 15133 
dpr13 dpr13 CG33996 17667 8347 
dpr14 dpr14 CG10946 8005 2594 
dpr15 dpr15 CG10095 46244 16391 
dpr16 dpr16 CG12591 31986 7769 
dpr17 dpr17 CG31361 8481 2937 
dpr18 dpr18 CG14948 983 96 
dpr19 dpr19 CG13140 42789 1065 
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dpr2 dpr2 CG33507 29741 15154 
dpr20 dpr20 CG12191 15254 5971 
dpr3 dpr3 CG33516 25110 9000 
dpr4 dpr4 CG33512 28518 13088 
dpr6 dpr6 CG14162 41161 4836 
dpr7 dpr7 CG33481 46216 16254 
dpr8 dpr8 CG32600 39203 14664 
dpr9 dpr9 CG33485 38690 7773 
Dscam 
Down syndrome cell 
adhesion molecule CG17800 3115 2596 
ed echinoid CG12676 938 79 
elav 
embryonic lethal, 
abnormal vision CG4262 37915 5206 
Fas1 Fasciclin 1 CG6588 23015 12817 
Fas2 Fasciclin 2 CG3665 8392 2579 
Fas3 Fasciclin 3 CG5803 42231 14367 
fra frazzled CG8581 6557 68 
fred friend of echinoid CG31774 33298 2574 
hbs hibris CG7449 9471 70 
hig hikaru genki CG2040 13266 5279 
htl heartless CG7223 27180 14457 
iHog interference Hedgehog CG9211 29897 14317 
ImpL2 
Ecdysone-inducible gene 
L2 CG15009 30930 6004 
kek1 kekkon-1 CG12283 36252 14381 
kek2 kekkon-2 CG4977 42449 9 
kek5 kekkon5 CG12199 1401 36 
kek6 kek6 CG1804 19184 8810 
kirre kin of irre CG3653 27227 14476 
klg klingon CG6669 36162 14314 
Lac Lachesin CG12369 35524 12649 
lea leak/Robo2 CG5481 11823 109 
Nrg Neuroglian CG1634 6688 82 
nrm neuromusculin CG8779 979 94 
Nrx-IV Neurexin IV CG6827 8353 2436 
Ppn Papilin CG33103 16523 6325 
PQBP-1 
Poly-glutamine tract 
binding protein 1 CG31369 28752 13399 
Pxn Peroxidasin CG12002 15276 5987 
robo roundabout CG13521 47921 14414 
robo3 robo3 CG5423 44702 14351 
Ror Ror CG4926 935 40 
rst roughest CG4125 951 86 
sdk sidekick CG5227 9437 2553 
sev sevenless CG18085 49924 3307 
side sidestep CG31062 1283 321 
sls sallimus CG1915 47301 9680 
sns sticks and stones CG33141 877 65 
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tutl turtle CG15427 3064 2558 
unc-5 unc-5 CG8166 8138 3510 
vn vein CG10491 50358  
wrapper wrapper CG10382 101567  
  CG13992 2642  
 CG15744  4800  
  CG13532 12848  
  CG5597 12875  
     
  CG13672 23488  
  CG33274 25365  
  CG30171 29412  
  CG13134 29729  
  CG34353 29845  
  CG31619 33102  
  CG5699 34517  
  CG31970 37842  
  CG15630 37843  
  CG34114 38809  
  CG15354 40821  
  CG16974 42226  
  CG34391 42353  
 CG8434 lambik 43898  
 CG11136 tartan/caps -like 44991 14419 
  CG14583 49553  
  CG15312 101286  
  CG31369 102322  
  CG13020 104044  
5.2.3. LRR-proteins 
Table 19 - VDRC lines of LRR-domain proteins used in the RNAi screen 
Symbol Name Annotation ID Transformant ID Construct ID 
caps capricious CG11282 3046 2530 
 CG10148  44841  
 CG10255  18600  
 CG10307  27150  
 CG11099  9272  
 CG11136 tartan/caps -like 44991 14419 
 CG11280 tartan 5242 2450 
 CG11807  38564  
 CG11910  14737  
 CG13125  17123  
 CG13487  44532  
 CG13708  17690  
 CG14185  32097  
 CG14351 tartan/caps -like 36220 14353 
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 CG14662  8472  
 CG14762  31014  
 CG1484  39528  
 CG14995  12725  
 CG1504  18513  
 CG15151 rdo 107213  
 CG15658  3040 2509 
CG15744 CG15744 CG15744 1096  
 CG17319  8384 2518 
 CG17335 CG1644 32691  
 CG17667  36144 14305 
 CG18024  16588  
 CG18095  886 1 
 CG18249  3816 2519 
 CG18480  1071 26 
 CG3040  19219  
 CG3095  14524  
 CG31076  28776  
 CG31635  33979  
 CG32085  34053  
 CG32372  18977  
 CG32687  20819  
 CG3408  36306 14429 
 CG3413  37209  
 CG3494  24760  
 CG3980  34773  
 CG4054  1702  
 CG4781  7605 2215 
 CG4950  9931 1664 
 CG5096  27060 14378 
 CG5195  31044  
 CG5407  27410  
 CG5490 toll precursor 100078  
 CG5528 Toll-9 36308 14431 
 CG5784  49386  
 CG5810  44988  
 CG5819  27076 14412 
 CG5820 Gp150 900 10 
 CG5851  42051  
 CG5888  12413  
 CG6098  27567  
 CG6590/32055  6335  
 CG6860  7306  
 CG6890 Toll, Tak1 9431 2510 
 CG7121 Tehoa, Toll-5 17903 2534 
 CG7250 Toll-6 27102 14438 
 CG7457  26740  
 CG7503  17898  
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 CG7509  51584  
 CG7702 connectin like 1059 21 
 CG7800  6673 2520 
 CG7896 tartan/caps -like 36343 14469 
 CG8272  24262  
 CG8561  44361  
 CG8595 Toll-7 24473 16 
 CG8930  904  
 CG9031  42188  
 CG9044  42193  
lbk lambik CG8434 4319 71 
5.2.4. Cadherins 
Table 20 - VDRC lines of all Cadherins used in the RNAi screen 
Symbol Name Annotation ID Transformant ID Construct ID 
 CG1744  108053  
stan starry night CG11895 1665 607 
shg shotgun CG3722 27081 14421 
Ret Ret oncogene CG14396 843 45 
lbm late bloomer CG2374 7937 1843 
ft fat CG3352 9396 881 
fat2 fat2 CG7794 35275 12286 
ds dachsous CG17941 4312 2646 
CG4655 CG4655 CG4655 26587 11388 
Cad74A Cad74A CG6445 36320 14440 
Cad86C Cad86C CG4509 3744 158 
Cad87A Cad87A CG6977 8578 3637 
Cad87A   49325 17452 
Cad88C Cad88C CG3389 36164 14315 
Cad89D Cad89D CG14900 36331 14455 
Cad99C Cad99C CG31009 3733 151 
CadN Cadherin-N CG7100 1092 161 
CadN2 CadN2 CG7527 36166 14316 
cals calsyntenin-1 CG11059 36348 14484 
5.2.5. Integrins 
Table 21 - VDRC lines of all Integrins used in the RNAi screen 
Symbol Name Annotation ID Transformant ID Construct ID 
if inflated/aPS2 CG9623 44885 1175 
mew 
multiple edematous 
wings 
CG1771 44890 1230 
mew/aPS1 
multiple edematous 
wings 
CG1771 5671 1230 
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mys myospheroid CG1560 29619 15002 
scb scab CG8095 4891 2006 
αPS4 αPS4 CG16827 37172 2007 
αPS5 αPS5 CG5372 6646 2181 
βInt-ν βν integrin CG1762 893 7 
5.2.6. Laminins 
Table 22 - VDRC lines of all Laminins used in the RNAi screen 
Symbol Name Annotation ID Transformant ID Construct ID 
crb crumbs CG6383 39177 14463 
drpr draper CG2086 27086 14423 
LanA Laminin A CG10236 18873 6022 
LanB1 Laminin B1 CG7123 23119 13179 
LanB2 Laminin B2 CG3322 42559 2394 
NetB Netrin-B CG10521 - 3356 
Nrx-1 Neurexin-1 CG7050 36328 14451 
trol 
terribly reduced optic 
lobes 
CG33950 22642 12341 
wb wing blister CG15288 3141 1560 
5.2.7. Semaphorins 
Table 23 - VDRC lines of all Semaphorins used in the RNAi screen 
Symbol Name Annotation ID Transformant ID Construct ID 
Sema-1a Sema-1a CG18405 36148 14307 
Sema-1b Sema-1b CG6446 107233 104666 
Sema-2a Sema-2a CG4700 15810 5476 
Sema-5c Semaphorin-5c CG5661 9429 2501 
plexA plexin A CG11081 4740 2499 
plexB plexin B CG17245 8382 2500 
dsd distracted CG5634 1106 135 
CG7166 CG7166 CG7166 27116 14443 
CG7466 CG7466 CG7466 42462 138 
CG33960 CG33960 CG33960 48056 16812 
5.2.8. Cell adhesion molecule interaction proteins 
Table 24 - VDRC lines of all CAM interaction proteins used in the RNAi screen 
Symbol Name Annotation ID Transformant ID Construct ID 
18w 18 wheeler CG8869 963 17 
arm armadillo CG11579 7767 1372 
baz bazooka CG5055 2914 1384 
boss bride of sevenless CG8285 4365 292 
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cno canoe CG2534 7769 1395 
CG18146 CG18146 CG18146 3120 2622 
CG32810 CG32810 CG32810 18225 7621 
CG7422 CG7422 CG7422 27997 12232 
CG8942 CG8942 CG8942 40747 14386 
cora coracle CG11949 9788 1405 
crq croquemort CG4280 45883 784 
Csp Cysteine string protein CG6395 34167 10571 
Dl Delta CG3619 3720 146 
dlg1 discs large 1 CG1725 2612 855 
dsh dishevelled CG18361 101525 108967 
Dg Dystroglycan CG18250 107029 100828 
eag ether a go-go CG10952 9127 3363 
fas faint sausage CG17716 42236 14405 
fz frizzled CG17697 43075 4614 
fz2 frizzled 2 CG9739 26928 13804 
fz3 frizzled 3 CG16785 30214 3174 
fz4 frizzled 4 CG4626 5451 3269 
Gli Gliotactin CG3903 37116 1735 
Glt Glutactin CG9280 15429 5017 
Glu-RI Glutamate receptor I CG8442 44438 3582 
grk gurken CG17610 3121 2624 
in inturned CG16993 26133 10892 
Nrt Neurotactin CG9704 8495 3597 
N Notch CG3936 27229 14477 
ppk12 pickpocket 12 CG10972 105131 101805 
Psn Presenilin CG18803 43083 4624 
santa-maria 
scavenger receptor acting 
in neural tissue and 
majority of rhodopsin is 
absent 
CG12789 33153 969 
scrib scribbled CG5462 27424 11663 
shakB shaking B CG34358 24578 7794 
shi shibire CG18102 3799 1529 
sli slit CG8355 38233 5822 
syt synaptotagmin CG3139 8875 842 
sdc syndecan CG10497 13322 4545 
Ten-a Tenascin accessory CG32659 8322 3330 
Ten-m Tenascin major CG5723 51173 3620 
trp 
transient receptor 
potential 
CG7875 1365 372 
 172 
5.3. Supplementary Figures and data summaries 
5.2.1. Supplementary data of the RNAi screen 
Table 25 - Top10 Hits of the RNAI screen based on the number of retractions 
ranking VDRC 
line 
name # of retraction/ 
3 animals 
Small retraction/ 
big retractions 
Class of proteins 
1 107991 nrg 62 24/38 Ig-domain 
2 38261* CG31708 - - Ig-domain 
3 18225 inc 60 47/13 CAM interaction 
4 9788 cora 42 26/16 CAM interaction 
5 31044 CG5536 37 25/12 LRR 
6 23243 CG33202 30 24/6 Ig-domain 
7 35275 CG7794 25 17/8 LRR 
8 107450 lac 23 17/6 Ig-domain 
9 9787 cora 23 13/10 CAM interaction 
10 27424 scrib 23 20/3 CAM interaction 
Ranking of the Top10 hits based on the number of retractions (* lethal after pre- and postsynaptic 
knock down thus not analyzed during the screen). The name of the gene is included if the gene is 
characterized otherwise the CG number is shown. The symbol is used instead of the full name (nrg= 
neuroglian, inc = insomniac, cora = coracle, lac = lachesin, scrib = scribbled). All muscles of three 
animals have been analyzed for synaptic retractions. This number was then separated in two 
categories of small (1-3 boutons) and big (4 or more boutons) retractions as. The numbers indicate the 
number of small and big retractions observed in three animals (all muscles analyzed). The last column 
indicates the class of CAMs to which the hit belongs based on Table 3. 
 
5.3.1. Supplementary data of Neuroglian 
5.3.1.1. Supplementary data of retraction 
 Table 26 - Quantification of retractions during development 
Retraction frequency [%] 
UAS stage Gal4 mu 4 mu 6/7 mu 12 mu 13 n 
RNAi1 L2 ed/neu3 28.00 ± 4.90 8.00 ± 4.16 7.00 ± 3.35 8.00 ± 3.27 10 
 earlyL3 ed/neu3 48.46 ± 4.78 23.07 ± 4.58 17.69 ± 5.21 22.31 ± 5.45 13 
 L3 ed/neu3 63.85 ± 3.32 44.5 ± 4.78 27.0 ± 3.41 35.65 ± 3.86 20 
Legend: RNAi1 = VDRC6688, Gal4 drivers: neu2 = elavC155-Gal4; UAS-dcr2, n = numbers of 
analyzed animals, numbers represent values ± SEM. 
 173 
Table 27 - Quantification of retractions after postsynaptic RNAi in Pacman background 
Genotype mu4 mu6/7 mu12 mu13 n 
nrg14/y; P[Nrgwt] 1.33 ± 0.91 0.67 ± 0.67 0.0 ± 0.00 0.0 ± 0.00 15 
nrg14/y; P[Nrg180∆FIQGY] 8.12 ± 1.81 11.70 ± 2.20 7.41 ± 1.60 6.25 ± 1.22 28 
nrg14/y; P[Nrgwt] mus3 RNAi2 0.0 ± 0.0 8.33 ± 3.07 0.0 ± 0.00 0.0 ± 0.00 6 
nrg14/y; P[Nrg180∆FIQGY] mus3 
RNAi2 
27.78 ± 4.65 24.44 ± 5.56 36.67 ± 5.27 10.00 ± 2.89 9 
Legend: P value is in comparison to nrg14/y; P[Nrgwt] (unpaired student`s t-test), RNAi2
 
 = 
VDRC107991, n = number of analyzed animals, numbers represent values ± SEM. 
Table 28 - Quantification of Nrg glial RNAi 
UAS Gal4 mu4 mu6/7 mu12 mu13 n 
ctrl repo 0.77 ± 0.77 0.00 ± 0.00 0.77 ± 0.77 0.77 ± 0.77 13 
Nrg RNAi1 repo 15.22 ± 3.06 2.67 ± 1.53 1.33 ± 0.91 15.48 ± 2.93 15 
Nrg RNAi1 dcr2; repo 28 ± 3.74 6.00 ± 4.00 6.00 ± 4.00 0.00 ± 0.00 5 
Ank1 RNAi repo 4.17 ± 1.49 6.66 ± 2.84 2.5 ± 1.79 0.83 ± 0.83 12 
Legend: ctrl = w1118 x repo-Gal4, RNAi1
5.3.1.2. Supplementary data of growth related phenotypes 
 = VDRC6688, P values are in comparison to the ctrl (all 
unpaired student`s t-test), n = number of analyzed animals, numbers represent values ± SEM. 
 
Table 29 - Quantification of growth defects after Nrg RNAi 
UAS Gal4 Bouton number P n 
Ctrl  16.6 ± 0.38  123 
RNAi1 e/neu1 18.36 ± 0.57 0.013 50 
RNAi1 eo/neu2 20.45 ± 0.60 ≤ 0.0001 75 
Legend: ctrl=w1118, P values are in comparison to the ctrl (all unpaired student`s t-test). Gal4 
drivers: neu1= elavC155-Gal4, neu2=elavC155-Gal4; ok371-Gal4, RNAi1 = VDCR line 6688, n= number 
of analyzed muscle 4 NMJ, numbers represent values ± SEM. 
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Table 30 - Quantification of protrusions in Nrg RNAi animals 
UAS Gal4 % mu 4 NMJ with protrusions P # of protrusions/NMJ P n 
ctrl eo/neu2 7.5 ± 1.64  0.075 ± 0.03  8 
RNAi1 eo/neu2 38.39 ± 7.09 0.0062 0.42 ± 0.06 ≤0.0001 16 
RNAi2 eo/neu2 48.63 ± 6.23 ≤0.0001 0.62 ± 0.07 ≤0.0001 14 
ctrl dB/mus2 10 ± 1.74  0.1 ± 0.03  12 
RNAi1 dB/mus2 46.36 ± 5.27 ≤0.0001 0.65 ± 0.08 ≤0.0001 11 
Legend: ctrl=w1118 x elavC155-Gal4; ok371-Gal4 or UAS-drc2; BG57-Gal4, P values are in 
comparison to the ctrl (all unpaired student`s t-test). Gal4 drivers: neu2 = elavC155-Gal4; ok371-Gal4, 
mus2 
Table 31 - Quantification of protrusions in Pacman rescued animals 
= UAS-dcr2; BG57-Gal4, n = number of analyzed animals, only stable NMJs were included, 
numbers represent values ± SEM. 
Pacman % mu 4 NMJ with protrusions P n 
nrg14/y; P[Nrgwt] 7.78 ± 3.64  9 
nrg14/y; P[Nrg180∆FIQGY] 37.64 ± 6.10 0.0009 11 
Legend: P value is in comparison to nrg14
Table 32 - Quantification of Nrg hypomorphic mutations 
/y; P[Nrgwt] (unpaired student`s t-test), n = number of 
analyzed animals, numbers represent values ± SEM. 
Retraction frequency [%] 
Genotype mu4 p mu6/7 mu12 mu13 n 
w1118 1.3 ± 0.66  2.4 ± 0.87 0.4 ± 0.4 0.4 ± 0.4 25 
nrg849/849 2.5 ± 1.64 0.39 3.75 ± 2.63 0 ± 0 1.25 ± 1.25 8 
nrg14/849 3.85 ± 1.85 0.1 3.85 ± 1.40 0 ± 0 1.54 ± 1.04 13 
nrg305/305 9.23 ± 2.39 0.0002 12.31 ± 2.57 3.08 ± 1.33 6.15 ± 1.8 13 
nrg305/14 15.83 ± 3.36 ≤ 0.0001 20 ± 3.26 4.17 ± 1.93 2.5 ± 1.80 12 
Growth defects (real numbers) 
Genotype NMJ length (n=20) p bouton area 
(n=10) 
p bouton number p n 
w1118 106.93 ± 4.36  6.95 ± 0.32  16.6 ± 0.38  123 
nrg849/849 99.72± 5.28 0.3 4.48 ± 0.23 ≤ 0.0001 18.42 ± 0.77 0.021  
nrg14/849 112.33 ± 6.36 0.48 4.25 ± 0.23 ≤ 0.0001 19.46 ± 0.69 ≤ 0.0001  
nrg305/305 131.85 ± 6.67 0.0034 4.43 ± 0.17 ≤ 0.0001 26.67 ± 0.71 ≤ 0.0001 146 
nrg305/14 154.24 ± 8.03 ≤ 0.0001 3.88 ± 0.18 ≤ 0.0001 26.95 ± 0.77 ≤ 0.0001 144 
Legend: P values are in comparison to w1118 (all unpaired student`s t-test), nretractions = number of 
animals (segments A2-A6 were scored in each animal), nboutonnumber = number of NMJ (segments A2-
A6 were scored in each animal), nNMJlength = number of NMJ (segments A3 and A4, 10 each), nboutonarea 
= number of NMJ (segment A3), numbers represent values ± SEM. 
 175 
Table 33 - Quantification of growth after Nrg overexpression 
UAS Gal4 Bouton number p n 
Ctrl  16.6 ± 0.38  123 
UASnrg180wt_EGFP ok371 17.06 ± 0.38 0.061 118 
UASnrg180∆FIGQY_EGFP ok371 30.89 ± 0.69 ≤ 0.0001 114 
Legend: ctrl = w1118
5.3.1.3. Supplementary data of genetic interaction experiments 
 x ok371-Gal4, P values are in comparison to ctrl (all unpaired student`s t-test). n 
= number of NMJs analyzes (segment A2-A6 were scored for each animal). Numbers represent values 
± SEM. 
Table 34 - Quantification of retractions in genetic interaction experiments with Ank2 
and α-Spectrin 
Retraction frequency [%] 
Genotype mu 4 P mu 6/7 mu 12 mu 13 n 
w1118 1.30 ± 0.66  2.40 ± 0.87 0.4 ± 0.4 0.40 ± 0.40 25 
nrg14/y; P[Nrgwt]/+ 1.33 ± 0.91 0.9 * 0.67 ± 0.67 0.00  ± 0.00 0.00  ± 0.00 15 
nrg14/y; P[Nrg180∆FIQGY] 8.12 ± 1.81 0.012 
11.70 ± 
2.20 
7.41 ± 1.60 6.25 ± 1.22 28 
nrg14/y; P[Nrgwt]/+; ank2518/+ 3.75 ± 1.83 0.2 5.00 ± 2.67 1.25 ± 1.25 3.75 ± 1.83 8 
nrg14/y; P[Nrg180∆FIQGY]/+; 
ank2518/+ 
27.86 ± 2.81 ≤ 0.0001 27.86 ± 4.71 16.43 ± 3.41 17.86 ±  4.22 14 
nrg14/y; P[Nrgwt]/+; α-specrg41/+ 6.15 ± 2.13 0.038 10.77 ± 3.83 1.54 ± 1.54 5.38 ± 2.43 13 
nrg14/y; P[Nrg180∆FIQGY] /+; α-
specrg41/+ 
33.33 ± 4.60 ≤ 0.0001 30.48 ± 4.39 15.24 ± 2.98 8.75  ± 2.10 21 
Legend: p value is in comparison to nrg14/y; P[Nrgwt] p* = in comparison to w1118
Table 35 - Quantification of retraction in genetic interaction experiments 
 (unpaired 
student`s t-test), n = number of analyzed animals, numbers represent values ± SEM. 
Genotype mu 4 mu 6/7 mu 12 mu 13 n 
w1118 1.30 ± 0.66 2.40 ± 0.87 0.4 ± 0.4 0.40 ± 0.40 25 
nrg14/y; P[Nrgwt] 1.33 ± 0.91 0.67 ± 0.67 0.0  ± 0.0 0.0  ± 0.0 15 
nrg14/y; P[Nrg180∆FIQGY] 8.12 ± 1.81 11.70 ± 2.20 7.41 ± 1.60 6.25 ± 1.22 28 
nrg14/y; P[Nrgwt]/+; witB11/+ 15.0 ± 4.28 20.00 ± 8.56 11.67 ± 6.54 6.67 ± 3.33 6 
nrg14/y; P[Nrg180∆FIQGY] /+; witB11/+ 19.10 ±  4.56 17.27 ± 3.59 12.72 ± 3.83 10.0 ± 3.30 11 
nrg14/y; P[Nrgwt]/+; witA12/+ 10.0 ± 4.71 9.00 ± 3.59 7.00 ± 2.60 3.00 ± 2.13 10 
nrg14/y; P[Nrg180∆FIQGY] /+; witA12/+ 20.0 ±  3.05 22.73 ± 5.83 14.54 ± 3.40 5.45 ± 2.07 11 
nrg14/y; P[Nrgwt]/mad1-2 5.0  ± 3.42 7.0 ± 2.13 0.0 ± 0.0 4.22 ± 1.33 10 
nrg14/y; P[Nrg180∆FIQGY]/mad1-2 10.0 ± 4.08 15.0 ± 6.46 2.5 ± 2.5 5.00 ± 2.89 4 
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nrg14/y; P[Nrgwt]/madk237 2.85 ± 1.84 4.29 ± 2.02 0.00 ± 0.00 7.14 ± 2.86 7 
nrg14/y; P[Nrg180∆FIQGY]/mad k237 20.0 ± 2.89 26.67 ± 5.00 24.44 ± 4.12 6.67 ± 2.36 9 
nrg14/y; P[Nrgwt]/tkv1 4.45 ± 2.07 4.45 ± 3.11 0.91 ± 0.91 0.91 ± 0.91 11 
nrg14/y; P[Nrg180∆FIQGY]/tkv1 42.22 ± 4.94 43.33 ± 4.71 30.00 ± 5.00 27.78 ± 3.64 9 
Genotype mu 4 mu 6/7 mu 12 mu 13 n 
tkv1/tkv1 0.9 ± 0.9 1.81 ± 1.81 0.0 ± 0.0 0.0 ± 0.0 11 
witB11/+ 2.5 ± 1.64 8.75 ± 2.95 0.0 ± 0.0 1.25 ± 1.25 8 
witA12/+ 4.0 ± 2.21 7.0 ± 3.0 1.0 ± 1.0 0.0 ± 0.0 10 
nrg14/+ 5.87 ± 2.08 8.57 ± 3.4 0.0 ± 0.00 2.86 ± 1.84 7 
Legend: n = number of analyzed animals, numbers represent values ± SEM. 
Table 36 - Quantification of bouton number in genetic interaction experiments 
Genotype Bouton number P n 
w1118 16.6 ± 0.38  123 
nrg14/y; P[Nrgwt] 15.74 ± 0.50 0.17* 98 
nrg14/y; P[Nrg180∆FIQGY] 29.30 ± 0.90 ≤ 0.0001 112 
nrg14/y; P[Nrgwt]/+; ank2518/+ 16.68  0.49 0.19 76 
nrg14/y; P[Nrg180∆FIQGY]/+; ank2518/+ 31.68  1.38 0.14** 56 
nrg14/y; P[Nrgwt]/+; witB11/+ 23.37 ± 0.73 ≤ 0.0001 70 
nrg14/y; P[Nrg180∆FIQGY] /+; witB11/+ 38.04 ± 1.38 ≤ 0.0001** 46 
Legend: P values are in comparison to nrg14/y; P[Nrgwt] , P* = in comparison to w1118 , P** = in 
comparison to nrg14/y; P[Nrg180∆FIGQY
5.3.1.4. Supplemental data to Uhu 
] (all unpaired student`s t-test), n = number of analyzed NMJs 
(segment A2-A6 were scored per animal), numbers represent values ± SEM. 
Table 37 - Quantification of retractions after uhu RNAi 
Retraction frequency [%] 
VDRC stage Gal4 mu 4 mu 6/7 mu 12 mu 13 n 
38261 L2 eo/neu2 1.11 ± 1.11 2.22 ± 2.22 1.11 ± 1.11 0.0 ± 0.00 9 
38261 early L3 eo/neu2 0.0 ± 0.0 8.0 ± 3.74 6.0 ± 2.45 2.0 ± 2.0 5 
38261 L3 eo/neu2 0.0 ± 0.0 52.83 ± 5.72 40.0 ± 5.77 41.67 ± 4.77 6 
Legend: VDRC38261 targets CG31708, Gal4 driver line = neu2 = elavC155-Gal4; ok371-Gal4, n = 
number of analyzed animals (segment A2-A6 were scored per animal), numbers represent values ± 
SEM. 
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Table 38 - Summary of SignalP and Phoebius prediction 
CG number SignalP Phoebius 
 Prediction Signal peptide Transmembrane 
CG14010-PA Non-secretory protein no yes 
CG11320-PB Signal peptide yes no 
CG14521-PA Signal peptide yes yes/no 
CG31646-PA Signal anchor yes/no yes/no 
CG32791-PA Signal peptide yes yes/no 
CG40378-PA Non-secretory protein no no 
CG34391-PC Non-secretory protein no no 
CG42343-PC Non-secretory protein no yes 
Result of the SignalP and Phoebius prediction of 9 genes with three Ig-like domains and the highest 
similarity to CG31708 and CG42368 are summarized for the presence of signal peptides, signal 
anchors and transmembrane domains. Signal peptides are about 19 amino acid long sequences at the 
N-terminus of proteins and are important for the localization to the endoplasmatic reticulum. A signal 
anchor indicates a single pass transmembrane protein. If the protein has neither a signal peptide nor a 
signal anchor it is predicted to be a non secretory protein. 
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5.3.2. Supplementary Figures 
 
 
Supplementary Figure 33 - Phylogentic trees of the Ig-domains of Drosophila proteins 
harboring three Ig-domains 
Analysis of all Drosophila proteins with exactly 3 Ig-like domains using ClustalW followed by 
PHYML (www. mobyle.pasteur): the Ig-like domains were analyzed separately and phylogentic trees 
have been generated based on the result (a) The result of the1st Ig-domain. (b) The result of the 2nd Ig-
domain. (c) The result of the 3rd
 
 Ig-domain. The red boxes indicate the cluster of 10 genes around 
CG31708 (Uhu). CG42368 is always the closest relative to Uhu. The Scalebar represents the branch 
length and is relative to the number of changes within the sequence. 
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Supplementary Figure 34 - result of the ProteinArchitect analysis for CG31708 and the 
10 closest relatives 
The protein sequences of Uhu and its closest relatives were analyzed using the online tool 
ProteinArchitekt (http://www.proteinarchitect.net). This program compares protein sequences on 
multiple levels and gives a representative visualization of the relationship between these sequences. 
This analysis showed that Uhu and CG42368 are closely related and have the same order and types of 
Ig-like domains. None of the other proteins showed this order of Ig-like domains. 
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